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RecQ-like proteins are a family of DNA helicases that are evolutionary conserved from 
prokaryotes to eukaryotes. A large amount of experimental evidence suggests these 
proteins have a major role in the maintenance of genome stability. In humans five 
RecQ-like helicase have been identified (RecQL1, BLM, WRN, RecQL4, and RecQL5), 
three of which are associated with rare genetic disorders with sever chromosomal and 
developmental abnormalities, and an elevated predisposition to cancer. Among the 
disease associated RecQ-like helicases, BLM and WRN have been subject to extensive 
research, while our collective knowledge about the function of RecQL4 is still very 
limited. Similarly, little is known about the role of RecQL1 and RecQL5 in maintenance of 
genome integrity. In the past studies of Sgs1, the Saccharomyces cerevisiae homolog of 
RecQ, have been very informative regarding BLM function. Thus, here we sought to 
further investigate BLM, RecQL1, and RecQL4 by using yeast as a model. By 
constructing humanized yeast strains we evaluated the ability of these genes to 
complement defects observed in sgs1∆. In Chapter 2, our investigation led to the 
development of a novel chimeric system, which was able to complement some defects 
of the sgs1∆ strain. In Chapter 3, by taking advantage of this chimeric system, we 
evaluated 41 known BLM variants identified in the general human population. This study 
resulted in identification of six novel variants that completely impaired BLM function and 
three novel variants that partially impaired BLM function. In Chapter 4 we conducted 
multiple yeast 2-hybrid screens in search for novel protein-protein interaction for RecQL1 
and RecQL4. We have identified two new putatively interacting partners for RecQL1 and 
  xv 
three putatively interacting partners for RecQL4. In Chapter 5, functional characterization 
of RecQL1, BLM, RecQL4 and RecQL5 in yeast suggested genetic interaction between 
BLM and RecQL4 and RecQL5. Finally, in Chapter 6 a random mutagenesis screen of 
BLM has led to identification a mutation that impairs BLM function by disrupting the 
HRDC domain. This mutant suggests that the HRDC domain of BLM has an important 
role in proper functionality of this helicase. 
  






CHAPTER 1:  
HISTORY OF THE RECQ-LIKE FAMILY OF DNA HELICASES 
 
The human genome encodes for 95 non-redundant helicase proteins, of which 
64 are RNA helicases and 31 are DNA helicases. The RecQ-like, MCM, and RuvB-like 
helicases are among the 31 DNA helicases. The identification of a group of helicases in 
humans and their homologs in other model organisms suggests that the primary 
members of helicase families are highly conserved throughout evolution (Umate, Tuteja 
et al. 2011).  
Discovery 
In 1984, the Nakayama group conducted a screen for mutations that conferred 
resistance to thymine starvation in Escherichia coli. They identified a mutant that 
exhibited an increased sensitivity to ultraviolet radiation and named the gene responsible 
“recQ” (Nakayama, Nakayama et al. 1984). Since its discovery, proteins identified in 
various organisms with high homology to this DNA helicase have been collectively 
referred to as the RecQ-like family. The RecQ-like DNA helicases are evolutionarily 
conserved in both prokaryotes and eukaryotes. To date, more than 60 members of this 
family have been identified in different organisms, including bacteria (E. coli), fungi 
(Saccharomyces cerevisiae, Schizosaccharomyces pombe, Neurospora crassa), plants 
(Arabidopsis thaliana) and animals (Caenorhabditis elegans, Drosophila melanogaster, 
Xenopus laevis, Mus musculus, Homo sapians). 
  2 
Similar to E.coli, the yeast S. cerevisiae has one known member of this helicase 
family, Sgs1. In contrast, five homologs of the RecQ helicases have been identified in 
humans. Moreover, some plant species (Arabidopsis thaliana) have as many as seven 
RecQ homologs (Hartung, Plchova et al. 2000). Figure 1.1 provides a visual 
representation of members of the RecQ-like family found in E.coli, S. cerevisiae, and 
humans while identifying key conserved regions and domains.  
 
 
Figure 1.1. Select members of the RecQ-like family of helicases 
RecQ-like family members identified in bacteria (RecQ), fungi (Sgs1), and humans 
(RecQL1, BLM, WRN, RECQL4, and RECQL5). The conserved helicase domain is used 
for alignment of the proteins, shown in red. The two other conserved RecQ-helicase-
conserved (RQC) and Helicase/RNase D C-terminal (HRDC) domains are shown in 
green and violet, respectively. The exonuclease domain in the N-terminal region of WRN 
is shown in navy blue. Regions of acidic residues are shown in black. The nuclear 
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Conserved domains of RecQ-Like members 
Although the details of the molecular function of the RecQ-like family are not yet 
clear, it is widely accepted that these proteins have a role in the maintenance of genome 
stability and function at the interface between DNA replication and repair. This 
hypothesis is derived from the knowledge acquired over the past 30 years about this 
family of helicases. 
RecQ-like proteins are part of a larger helicase family called Superfamily 2 (SF2). 
The SF2 proteins are the largest superfamily and function in a variety of cellular 
processes (Singleton, Dillingham et al. 2007). The members of the RecQ-like family all 
share the seven-motif helicase domain (motifs I, Ia, II, III, IV, V, and VI) (Figure 1.1) 
found in both helicase Superfamilies 1 and 2.  In addition, the RecQ-like proteins 
possess a conserved motif upstream of motif I, referred to as motif 0 that is only found in 
the SF2 family (Bernstein and Keck 2003).  
The function of most of the motifs in the helicase domain have been identified, 
either directly or by extrapolation, based on similarities to other proteins. For instance, 
due to the high degree of similarity between motif 0 and the Q motif of the DEAD-box 
RNA helicase (another member of the SF2 superfamily), characterization of the Q motif 
has helped elucidate function of motif 0. As demonstrated by Tanner et.al (2003), this 
motif assists in NTP binding and hydrolysis (Tanner, Cordin et al. 2003). Examination of 
the crystal structure of the catalytic core of E.coli RecQ reveals that motif 0 creates a 
pocket by which it accommodates ATP binding more efficiently than other NTP 
molecules (Bernstein, Zittel et al. 2003). This finding correlates well with the fact that 
RecQ of E.coli prefers ATP as a cofactor (Umezu, Nakayama et al. 1990). 
  
  4 
 
Figure 1.2. Three-dimensional structure of the RecQL1 helicase core 
The helicase core is comprised of the helicase domain and the RQC domain. The 
helicase domain forms two lobes, denoted as lobe 1 and lobe 2 shown here in purple 
and green respectively. A linker region indicated by a solid oval connects lobes 1 and 2. 
The RQC domain is comprised of the zinc-binding subdomain (shown in yellow) and the 
winged-helix subdomain (shown in orange). Included in this illustration are, the ADP 
molecule in pink, Mg2+ as a yellow sphere, and Zn2+ as a red sphere. Similar domain 
structure is present in RecQ, Sgs1, RecQL1, and BLM. Illustration modified from 
(Bernstein, Zittel et al. 2003; Bernstein and Keck 2005). 
 
Motifs I and II, most commonly known as Walker A and Walker B motifs, 
respectively, are conserved among many proteins with ATP hydrolysis function (Walker, 
Saraste et al. 1982; Ye, Osborne et al. 2004).  Motifs I and II play a crucial role in 
coordinating a Mg2+ ion adjacent to the ATP molecule (Ye, Osborne et al. 2004). The 
combination of the phosphate binding loop formed by motif I, the interaction of the DExH 
domain of motif II with ATP, and coordination of the Mg2+ ion by both motifs is required 
for ATP hydrolysis. Distal to the Walker B motif (motif II) is an aromatic rich loop region 
(AR loop). The AR loop, originally described in the helicase PcrA, has been 
Lobe 1 Lobe 2 
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demonstrated to have an important role in the coupling of ATP hydrolysis to DNA binding 
and unwinding. (Dillingham, Soultanas et al. 1999; Velankar, Soultanas et al. 1999; 
Dillingham, Soultanas et al. 2001). Motif VI has an arginine finger, which can be used to 
communicate between the RecA-like domains of helicases.  In the SF1 superfamily, this 
arginine finger reaches into the ATP binding pocket and interacts with ATP. In RecQ-like 
proteins, the arginine finger, in combination with the linker between the two lobes of the 
helicase domain (Figure 1.2), could play a role in assisting with binding and hydrolysis of 
ATP (Soultanas, Dillingham et al. 1999; Velankar, Soultanas et al. 1999; Killoran and 
Keck 2006). 
Motif Ia, which resides between the two Walker motifs, in collaboration with 
motifs III and V, has been demonstrated to have role in single strand DNA (ssDNA) 
annealing as determined by structural analysis (Korolev, Hsieh et al. 1997; Korolev, Yao 
et al. 1998; Dillingham, Soultanas et al. 2001). Although very little is known about the 
exact role of motif IV, it is hypothesized to have a role in stabilizing the helicase core and 
assisting in DNA binding. 
In addition to the helicase domain, most members of the RecQ-like family also 
have a RecQ-helicase-conserved (RQC) domain and/or a Helicase/RNase D C-terminal 
(HRDC) domain (Figure 1.1). The RQC domain and the helicase domain make up the 
helicase core (Figure 1.2). The RQC domain is comprised of the zinc-binding and the 
winged-helix (WH) subdomains. The zinc-binding subdomain consists of four conserved 
cysteine residues, which together coordinate a zinc ion making a scaffold, which is 
fundamental to the structural stability of the protein (Bernstein, Zittel et al. 2003; 
Janscak, Garcia et al. 2003). In contrast, the WH subdomain appears to have varying 
functions in different members of the RecQ-like family. Kitano et al., has demonstrated 
that the WH subdomain plays a major role in binding and unwinding of DNA in the WRN 
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helicase (Kitano, Kim et al. 2010). The authors illustrated that in the WRN helicase the 
unwinding of the DNA double helix relies mostly on the RQC domain rather than the 
helicase domain. However, in BLM, helicase activity is not impaired in the absence of 
the WH subdomain (Gyimesi, Harami et al. 2012).  
The exact function of the HRDC domain has not yet been established. Studies 
from some groups have shown that this domain is not required for Sgs1 function, or 
unwinding activity of BLM (Mullen, Kaliraman et al. 2000; Mirzaei, Syed et al. 2011; 
Gyimesi, Harami et al. 2012). In contrast, others have demonstrated that the BLM HRDC 
domain has an important role in the dissolution of the double Holliday junctions (Wu, 
Chan et al. 2005; Kim and Choi 2010). The three-dimensional structure of the yeast 
Sgs1 HRDC domain determined by NMR spectroscopy shows a structural scaffold 
resembling auxiliary domains in proteins that are involved in DNA metabolism. Liu et al. 
suggest that the HRDC domain of Sgs1 could function in regulation of the helicase 
activity by providing additional contact with DNA (Liu, Macias et al. 1999).  
In S. cerevisiae Sgs1 and E. coli RecQ, the HRDC domain preferentially binds 
ssDNA. In contrast, the same domain in human WRN cannot bind ssDNA (Bernstein and 
Keck 2005; Kitano, Yoshihara et al. 2007). Moreover, three-dimensional structure 
analysis of the BLM HRDC domain by NMR reveals that, similar to Sgs1 and RecQ, the 
BLM HRDC domain preferentially binds ssDNA. However, analysis of the affinity of each 
of the HRDC domain in each of the three helicases (RecQ, Sgs1, and BLM) indicates 
that E. coli RecQ has the highest affinity for ssDNA, while BLM has the lowest affinity 
(Kim and Choi 2010).  
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The Escherichia coli RecQ 
The RECQ gene of E.coli is 1830 bp in length, which encodes a 609-residue 
protein with a molecular weight of 68 kDa. This protein is an ATP-dependent DNA 
helicase with 3’ to 5’ polarity (Umezu, Nakayama et al. 1990) and was discovered as a 
component of the RecF recombinational pathway (Nakayama, Nakayama et al. 1984). 
Aside from its helicase activity, this protein enhances the activity of topoisomerase III 
while unwinding, resulting in enhanced supercoiling and catenation of covalently closed 
DNA (Harmon, DiGate et al. 1999). As described by Hanada et al., this DNA helicase 
also functions in blocking illegitimate recombination (Hanada, Ukita et al. 1997). 
Furthermore, the activity of this protein is dependent on an Mg2+ ion and single strand 
binding protein (SSB) (Harmon and Kowalczykowski 2001; Xu, Deprez et al. 2003). 
RecQ has been shown to initiate SOS signaling when aiding in clearing of blocked 
replication forks (Hishida, Han et al. 2004). The downstream affect of initiation of the 
SOS signal leads to arrest of cell cycle progression followed by activation of various 
other downstream pathways required for DNA repair (Radman 1975; Luchnik 1979). The 
current model for the role of RecQ consists of two parts. First, by disruption of RecA 
filament and D-loops, this helicase prevents illegitimate recombination (Figure 1.3). Next, 
by assisting in removal of secondary DNA structures (or obstacles) in front of the 
replication fork, this protein may help in restart of collapsed and stalled replication forks. 
This task is further facilitated by the genetic interaction between RecQ and TopIII 
(Figure 1.4).   
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Figure 1.3. Disruption of homologous recombination (HR) intermediates by 
RecQ-like helicases 
In vitro analyses have demonstrated RecQ, BLM, and Sgs1 are able to disrupt HR at 
crucial steps. (A) Disruption of the nucleoprotein filament. (B) Disruption of D-loop 
formation. Illustration adopted from Bugreev, Mazina et al., (2009). 
 
The Bernstein group has successfully crystalized the helicase core (comprising 
the helicase domain and the RQC domain) as well as the HRDC domain (Bernstein, 
Zittel et al. 2003; Bernstein and Keck 2005). The crystal structure revealed that the 
catalytic core of this protein is composed of four subdomains (Figure 1.2). The first two 
subdomains form the two lobes of the conserved helicase domain while the second two 
subdomains together form the conserved RQC domain consisting of the zinc-binding 
subdomain and the WH subdomain (Bernstein, Zittel et al. 2003). 
A 
B 
RecA, RPA,  or Rad51 
RecQ, Sgs1, or BLM 
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Figure 1.4. DNA structures processed by RecQ-like homologs 
In vitro studies have demonstrated the ability of some members of the RecQ-like family 
to unwind secondary DNA structures and to process stalled replication forks. Green 
arrows indicate involvement of RecQ-like proteins while purple arrows indicate 
processing in absence of RecQ-like proteins. (A) The resolution of DNA secondary 
structures such as hairpins and G-quadruplexes. (B) The replication fork encountering a 
blockage (shown in orange), which can be resolved by using the newly synthesized 
strand as template to process through the blockage. (C) In the absence of RecQ-like 
proteins, nicks and blocks could lead to replication fork collapse. The homologous 
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The Saccharomyces cerevisiae RecQ-like helicase 
Similar to E.coli, S. cerevisiae only has one known RecQ homolog named Sgs1 
(Slow Growth Suppressor 1). The 4344 bp long SGS1 gene encodes a 1447 residue 
protein with a molecular weight of 163 kDa. Similar to RecQ of E.coli, the encoded 
protein is a DNA helicase with 3’ to 5’ polarity (Bennett, Sharp et al. 1998). Sgs1 is most 
closely related to the human BLM protein, which has led discoveries in Sgs1 to help 
better understand many aspects of the BLM protein. 
Sgs1 was first discovered when an sgs1 mutant strain suppressed the slow 
growth observed in a top3 mutant strain (Gangloff, McDonald et al. 1994). Top3 is a 
type IA topoisomerase and is able to relax negatively supercoiled DNA.  This unique 
interaction observed between Sgs1 and Top3 is evolutionarily conserved. First identified 
as a genetic interaction in E.coli (Harmon, DiGate et al. 1999), in eukaryotes Sgs1 and 
Top3 have evolved to physically interact (Gangloff, McDonald et al. 1994; Bennett, 
Noirot-Gros et al. 2000; Johnson, Lombard et al. 2000; Fricke, Kaliraman et al. 2001).  
An sgs1∆ mutant strain exhibits hypersensitivity when exposed to the DNA 
damaging agent’s methyl methanesulfonate (MMS) or hydroxyurea (HU) (Yamagata, 
Kato et al. 1998; Frei and Gasser 2000; Mirzaei, Syed et al. 2011). Upon treatment with 
HU and MMS, Sgs1 has been shown to localize to stalled replication forks and physically 
interact with Top3, Rmi1, and Rad53. This observation suggests that Sgs1 plays a role 
in aiding with the restart of stalled replication forks (Frei and Gasser 2000). Moreover, 
studies from the Brill laboratory have shown that there is a separation of function 
between the amino terminus and the carboxyl terminus of the Sgs1 protein. They 
demonstrated that the N-terminus is required for physical interaction with Top3 and has 
no apparent catalytic function, whereas the C-terminal helicase domain is responsible for 
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all catalytic activity. Nevertheless, both the C- and N-terminus are required for proper 
function of this protein (Mullen, Kaliraman et al. 2000). 
Similar to Bloom’s syndrome cells, sgs1∆ cells exhibit defective chromosome 
segregation during mitosis and meiosis (Watt, Louis et al. 1995; Watt, Hickson et al. 
1996). They also exhibit hyper-recombination between homologous chromosomes, 
unequal sister chromatid recombination (Onoda, Seki et al. 2000), a moderate increase 
in the rate of gross chromosomal rearrangement (Myung, Datta et al. 2001; Schmidt and 
Kolodner 2006), and illegitimate recombination (Yamagata, Kato et al. 1998). In addition, 
sgs1 mutants have a slightly suppressed growth rate and exhibit signs of premature 
aging (Watt, Louis et al. 1995; Watt, Hickson et al. 1996; Sinclair, Mills et al. 1997). 
The illegitimate recombination and hyper-recombination phenotype observed in 
sgs1∆ cells is attributed to the absence of anti-recombinase activity normally associated 
with Sgs1, similar to RecQ of E. coli and BLM (Gangloff, McDonald et al. 1994; Watt, 
Hickson et al. 1996; Hanada, Ukita et al. 1997; Oh, Lao et al. 2007).  
Sgs1 has also been demonstrated to play a role in processing double strand 
breaks (DSBs) by aiding in resection and generation of ssDNA overhangs (Figure 1.5). 
After recognition of the DSB by the MRX (Mre11, Rad50, Xrs2) complex, Sae2 in 
collaboration with the MRX complex minimally process the break site producing 
substrates for further resection by Exo1 or Sgs1/Dna2 (Mimitou and Symington 2008; 
Cejka, Cannavo et al. 2010). In the proposed model, Sgs1 unwinds the DNA in the 
presence of replication protein A (RPA) while exonuclease activity of Dna2 degrades the 
5’ end of DNA. 
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Figure 1.5. Resection by Sgs1/Dna2  
This model demonstrates resection of the DNA at the site of DSB by collaboration 
between Sgs1, Dna2, and RPA. In addition, provides an illustration of genetic interaction 
between Sgs1/Dna2, Sae2 and Exo1. After recognition of a DSB by the MRX complex, 
Sae2 collaborates with MRX to trim the ends of the break producing a substrate for Exo1 
and Sgs1/Dna2. Illustration modified from Mimitou and Symington (2008). 
 
In eukaryotes, DSBs are repaired by two major pathways: non-homologous end 
joining (NHEJ) and homologous recombination (HR). In NHEJ, which is mostly active 
during G1 phase of the cell cycle, the two ends of the break are minimally processed 
and re-ligated. This type of repair is error-prone and can result in frame shifts. In 
contrast, the HR pathway is considered mostly error-proof. HR pathway can be 
subdivided into separate pathways, Synthesis Dependent Strand Annealing (SDSA) and 
Double Strand Break Repair (DSBR). The main difference between the two pathways is 
that repair by SDSA always results in non-crossover products (Figure 1.6). However, if 
repair is completed by the DSBR, the resulting double Holliday junctions have a 50% 
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Figure 1.6. Double strand break repair by homologous recombination  
After the ends of the site of DSB have been processed, the 3’ overhang invades a donor 
molecule with the help of Rad51, the resulting D-loop is hypothesized to be processed in 
one or all of the three possible models demonstrated here. The blue arrows illustrate a 
path referred to as the Synthesis Dependent Strand Annealing (SDSA), the outcome of 
which is always non-crossover products. In contrast, the red arrows show the path to 
traditional repair by formation of a double Holliday junction, resolution of which can lead 
to either non-crossover or crossover products. Last, the orange arrows show the path to 
dissolution of the double Holliday junctions leading to only non-crossover products. BLM 
and Sgs1 are thought to be involved in all three pathways but have a more important 
role in SDSA pathway and those resulting in dissolution of double Holliday junction 
leading to non-crossover products of the DSBR pathway. Green arrows represent Sgs1 
or BLM while pink arrow represents Top3 or TopIIIα. 
 
Sgs1 (and BLM) has been implicated in the dissolution of double Holliday 
junctions (an intermediate of the DSBR pathway, Figure 1.6) leading to non-crossover 
products. Although the details of the mechanism behind dissolution of double Holliday 
junctions are not well understood, one model suggests that Sgs1 (and BLM) using 
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merged, Top3 (or TopIIIα in humans) is able to decatenate and separate the two DNA 
molecules (Wu and Hickson 2003; Johnson-Schlitz and Engels 2006; Branzei and Foiani 
2007; Cejka, Cannavo et al. 2010). The Sgs1-Top3-Rmi1 complex is thought to be 
responsible for this process in yeast. In humans, the BLM-TopIIIα-Rmi1/Rmi2 complex 
(BRT) preforms this task (Ira, Malkova et al. 2003; Wu and Hickson 2003; Branzei and 
Foiani 2007).  More recently, biochemical studies have led to the hypothesis that Sgs1 
(and probably BLM) aid in processing DSBs by repair through the SDSA pathway 
(Figure 1.6). After formation of the D-loop and the joint molecule, the donor molecule is 
used as template for synthesis of new DNA. Sgs1 assists by first unwinding the donor 
DNA in front of the replication machinery and then by separating the two DNA molecules 
after enough DNA has been synthesized.  This process always results in non-crossover 
products (Ira, Malkova et al. 2003; Cejka, Cannavo et al. 2010). The hypothesis is 
further strengthened by the presence of elevated levels of sister chromatid exchange 
and a shift towards crossover products in both sgs1∆ strains and BS cells. 
Aside from Sgs1’s involvement in mediating repair of DSBs and the restart of 
stalled replication forks, it has been suggested that Sgs1 might have a role in the 
Alternative Lengthening of Telomeres (ALT) pathway. The ALT pathway also relies on 
the HR machinery, and therefore it is hypothesized to involve Sgs1 (Cohen and Sinclair 
2001; Johnson, Marciniak et al. 2001). The ALT repair pathway has two distinct products 
referred to as type I and II. In type I repair, products are the result of subtelomeric 
Y` element amplification while in type II products are the result of amplification of 
TG-telomeric repeats. Sgs1 is assumed to have a role in bypassing cellular senescence 
due to faulty telomerase by aiding in elongation of the TG-telomeric repeats (Cohen and 
Sinclair 2001; Johnson, Marciniak et al. 2001).  
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The Human RecQ-like homologs 
Five homologs of the RecQ protein have been identified in humans: RecQL1, 
BLM (RecQL2), WRN (RecQL3), RecQL4, and RecQL5 (Umate, Tuteja et al. 2011). 
These five DNA helicases can be categorized into two classes based on protein size. 
The smaller class is comprised of RecQL1 and RecQL5 (649 and 991 amino acids, 
respectively) while the larger class is comprised of BLM, WRN and RecQL4 (1,417, 
1,432 and 1,208 amino acids, respectively) (Umate, Tuteja et al. 2011). Interestingly, the 
three RecQ-like proteins in the larger class are all associated with known genetic 
disorders, while no diseases have yet been associated with members of the smaller 
class. Defects in the BLM gene are associated with Bloom’s syndrome, while deleterious 
mutations in the WRN gene are associated with Werner syndrome (Bachrati and 
Hickson 2003). RecQL4 has been associated with three syndromes: RAPADILINO 
syndrome, Baller-Gerold syndrome and Rothmund-Thomson syndrome (Dietschy, 
Shevelev et al. 2007).  
Bloom’s syndrome (BS) 
Bloom’s syndrome (OMIM 210900)1 was first discovered and described in 1954 
by David Bloom, a doctor of dermatology (Bloom 1954). Dr. Bloom described his patient 
as a dwarf with a congenital telangiectatic erythema of the face resembling lupus 
erythematosus and hypersensitivity to sunlight. The identification of two other patients 
with almost identical characteristics including hypersensitivity to sunlight and butterfly-
shaped rash across the nose and cheeks, suggested a possibility of a syndrome entity 
(Bloom 1954).  
                                                
1 Online Mendelian Inheritance in Man, http://omim.org 
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Since the discovery, 264 individuals have been diagnosed with this disease 
(Ellis, Sander et al. 2008). BS caused by inactivation of the BLM gene, is an autosomal 
recessive disorder with a founder effect identified in the Ashkenazi Jew population, 
designated as BLMAsh. The BLMAsh mutation is present in the homozygous state in 
almost all BS cases amongst this group, with a very high carrier frequency of 1%. This 
allele is a result of a frame shift mutation caused by a six base deletion and a seven 
base insertion upstream of the helicase domain (Straughen, Johnson et al. 1998). 
BS is characterized by sun-sensitivity, proportionate pre- and postnatal growth 
deficiency, telangiectatic erythema, hypopigmentation and hyperpigmentation, immune 
deficiencies, infertility or subfertility, and an elevated predisposition to cancer (Sanz and 
German 1993). Figure 1.7 provides a few examples of the symptoms observed in BS 
individuals.  Other complications observed in individuals with BS include gastro 
esophageal reflux, infection of the upper respiratory tract, middle ear infection, lung 
infection, and type-II diabetes (Chaganti and German 1974; Sanz and German 1993; 
Ellis and German 1996; Bachrati and Hickson 2003; Hickson 2003; Wu and Hickson 
2003).  
At the cellular level, BS cells present chromosomal instability in the form of 
chromosomal breaks and gaps, structurally rearranged chromosomes, symmetrical 
quadriradial configurations, translocations, telomere-associated breaks, lagging 
chromosomal fragments, and an elevated level of sister chromatid exchange (Figure 1.8) 
(Chaganti, Schonber.S et al. 1974; German, Crippa et al. 1974). Both, elevated sister 
chromatid exchange and formation of quadriradials are used as diagnostic tools for BS 
(Sanz and German 1993) 
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Figure 1.7. Select clinical features observed in Bloom’s syndrome individuals. 
 (A) Proportional dwarfism shown amongst two brothers. The one on the left has BS 
while the brother on the right is unaffected (B) Hallmark butterfly-shaped rash across the 
nose and cheeks (C) Hypopigmentation of the skin (D and E) congenital telangiectatic 
erythema Photographs obtained from The Bloom’s Syndrome Registry2 and free online 
collections (Bloom 1954; Sanz and German 1993). 
 
. 
                                                
2 http://med.cornell.edu/bsr/ 
A B C 
D E 
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Figure 1.8. Chromosomal abnormalities observed in Bloom’s syndrome cells 
(A) Chromosomal breaks. (B) Formation of symmetrical quadriradial configurations. (C) 
Elevated level of sister chromatid exchange. (D) Normal levels of sister chromatid 
exchange. (E) Chromosomal translocation. Photographs obtained from The Bloom’s 
Syndrome Registry 3  and Carcinogenic Risk In Occupational Settings (CRIOS) 4 
(Chaganti, Schonber.S et al. 1974; German, Crippa et al. 1974) 
 
Although the exact function of BLM and the underlying cellular mechanism for the 
appearance of chromosomal abnormalities observed in BS are unknown, in vivo and 
in vitro studies have provided some explanation. As described earlier, appearance of 
hyper- and illegitimate recombination observed in BS cells is thought to be the result of 
the absence of anti-recombinase activity attributed to BLM (Gangloff, McDonald et al. 
1994; Watt, Hickson et al. 1996). Evidence for BLM’s anti-recombinase activity is 
provided by in vitro analysis, demonstrating BLM’s ability to disrupt homologous 
recombination at two crucial steps of nucleoprotein filament and D-loop formation 
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(Figure 1.3A and B) (van Brabant, Ye et al. 2000; Bachrati, Borts et al. 2006; Bugreev, 
Yu et al. 2007; Bugreev, Mazina et al. 2009). Briefly, Rad51 (a homolog of E.coli RecA) 
forms a filament on the processed ssDNA at the site of a DSB. This nucleoprotein 
filament is responsible for homology search and strand exchange (Park, Yoo et al. 
2008), and can be displaced by BLM, thus preventing the initiation of homologous 
recombination. Surprisingly, BLM has also been shown to stimulate Rad51 DNA 
exchange activity depending on whether Rad51 is in the active ATP-bound or the 
inactive ADP-bound form (Bugreev, Mazina et al. 2009). When Rad51 is in its inactive 
form, BLM disrupts the filament; however, in the active form of Rad51, BLM interaction 
with Rad51 stimulates DNA pairing (Bugreev, Mazina et al. 2009). Stimulation of Rad51 
DNA pairing can be explained by the role of BLM in SDSA. It is hypothesized that similar 
to Sgs1, BLM plays an important role in SDSA during which it aids formation of the joint 
molecule and later helps by separating the two DNA molecules (Figure 1.6). This 
function of BLM could explain the elevated sister chromatid exchange observed in BS 
cells, which could be due to an increase in percent of crossover products when 
non-crossover-yielding pathways are impaired in the absence of BLM.  
Moreover, BLM has been demonstrated to promote Holliday junction branch 
migration (Karow, Constantinou et al. 2000). Similar to Sgs1, BLM in complex with 
TopIIIα and Rmi1/Rmi2 has been shown to be important in dissolution of double Holliday 
junctions, resulting in non-crossover products (Figure 1.6) (Wu, Davies et al. 2001; Wu 
and Hickson 2003; Yin, Sobeck et al. 2005; Raynard, Zhao et al. 2008). An elevated rate 
of sister chromatid exchange observed in BS cells could also be explained partly due to 
resolution of double Holliday junctions resulting in crossover products in the absence of 
a functional BLM. Aside from BLM’s function in association with homologous 
recombination machinery, in vitro studies have identified this proteins ability to unwind 
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various DNA structures including those that may be encountered by moving replication 
forks such as G-quadruplexes, hairpin structures (Figure1.4) (Karow, Chakraverty et al. 
1997; Wu and Hickson 2003; Popuri, Bachrati et al. 2008). 
Syndromes associated with RecQL4 defects 
Defects in RecQL4 have been associated with three syndromes: RAPADILINO 
syndrome, Baller-Gerold syndrome (BGS), and Rothmund-Thomson syndrome (RTS), 
though there is some debate regarding whether they are actually variations of the same 
disorder. This uncertainty is due to the fact that defects in RecQL4 specifically are 
responsible for most reported cases of all three syndromes and because all three are 
characterized by skeletal abnormalities, radial ray defects, growth deficiency, facial 
dysmorphia, gastro-intestinal disturbance, and patellar abnormalities. RAPADILINO and 
RTS individuals also present a higher occurrence of osteosarcoma in addition to the 
above symptoms (Van Maldergem, Siitonen et al. 2006) (Figure 1.9). 
Baller-Gerold syndrome (OMIM 218600) is a rare autosomal recessive disorder 
characterized by radial aplasia/hypoplasia and craniosynostosis (premature fusion of 
certain skull bones). BGS was named after Baller and Gerold who described the first 
patients with radial hypoplasia associated with craniosynostosis in 1950 and 1959, 
respectively (Van Maldergem, Siitonen et al. 2006; Siitonen, Sotkasiira et al. 2009). 
Since the discovery, fewer than 20 cases of BGS have been reported, possibly 
due to significant clinical overlap between BGS and other RecQL4-related syndromes 
(RAPADILINO and Rothmund-Thomson syndrome) and non-RecQL4-related disorders 
such as Fanconi anemia (OMIM 227650). Some of the overlapping Fanconi anemia 
symptoms include: growth retardation, skeletal abnormalities, and radial ray defects.  
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Figure 1.9. clinical features associated with RecQL4 Syndromes 
Clinical features and overlaps associated with of the three syndromes caused by defects 
in RecQL4. RecQL4 associated syndromes are RAPADILINO syndrome, Baller-Gerold 
syndrome (BGS), and Rothmund-Thomson syndrome (RTS).   
 
Rothmund-Thomson syndrome (OMIM 268400) was first described in 1868 by 
German ophthalmologist Auguste Rothmund. At the time he was treating individuals of 
an inbred family who presented a peculiar rash and bilateral juvenile cataracts (Wang, 
Levy et al. 2001; Siitonen, Sotkasiira et al. 2009). In addition to the clinical symptoms 
shared with RAPADILINO, RTS individuals present skeletal defects, dystrophic nails, 
abnormal teeth, and cataracts. To varying degrees, they also show sensitivity to sunlight. 
In some cases, radial ray hypoplasia or absent thumbs are observed (Wang, Levy et al. 
2001). Clinical diagnosis of RTS relies predominately on the poikilodermatous rash. In 
the event that onset or distribution of poikiloderma is atypical, diagnosis relies on two 
additional features such as bone abnormalities, cataracts, or osteosarcoma (Wang, Levy 
et al. 2001). Among all the reported cases of RTS, 60% are the result of a mutation in 
!!!!
skeletal abnormalities 
Radial ray defects 
Growth deficiency 
Facial dysmorphia 
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Joint dislocation 
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RecQL4, however the remaining 40% are a result of defects in unidentified genes 
(Wang, Levy et al. 2001).  
Similar to BGS and RTS, RAPADILINO syndrome (OMIM 266280) is a very rare 
autosomal recessive malformation syndrome. The name of this syndrome is an acronym 
referring to the main clinical features (Radial ray defect; Patellae hypoplasia or aplasia 
and cleft or highly arched palate; Diarrhea and dislocated joints; Little size and limb 
malformation; Nose slender and normal intelligence) observed in individuals with 
RAPADILINO (Siitonen, Kopra et al. 2003).  Similar to BGS, fewer than 20 individuals 
have been reported with this disorder. Interestingly, 14 of these patients have been 
diagnosed in Finland and only a few in other countries (Siitonen, Kopra et al. 2003).  
Currently there are two RecQL4 mutant mouse models: Model 1, which has an 
exon 13 deletion (Hoki, Araki et al. 2003), and Model 2, which is missing exons 9 to 13 
(Mann, Hodges et al. 2005).  Evaluation of the two mouse models has revealed that 
deletion of exon 13 (a hot spot for RTS causing mutations) is far more detrimental to the 
fate of the cell than deletion of exons 9 to 13; however, the reason for this difference is 
unclear. For Model 1, only 5% of mutant mice survived the first 14 days, in contrast to 
the 84% that survived to adulthood in Model 2 (Hoki, Araki et al. 2003; Mann, Hodges et 
al. 2005; Dietschy, Shevelev et al. 2007) 
Despite the multiple disorders attributed to RecQL4, very little is known about the 
cellular function and underlying mechanisms that result in these disorders. RecQL4 is 
the only one of the human RecQ-like homologs that possesses neither an RQC nor an 
HRDC domain. 
Original biochemical characterization of RecQL4 demonstrated only ATPase and 
strand annealing activities, but no detectable unwinding activity (Sharma, Doherty et al. 
2006). More recently, two independent studies of purified RecQL4 were able to display 
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weak helicase activity (Suzuki, Kohno et al. 2009; Xu and Liu 2009). The authors were 
only able to demonstrate helicase activity for RecQL4 in the presence of excess ssDNA, 
which trapped the released strands (Suzuki, Kohno et al. 2009; Xu and Liu 2009). In 
another study, it was demonstrated that the strand annealing activity of RecQL4 protein 
is independent of its DNA unwinding activity (Rossi, Ghosh et al. 2010).  
RecQL4 is highly expressed in the thymus and testis (Kitao, Ohsugi et al. 1998). 
Interestingly, the expression profile of RecQL4 throughout the cell cycle is very similar to 
yeast Sgs1 and BLM. All three helicases appear in S-phase, are maintained at similar 
levels through G2/M, but have mostly disappeared by the time cells re-enter G1 
(Dutertre, Ababou et al. 2000). Moreover, RecQL4 has been shown to not only 
physically interact with BLM, but also to stimulate the helicase activity of BLM on 
replication fork substrates in vitro (Singh, Popuri et al. 2012). Similarly, in vivo analysis 
has demonstrated that interaction between the two proteins is enhanced during S-phase 
in cells treated with ionizing radiation, reinforcing the evidence for interaction at DNA 
break sites or stalled replication forks (Singh, Popuri et al. 2012). In cells lacking BLM 
(BLM-/-) the presence of RecQL4 at the DNA break is shortened, and when RecQL4 is 
depleted in these cells the frequency of sister chromatid exchange increases in 
comparison to what is observed when RecQL4 is not depleted in BLM-/- cells (Singh, 
Popuri et al. 2012). In the same study, the authors demonstrate that the interaction 
between BLM and RecQL4 takes place at the N-terminus of both helicases (Singh, 
Popuri et al. 2012).     
Live cell imaging of tagged RecQL4 shows a nucleoplasmic localization that does 
not change in the presence of DNA-damaging agents (Woo, Futami et al. 2006). In 
contrast, BLM has been shown to relocate to specific foci after exposure to 
DNA-damaging agents to aid in the restart of stalled replication forks (Bischof, Kim et al. 
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2001). However, RecQL4 does respond to oxidative stress and localizes to the nucleolus 
(Woo, Futami et al. 2006). In response to oxidative damage, RecQL4 has been shown to 
interact with PARP1 [poly(ADP-ribose) polymerase-1]. PARP1 is a nuclear protein with 
dynamic roles in the regulation of transcription, replication, and DNA repair (Diefenbach 
and Burkle 2005). Moreover, nucleolus localization of RecQL4 is lost and RecQL4 
returns to a nucleoplasmic localization when cells are treated with PARP1 inhibitors 
even in the presence of oxidative damage (Woo, Futami et al. 2006), which further 
supports the notion that these proteins function in the same manner to overcome 
oxidative stress. It is not clear how RecQL4 aids in recovery from oxidative stress. 
Further more 
RecQL4 has also been suggested to be involved in repair of DNA DSBs. This 
hypothesis is based on the identification of RecQL4 in a complex with Rad51 upon 
induction of DSBs and the presence of RecQL4 foci in proximity of promyelocytic 
leukemia (PML) bodies (Petkovic, Dietschy et al. 2005). PML bodies have been 
previously demonstrated to be the sites of assembly for DSB repair proteins BLM, 
RAD51, MRE11 and p53 during late S-G2 phase (Bischof, Kim et al. 2001; Carbone, 
Pearson et al. 2002). More recently, it has been shown that RecQL4 deficient fibroblast 
cells are slightly more sensitive to gamma radiation and accumulate ɣH2AX. Moreover, 
upon live imaging of laser induced DNA damage, RecQL4 is recruited to damage sites 
prior to BLM and WRN, but does not remain at the site for as long as BLM and WRN 
(Singh, Karmakar et al. 2010). 
Mass spectrometry analysis of stably transfected FLAG-tagged RecQL4 in 293T 
cells places RecQL4 in complex with MCM10 and the MCM2-7 complex, which are 
replicative helicases important for assembly of the pre-replication complex and 
progression of the replication fork (Xu, Rochette et al. 2009). This interaction has been 
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further confirmed with the aid of co-immunoprecipitation of MCM10 and MCM7 with 
endogenous RecQL4 (Xu, Rochette et al. 2009). In the same study the authors 
demonstrate that RecQL4 interacts directly with MCM10 and this interaction regulates 
the unwinding activity of MCM10. Furthermore, the interaction between RecQL4 and the 
members of the MCM helicase complex is controlled by the cell cycle and limited to G1 
and S. This finding highlights RecQL4 as an essential component of the MCM complex 
and by extension suggests that RecQL4 plays a role in DNA replication (Xu, Rochette et 
al. 2009). 
 Additionally, in Xenopus laevis egg extracts it has been shown that 
immunodepletion of the RecQL4 homolog, xRTS, from egg extracts leads to reduction of 
chromatin replication. This phenotype can be rescued by expression of human RecQL4 
(Sangrithi, Bernal et al. 2005). Further investigation into the role of xRTS revealed a 
function to promote loading of replication factors at origins after formation of the 
pre-replication complex (Sangrithi, Bernal et al. 2005; Dietschy, Shevelev et al. 2007). 
Human RecQL1 
RecQL1 is the most abundant and the least studied of the human RecQ-like 
homologs (Kawabe, Tsuyama et al. 2000). Nevertheless, similar to other members of the 
RecQ-like family, it is hypothesized to function in DNA metabolism pathways. 
Biochemical analyses of RecQL1 have demonstrated that, in addition to possessing the 
canonical ssDNA annealing and helicase activity with 3’ to 5’ polarity, this helicase can 
unwind many structures including 5’ flaps, 3’ flaps, D-loops, and replication fork 
structures (Sharma, Sommers et al. 2005; Popuri, Bachrati et al. 2008).  
RecQL1 has been shown to have the ability to conduct branch migration and 
process Holliday junctions (LeRoy, Carroll et al. 2005; Bugreev, Brosh et al. 2008; 
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Popuri, Bachrati et al. 2008; Mazina, Rossi et al. 2012). A comparison of the branch 
migration efficiency of RecQL1 and RAD54 indicates that RAD54 is more efficient in 
promoting branch migration of homologous joint molecules. However, it has been 
hypothesized that RecQL1 has an advantage in driving Holliday junctions when 
encountering non-homologous sequences (LeRoy, Carroll et al. 2005; Mazina, Rossi et 
al. 2012).  
RecQL1 has also been identified to physically interact with Exo1 and mismatch 
repair factors MSH2/MSH6, MLH1/PMS2 (Doherty, Sharma et al. 2005). The authors 
utilized a candidate approach and identified interactions using both in vitro and 
overexpression analyses in HeLa cells (Doherty, Sharma et al. 2005). Identification of a 
physical interaction between RecQL1 and mismatch repair factors and Exo1 support the 
hypothesis that this helicase is involved in DNA metabolism pathways, in particular DNA 
damage repair. Mass spectrometry analysis has placed RecQL1 in association with 
PARP1. This interaction has been further confirmed by co-immunoprecipitation analysis 
of tagged RecQL1 and PARP1 (Sharma, Phatak et al. 2012). This finding indicates that, 
similar to RecQL4, RecQL1 may play a role in the oxidative stress response. 
When analyzing the oligomerization state of recombinant RecQL1, Cui et al. 
have provided evidence suggesting that this helicase functions as a dimer in solution 
(Cui, Arosio et al. 2004). Further analysis by the same group has demonstrated that 
RecQL1 physically interacts with replication protein A (RPA), an essential component of 
DNA metabolism. This interaction is shown to stimulate the helicase activity of RecQL1 
(Cui, Klima et al. 2003; Cui, Arosio et al. 2004). Other groups have shown RecQL1 also 
physically interacts with importin-α (also known as KPNA4 or Qip1) in a yeast-2 hybrid 
assay (Seki, Tada et al. 1997) and TopIIIα in co-immunoprecipitations from HeLa cells 
(Johnson, Lombard et al. 2000). 
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Lastly, although RecQL1 has not been linked to any disorder, a patient study 
conducted by the University of Texas, M.D. Anderson Cancer Center, to investigate 
whether or not variants in DNA repair genes influence the clinical outcome of pancreatic 
cancer has indicated a connection between RecQL1 and tumorigenesis. Patients were 
treated and monitored for tumor progression and for overall survival over a five-year 
period. Thirteen variants of eight DNA damage response and repair genes were 
compared in this study. Their results demonstrate that one variant of RecQL1 
(RECQL1-159) is associated with a poor prognosis and reduced pancreatic cancer 
survival (Li, Frazier et al. 2006). The patient studies conducted at the M.D. Anderson 
Cancer Center, together with the protein interacting partners discussed earlier and 
characterization of RecQL1 catalytic activity, support the hypothesis that RecQL1, 
similar to BLM and RecQL4, functions within DNA metabolism pathways.  
This dissertation aims to further expand our knowledge of the role of the human 
RecQ-like helicases, BLM, RecQL1 and RecQL4 by functional and mutational 
characterization of these proteins in a yeast model.  
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RecQ-like DNA helicases are conserved from bacteria to humans. They perform 
functions in the maintenance of genome stability, and their mutation is associated with 
cancer predisposition and premature aging syndromes in humans. Here, a series of 
C-terminal deletions and point mutations of Sgs1, the only RecQ-like helicase in yeast, 
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show that the Helicase/RNase D C-terminal domain and the Rad51 interaction domain 
are dispensable for Sgs1's role in suppressing genome instability, whereas the 
zinc-binding domain and the helicase domain are required. BLM expression from the 
native SGS1 promoter had no adverse effects on cell growth and was unable to 
complement any sgs1Δ defects. BLM over- expression, however, significantly increased 
the rate of accumulating gross- chromosomal rearrangements in a dosage-dependent 
manner and greatly exacerbated sensitivity to DNA-damaging agents. Co-expressing 
sgs1 truncations of up to 900 residues, lacking all known functional domains of Sgs1, 
suppressed the hydroxyurea sensitivity of BLM-overexpressing cells, suggesting a 
functional relationship between Sgs1 and BLM. Protein disorder prediction analysis of 
Sgs1 and BLM was used to produce a functional Sgs1-BLM chimera by replacing the 
N-terminus of BLM with the disordered N-terminus of Sgs1. The functionality of this 
chimera suggests that it is the disordered N-terminus, a site of protein binding and 
posttranslational modification that confers species specificity to these two RecQ-like 
proteins. 
Introduction  
RecQ-like DNA helicases, named after the DNA repair protein RecQ of 
Escherichia coli, (Hegde, Qin et al. 1996; Morimatsu and Kowalczykowski 2003; Ivancic-
Bace, Salaj-Smic et al. 2005) are evolutionarily highly conserved. These 3’ to 5’ 
helicases function at the interface between DNA replication and recombination to 
maintain genome integrity. Sgs1 is the only known member of this helicase family in 
Saccharomyces cerevisiae (Gangloff, McDonald et al. 1994). Sgs1-deficient cells show 
increased sensitivity to the DNA-damaging agents hydroxyurea (HU) and methyl 
methanesulfonate (MMS), missegregate chromosomes, accumulate gross-chromosomal 
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rearrangements (GCRs), and have a shortened life span (Sinclair, Mills et al. 1997; 
Mullen, Kaliraman et al. 2000; Fricke and Brill 2003; Schmidt, Wu et al. 2006). In 
contrast, five RecQ-like helicases (RecQL1, BLM, WRN, RecQL4, and RecQL5) are 
known in humans, and mutations in the BLM, WRN, and RECQL4 genes are associated 
with the rare, cancer-prone Bloom's syndrome (BS), Werner syndrome, and 
Rothmund-Thompson syndrome, respectively (Ellis, Groden et al. 1995; Yu, Oshima et 
al. 1996; Kitao, Ohsugi et al. 1998; Kitao, Shimamoto et al. 1999; German, Sanz et al. 
2007). All RecQ-like helicases share a seven-motif helicase domain with Walker A and 
DEAH motifs. The RecQ-helicase-conserved (RQC) domain, located C-terminal to the 
helicase domain, is thought to be involved in DNA binding and conferring specificity of 
binding to DNA structures, such as G4 tetrads (von Kobbe, Thoma et al. 2003; Guo, 
Rigolet et al. 2005; Lee, Kusumoto et al. 2005; Huber, Duquette et al. 2006). The 
Helicase/ RNase D C-terminal (HRDC) domain is the most C-terminal of the conserved 
domains and resembles domains in other proteins that are involved in nucleic acid 
metabolism, such as RNase D and UvrD; however, similar to the RQC domain, it is not 
found in all RecQ-like helicases (Morozov, Mushegian et al. 1997; Kitano, Yoshihara et 
al. 2007). The HRDC domain has been implicated in binding and resolving DNA 
structures, such as Holliday junctions, and in mediating protein-protein interactions (Liu, 
Macias et al. 1999; Bernstein and Keck 2005; Wu, Chan et al. 2005; Kitano, Yoshihara 
et al. 2007; Killoran and Keck 2008). Two acidic regions have also been identified 
N-terminal of the helicase domain and may be involved in mediating protein-protein 
interactions (Kitao, Ohsugi et al. 1998; Miyajima, Seki et al. 2000; Bernstein, Shor et al. 
2009). Sgs1 is found in a complex with Top3 and Rmi1, and there is also evidence of 
physical interactions of the N-terminal half of Sgs1 with Top2, Srs2, and Rad16 and 
interactions of the C-terminus with Mlh1 and Rad51(Watt, Louis et al. 1995; Bennett, 
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Noirot-Gros et al. 2000; Duno, Thomsen et al. 2000; Fricke, Kaliraman et al. 2001; 
Chang, Bellaoui et al. 2005; Chiolo, Carotenuto et al. 2005). 
Defects in BLM, the human RecQ helicase considered to be most closely related 
to Sgs1, cause BS, an autosomal recessive disorder characterized by chromosome 
gaps and breaks, elevated sister chromatid exchange, mitotic hyper-recombination, and 
aberrant DNA replication events (Chaganti, Schonberg et al. 1974; Hojo, van Diemen et 
al. 1995; Bachrati and Hickson 2003). Affected individuals suffer from a high incidence 
and wide variety of cancers, infertility, and dwarfism (reviewed in Ref. 33). BLM 
catalyzes ATP-dependent 3’- to 5’-DNA unwinding, with a preference for DNA structures 
that may arise spontaneously during DNA replication or as a result of homologous 
recombination (HR) (Mohaghegh, Karow et al. 2001). For example, by unwinding 
unusual secondary DNA structures, BLM may aid replication fork progression, prevent 
illegitimate recombination during replication, and assist in restarting stalled forks (Ralf, 
Hickson et al. 2006; Wu and Hickson 2006; Hanada and Hickson 2007). Evidence 
supporting a role of BLM in maintaining genome integrity has been accumulating. For 
example, BLM-defective cells exhibit a retarded rate of strand elongation during DNA 
replication,(Hand and German 1975) accumulate abnormal replication intermediates, 
(Lonn, Lonn et al. 1990) and are hypersensitive to agents that impair DNA 
replication(Davies, North et al. 2004). BLM physically interacts with several proteins that 
play important roles during DNA replication and repair, such as replication protein A, flap 
endonuclease 1, chromatin assembly factor 1, the mismatch repair protein Mlh1, HR 
factor Rad51, and topoisomerase III "(Brosh, Li et al. 2000; Johnson, Lombard et al. 
2000; Langland, Kordich et al. 2001; Wu, Davies et al. 2001; Jiao, Bachrati et al. 2004; 
Sharma, Sommers et al. 2004; Wu, Bachrati et al. 2006). BLM peaks in S phase and it 
localizes to replication foci, most likely through its physical interaction with a subunit of 
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DNA polymerase α (Dutertre, Ababou et al. 2000; Sanz, Proytcheva et al. 2000; 
Yankiwski, Marciniak et al. 2000; Bischof, Kim et al. 2001; Selak, Bachrati et al. 2008). 
Here, we have determined the role of C-terminal domains and protein interaction 
sites of Sgs1 in suppressing GCR accumulation by expressing point mutants and 
truncations of Sgs1, lacking as few as 20 residues and as many as 1428 residue’s 
Human BLM cDNA was expressed under control of the native SGS1 promoter and 
overexpressed from a galactose-inducible promoter to investigate BLM's ability to 
complement sgs1Δ defects (such as increased genome instability and sensitivity to HU 
and MMS), revealing that BLM could suppress sgs1Δ defects neither in haploid nor in 
diploid cells. However, using computational protein disorder prediction tools, we have 
designed a yeast-human chimera that consists of two nonfunctional segments of BLM 
and Sgs1. The ability of this chimera to suppress all sgs1Δ defects that we tested 
suggests a functional relationship between BLM and Sgs1, which is also supported by 
our finding that short N-terminal fragments of Sgs1, which are devoid of all known 
functional domains for helicase activity and DNA binding, suppress severely detrimental 
effects of BLM overexpression in yeast. 
Results 
Requirement of the RQC domain of Sgs1,  but not the HRDC 
domain, for GCR suppression 
Sgs1 contains a conserved DEAH helicase domain, a conserved HRDC domain, 
two acidic regions (AR1 and AR2), and an RQC domain composed of zinc-binding and 
winged-helix domains. Several protein interaction sites have also been located in the 
1447-amino-acid-long protein (Figure 2. 1a). To determine the role of these domains in 
the maintenance of genome stability, we generated systematic deletions to the 3’-end of 
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the chromosomal SGS1 gene, such that truncations of the C-terminus of Sgs1, ranging 
from 20 to 1428 amino acids, were expressed as fusions to a myc epitope. Truncations 
of up to 80 amino acids were constructed to not affect any known functional domain of 
Sgs1, while ΔC100 and ΔC200 deletions partially and completely re- moved the HRDC 
domain and ΔC300 and ΔC400 deletions partially and completely removed the RQC 
domain, respectively. The largest deletions (ΔC700, ΔC800, ΔC900, ΔC1000, and 
ΔC1100) eliminate the entire helicase domain, including the Walker A motif (residues 
803-812), with the ΔC800-ΔC1100 deletions also affecting the part of the N-terminal half 
of Sgs1 that contains protein interaction sites (e.g., Rad16, residues 421-792; Top2, 
residues 432-724; and Srs2, residues 422-722) and two acidic regions (AR1, residues 
321-447; AR2, residues 502-648), whereas ΔC500 and ΔC600 deletions partially 
remove the helicase domain while leaving the Walker A motif intact (Figure 2. 1a). All 
truncation alleles were stably expressed from the chromosomal SGS1 locus under 
control of the native SGS1 promoter (Figure 2. 1b). C- terminal fusion to the myc epitope 
did not adversely affect Sgs1 function, as indicated by equal sensitivity to HU and MMS 
of strains expressing tagged and untagged Sgs1 (wild type) (Figure 2. 2a). The largest 
deletion, leaving intact only the 19 N-terminal amino acids of Sgs1 (sgs1ΔC1428), was 
as sensitive to HU and MMS as a complete SGS1 deletion (sgs1Δ), thus behaving 
similar to a null allele (Figure 2. 2a). Loss of up to 200 C-terminal amino acids did not 
increase sensitivity to HU or MMS, whereas loss of 300 or more amino acids led to 
sensitivity similar to that of the sgs1ΔC1428 and sgs1Δ mutants (Figure 2. 2a). The 
construction of additional 20-amino-acid truncations extended the C-terminal region that 
is dispensable for HU/MMS resistance to 240 amino acids (Figure 2. 2b). 
It was previously shown that cells lacking the DNA helicase Srs2 (srs2Δ) depend 
on functional Sgs1 for their viability.(Lee, Johnson et al. 1999) To assess the ability of 
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sgs1 truncation alleles to support growth of the srs2Δ mutant, we constructed diploid 
strains heterozygous for the srs2Δ deletion and heterozygous for the sgs1ΔC200, 
sgs1ΔC260, or sgs1ΔC300 allele. The meiotic products of the sporulated diploids were 
spread on nonselective, rich media [yeast-peptone-dextrose (YPD)], allowing all spores 
to grow (Figure 2. 2c). Diploids heterozygous for the srs2Δ deletion and for the 
sgs1ΔC200 truncation yielded spores that grew into colonies of the same size, 
suggesting that the 200 C-terminal amino acid residues of Sgs1, which harbor the HRDC 
domain and an interaction site with the HR factor Rad51, are not required for the viability 
of the srs2Δ mutant. In contrast, sporulation of diploids heterozygous for the srs2Δ 
deletion and sgs1ΔC260 or sgs1ΔC300 allele yielded mixtures of normal-sized and 
small colonies. Genotyping revealed that the small colonies were srs2Δ sgs1ΔC260 or 
srs2Δ sgs1ΔC300 mutants, whereas the normal-sized colonies corresponded to 
wild-type spores or single mutants. Thus, Sgs1 that lacks 260 or more C-terminal 
residues and therefore does not contain a complete RQC domain cannot support normal 
growth of cells lacking Srs2. 
When we tested the effect of the C-terminal deletions on the accumulation of 
GCRs, we found that 240 C-terminal amino acids were dispensable for maintaining 
genome integrity, whereas deleting as little as an additional 20 amino acids 
(sgs1ΔC260) caused the GCR rate to increase to that exhibited by the null mutant 
without a discernable intermediate phenotype (Table 2.1). Combining the sgs1ΔC300 
truncation allele with a deletion of the DNA-damage checkpoint sensor MEC3 led to a 
synergistic GCR rate increase, while, as expected, combining the sgs1ΔC200 allele with 
a mec3Δ mutation did not. 
Thus, these findings show that the HRDC domain and the previously reported 
C-terminal interaction with Rad51 are not required for Sgs1's role in preventing the 
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accumulation of GCRs and supporting normal growth of the srs2Δ mutant, whereas the 
integrity of the RQC domain, which has been suggested to span residues 1075-1207 
based on the alignment of three-dimensional structures (Kitano, Kim et al. 2010),  is 
essential. 
BS-associated RQC domain mutations cause loss of Sgs1 
function in vivo 
Of the 32 exonic base substitutions that are causative of BS, 13 are missense 
mutations (Ellis, Groden et al. 1995; Foucault, Vaury et al. 1997; Barakat, Ababou et al. 
2000; German, Sanz et al. 2007), with 6 of these mutations affecting conserved residues 
that have been shown in vitro to participate in zinc binding and G-tetrad DNA binding 
activity (Figure 2. 3a). Studies, however, have been limited to biochemical and 
biophysical analyses of mutant proteins and were hampered by the inability to purify 
some mutant BLM proteins (Janscak, Garcia et al. 2003; Guo, Rigolet et al. 2005; 
Huber, Duquette et al. 2006). Since the cysteine residues are highly conserved between 
RecQ-like helicases, including Sgs1, we replaced the corresponding cysteine residue in 
Sgs1 with the BS- associated mutation (sgs1-C1047F). Unlike BLM with mutations in 
any of the three conserved cysteine residues C1036, C1063, or C1066, which degraded 
upon purification and could therefore not be characterized(Janscak, Garcia et al. 2003),  
the sgs1-C1047F mutant allele was stably expressed in vivo from the native SGS1 locus 
(Figure 2. 3b). The sgs1-C1047F mutant showed an increased HU and MMS sensitivity, 
which, however, did not reach the level of the sgs1Δ allele, and exhibited levels of GCR 
accumulation comparable to the sgs1Δ mutant, demonstrating that the C1047F mutation 
severely impairs Sgs1 function (Figure 2. 3c; Table 2.1). In addition to conserved 
cysteine residues and immediately adjoining arginine (R1037) and aspartic acid (D1064) 
residues, ClustalW2 alignments showed F1056 to be the only other fully conserved 
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amino acid residue in the zinc-binding domain of Sgs1 (Figure 2. 3a). Although the 
corresponding residue in BLM (F1045) is not associated with a BS mutation, the 
BLM-F1045A mutation has been shown to cause a severe helicase defect and a 
single-stranded DNA (ssDNA) binding deficiency in vitro(Janscak, Garcia et al. 2003). 
When we introduced the corresponding mutation into Sgs1 (F1056A), however, the 
mutant was no more sensitive to HU and MMS than wild-type cells (Figure 2. 3c) but 
instead appeared fully functional with a wild-type GCR rate (Table 2.1). 
Expression of human BLM cDNA from the endogenous SGS1 
promoter does not complement sgs1Δ defects 
RecQ-like DNA helicases are evolutionarily conserved from bacteria to humans. 
Since cells from BS patients share defects seen in sgs1Δ cells, including increased 
sensitivity to DNA-damaging agents, increased levels of aberrant genetic exchange, and 
reduced life span, it has been suggested that RecQ- like DNA helicases from different 
phyla or even kingdoms might complement each other, thus allowing the development of 
simple model organisms for the functional and mutational characterization of 
disease-associated human RecQ-like helicases, such as BLM and WRN(Yamagata, 
Kato et al. 1998). Thus, to assess the ability of BLM to suppress genome instability in 
the sgs1Δ mutant, BLM cDNA was inserted in-frame with the start codon of SGS1 at its 
chromosomal locus (PSGS1BLM). We reasoned that insertion at the wild-type SGS1 
locus would promote cell-cycle- dependent regulation of BLM expression and expression 
levels similar to those previously shown for Sgs1(Frei and Gasser 2000). Stable 
expression of BLM was confirmed by Western blot analysis, using a yeast strain 
expressing myc-tagged BLM (Figure 2. 4a); however, all subsequent experiments were 
carried out with untagged BLM. Expression of a single copy of BLM (PSGS1BLM) neither 
led to a statistically significant difference in the GCR rate compared to the sgs1Δ mutant 
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(Tables 1 and 2) nor alleviated HU sensitivity (Figure 2. 4b), demonstrating that BLM can 
be successfully expressed in yeast under control of the native SGS1 promoter without 
detrimental effects on cell growth, but is unable to complement the tested sgs1Δ defects 
to any extent. 
Overexpression of BLM leads to increased sensitivity to 
DNA-damaging agents and rapid accumulation of GCRs 
Since a single copy of BLM (PSGS1BLM) did not complement sgs1Δ defects, we 
examined the effect of increasing BLM expression levels on sgs1Δ mutant phenotypes. 
For this purpose, the native SGS1 promoter was replaced with a GAL1 promoter and 
galactose-dependent expression of BLM was verified by fusing BLM to a myc epitope 
tag (Figure 2. 4a). Overexpression of BLM did not compensate for the lack of Sgs1 when 
cells were exposed to HU but instead led to a further increase in sensitivity to HU 
compared to the sgs1ΔC1428 cells or cells expressing BLM under the SGS1 promoter 
(Figure 2. 4b). We found that maximum induction of BLM expression led to a 1665-fold 
increase in the GCR rate compared to wild type and a 34-fold increase compared to the 
sgs1Δ mutant assayed under the same conditions (Table 2.2). In contrast, 
overexpression of Sgs1 from the GAL1 promoter did not lead to GCR accumulation 
(Table 2.2). The GCR rate increase upon BLM overexpression was dependent on 
induction levels, with the GCR rate gradually decreasing to that of the sgs1Δ mutant as 
the galactose concentration in the media decreased (Table 2.2). Thus, sgs1Δ defects 
cannot be complemented by any level of BLM expression; in fact, increasing BLM 
expression levels induce higher sensitivity to DNA-damaging agents and significantly 
higher genome instability compared to that of the sgs1Δ mutant. 
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N-terminus of Sgs1 suppresses detrimental effects of BLM 
overexpression 
Since Sgs1 is important for the suppression of illegitimate recombination 
between identical sequences, such as those found in related genes, on homologous 
chromosomes, and on sister chromatids, we tested the HU sensitivity of diploid strains 
expressing truncated sgs1 alleles in the presence or in the absence of the SGS1 
wild-type allele (Figure 2. 5). HU sensitivity was fully suppressed for all alleles if a single 
copy of wild-type SGS1 was expressed from the other allele (Figure 2. 5a), 
demonstrating that the sgs1 truncation alleles did not have a dominant effect. As in 
haploid cells, only the sgs1ΔC200 allele complemented HU sensitivity of the sgs1Δ 
diploid completely (Figure 2. 5b); however, cells expressing the sgs1ΔC300 to 
sgs1ΔC900 alleles were less sensitive than diploids that expressed larger truncations or 
the sgs1ΔC1428 null allele (Figure 2. 5b). This ability of sgs1Δ300-sgs1ΔC900 
truncation alleles to at least partially suppress HU sensitivity indicates that there may be 
N-terminal segments in Sgs1 that contribute to HU resistance. 
Diploids expressing BLM from native SGS1 promoters on both alleles were as 
sensitive to HU as diploids not expressing Sgs1, whereas diploids overexpressing BLM 
from one allele or from both alleles were severely HU sensitive, with the highest 
expression level lacking any growth on 100 mM HU (Figure 2. 5c), reflecting the severe 
HU sensitivity of haploid cells expressing the PGALBLM allele (Figure 2. 4b). Diploids 
overexpressing BLM also appeared to grow more slowly than any other diploid tested 
here (Figure 2. 5c). Remarkably, expression of a single copy of SGS1 from its 
endogenous promoter (SGS1/PGALBLM) completely eliminated the severe HU sensitivity 
conferred by overexpression of BLM. To determine if full-length Sgs1 was required for 
this suppression, we crossed the haploid strain overexpressing BLM with haploids 
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expressing various Sgs1 truncations. We found that a single copy of the sgs1ΔC200 
allele was as sufficient as wild-type Sgs1 in suppressing HU sensitivity and slow growth 
of the BLM overexpressing strain, and as few as 547 N-terminal amino acids remaining 
in the sgs1ΔC900 allele were sufficient for significant suppression of HU sensitivity and 
slow growth caused by BLM overexpression (Figure 2. 5c). These findings suggest that 
none of the known enzymatic activities or functional and conserved domains are 
required for suppressing the HU sensitivity of the BLM overexpressing diploids but that 
547 N-terminal amino acids are sufficient for suppressing the detrimental effects of BLM 
overexpression in a diploid. That the sgs1ΔC1000 and sgs1ΔC1100 alleles were clearly 
less effective at suppressing HU sensitivity shows that 447 N- terminal amino acids, 
which contain the Top3 interaction site, are necessary but not sufficient for 
complementation. 
Design of a functional Sgs1-BLM chimera 
Sgs1 and BLM share about 21% of their amino acid residues in a pairwise 
alignment of the full- length proteins (ClustalW2), with most of the identical residues in 
the helicase domain. In fact, the N-terminal segment of Sgs1 expressed by the 
sgs1ΔC800 allele, which is able to suppress the HU sensitivity of BLM overexpressing 
diploids, shares only 11% with the corresponding N- terminal segment of BLM. Devoid of 
conserved domains and known enzymatic activities, the N- terminus of Sgs1 has been 
shown to be required for physical interactions with Top3, Top2, Srs2, and Rad16(Watt, 
Louis et al. 1995; Bennett, Noirot-Gros et al. 2000; Duno, Thomsen et al. 2000; Mullen, 
Kaliraman et al. 2000; Fricke, Kaliraman et al. 2001; Chiolo, Carotenuto et al. 2005). 
Using IUPred, an algorithm for the prediction of intrinsically disordered proteins, we 
found that the 650 N-terminal residues contain a similar distribution of ordered and 
intrinsically disordered segments (Figure 2. 6a and b). In disorder prediction algorithms, 
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such as IUPred, (Dosztanyi, Csizmok et al. 2005) a score of N0.5 predicts a disordered 
amino acid residue and a score of b0.5 predicts an ordered residue, with 30 consecutive 
disordered amino acids commonly being used as a lower limit for detecting disorder in 
whole proteome searches.(Ward, Sodhi et al. 2004; Dosztanyi, Csizmok et al. 2005; 
Dosztanyi, Csizmok et al. 2005; Peng, Vucetic et al. 2005) The helicase domains of 
Sgs1 and of BLM coincide with the predicted ordered regions in both proteins, starting at 
around residue 648, and are surrounded by a long N-terminal and a short C-terminal 
segment, which contain mostly disordered residues. In fact, based on the IUPred output 
scores, 83% of the 648 N-terminal residues of Sgs1 (538/648) are disordered, with 70% 
of all 648 residues being located in segments of more than 30 consecutive disordered 
residues, whereas only 16% of the 800 C-terminal residues of Sgs1 are predicted to be 
disordered, with only a single disordered segment that is longer than 30 residues 
(residues 1396-1447). Based on the IUPred prediction, BLM can also be divided into a 
disordered N- terminus and an ordered C-terminus (Figure 2. 6a and b). For BLM, 52% 
of 648 N-terminal residues are predicted to be disordered, but only 15% of these 
residues are found in stretches of more than 30 disordered residues. The difference in 
the pattern of disorder predicted for the N-terminal segments of Sgs1 and BLM led us to 
hypothesize that this region may be involved in conferring species specificity to BLM and 
Sgs1 function and, thus, prevent BLM from functioning in yeast. This hypothesis is 
supported by the fact that the N-terminus of Sgs1 is sufficient for the complementation of 
the HU sensitivity induced by overexpression of BLM. To test this hypothesis, we 
constructed a yeast-human chimera in which the 647 N-terminal residues of BLM were 
replaced by the 647 N-terminal residues of Sgs1 (sgs1ΔC800- blmΔN647) (Figure 2. 
6c). To express this chimera from the native SGS1 promoter, we replaced nucleotides 
1941 to 4344 of the endogenous SGS1 gene with nucleotides 1941 to 4254 of BLM 
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cDNA (Figure 2. 6e). Remarkably, the chimera was nearly as effective as wild-type 
SGS1 in conferring resistance to HU, whereas the N-terminal segment of Sgs1 by itself 
was ineffective (Figure 2. 6d). Moreover, when we combined the chimeric allele with a 
mec3Δ mutation, GCRs accumulated at a significantly lower rate than in the mec3Δ 
mutant carrying the GCR-deficient sgs1ΔC300 or sgs1ΔC800 allele, albeit not at the low 
rate of the mec3Δ mutant carrying the GCR- proficient sgs1ΔC200 allele, signifying 
partial functionality of the chimerical protein in the suppression of chromosomal 
rearrangements (Table 2.1). Finally, besides Srs2, the sgs1Δ mutant also requires the 
DNA helicase Rrm3 for viability. Synthetic lethality between sgs1Δ and rrm3Δ mutations 
is suppressed by disrupting HR factors such as Rad51 and Rad55, suggesting that the 
lethality is due to accumulation of aberrant HR intermediates(Ooi, Shoemaker et al. 
2003; Schmidt and Kolodner 2004; Torres, Schnakenberg et al. 2004). To assess if the 
Sgs1-BLM chimera was capable of preventing the accumulation of lethal levels of 
aberrant recombination intermediates, we constructed a diploid heterozygous for the 
rrm3Δ mutation and heterozygous for the sgs1ΔC800-blmΔN647 allele, expressing the 
Sgs1-BLM chimera. Spreading of spores from this diploid on YPD, which allows all 
spores to grow, showed that the rrm3Δ mutant expressing the chimera grows normally 
with the diameter of double-mutant colonies measuring approximately 90% of that of the 
single mutants (Figure 2. 6f). These findings indicate that the Sgs1-BLM chimera is 
functional and, while not capable of fully suppressing chromosomal rearrangements, 
prevents the accumulation of lethal levels of aberrant recombination intermediates when 
Rrm3 helicase is absent. 
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Discussion 
Yeast cells that lack Sgs1 exhibit upregulated and aberrant recombination in 
mitosis, increased sensitivity to DNA-damaging agents, accumulation of GCRs, synthetic 
lethality with mutations in other DNA metabolic genes, such as the SRS2 and RRM3 
helicase genes, and meiotic defects that lead to poor spore viability(Watt, Louis et al. 
1995; Lee, Johnson et al. 1999; Frei and Gasser 2000; Miyajima, Seki et al. 2000; 
Myung, Datta et al. 2001; Cobb, Bjergbaek et al. 2002; Ira, Malkova et al. 2003; Versini, 
Comet et al. 2003; Schmidt and Kolodner 2004; Schmidt, Wu et al. 2006). Sgs1 contains 
several conserved domains (DEAD helicase, RQC, HRDC, AR1, and AR2), and protein 
interaction sites (Top2, Top3, Srs2, Rad16, Rad51, and Mlh1) have been identified by 
two-hybrid screens.(Watt, Louis et al. 1995; Duno, Thomsen et al. 2000; Saffi, Feldmann 
et al. 2001; Wu, Davies et al. 2001; Chiolo, Carotenuto et al. 2005) How the integrity of 
these conserved motifs and protein-protein interaction sites affects the role of Sgs1 in 
suppression of aberrant genome rearrangements has not been determined. The 
requirement of some domains and/or protein interaction sites, but not others, may shed 
light on the poorly understood mechanism(s) by which Sgs1 contributes to the 
maintenance of genome integrity in yeast. Here, we find that the segment made up of 
240 C-terminal amino acids, which contains Rad51 and Mlh1 interaction sites and the 
conserved HRDC domain thought to be involved in DNA binding and in recognition and 
processing of double Holliday junctions,(Liu, Macias et al. 1999; Wu, Chan et al. 2005) is 
dispensable for Sgs1's role in suppressing GCRs. The integrity of the RQC domain, 
however, is essential for GCR suppression. That zinc binding is crucial for Sgs1 activity, 
as well as the fact that loss of function of the C- terminal truncation allele was not due to 
disruption of protein structure/function because of such a large deletion, was further 
confirmed by the finding that the point mutation of a conserved zinc-coordinating 
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cysteine, which has also been observed in BS patients,(Foucault, Vaury et al. 1997) led 
to the loss of Sgs1's ability to suppress HU sensitivity and GCR accumulation. This loss 
of function was not due to degradation of the mutant protein as had been previously 
observed for some cysteine mutants of BLM during attempts at overexpression and 
purification from E. coli. However, we cannot exclude the possibility that the loss of 
function resulted from intracellular mislocalization of the mutant protein. Previously, 
modeling of the zinc- binding domain of BLM and instability of purified mutant proteins 
had indicated that hydrogen bonds between three conserved residues, Y1029 (Y1040 in 
Sgs1), R1037 (R1048 in Sgs1), and D1064 (D1070 in Sgs1), are required for the folding 
of the zinc-binding domain and overall protein stability(Guo, Rigolet et al. 2005). 
Although F1056 of Sgs1 does not appear to be involved in this zinc-domain stabilization 
and the Sgs1-F1056A mutant protein appears stable in this study, F1056 is the only 
other fully conserved residue in the zinc-binding domain of RecQ-like helicases, 
suggesting functional significance. However, introduction of the F1056A mutation had no 
effect on Sgs1 function in vivo when we assessed HU sensitivity, consistent with a 
previous study,(Ui, Satoh et al. 2001) or GCR accumulation. That, in a previous in vitro 
study,(Janscak, Garcia et al. 2003)  the corresponding BLM mutation (F1045A) had 
severely impaired helicase and ssDNA binding activities could be either due to 
differences in the importance of this residue for enzymatic activity of BLM and Sgs1 or, 
more likely, due to the fact that only the helicase-core segment of BLM, lacking 769 
residues of N- and C-termini, was purified. The in vitro function of this isolated domain 
could be more strongly affected by a mutation than the in vivo function of the full- length 
Sgs1 mutant protein assessed here. Although nearly half of all BLM alleles that are 
associated with single-amino-acid changes (7 of 17 alleles) in BS patients are located in 
the RQC domain,(Ellis, Groden et al. 1995; Foucault, Vaury et al. 1997; Barakat, Ababou 
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et al. 2000; German, Sanz et al. 2007) none affect F1045, consistent with our finding that 
mutation of this conserved residue may not be associated with significant loss of function 
in vivo. 
We find that Sgs1 retains partial functionality even when it lacks the HRDC, 
RQC, and DEAH helicase domains, as demonstrated by the greater HU resistance of 
diploids that only express 547 N- terminal amino acid residues compared to those alleles 
expressing fewer than 447 residues of Sgs1. One possible explanation for this finding is 
that protein-protein interactions conferred by the N- terminus could contribute to the 
structural stability of multi-protein complexes, such as the Sgs1-Top3-Rmi1(Chang, 
Bellaoui et al. 2005) complex or, even more relevant to HU resistance, 
DNA-damage-specific complexes with Srs2 and Mre11(Chiolo, Carotenuto et al. 2005). 
In these multi-protein complexes, enzymatic activity of Sgs1 may be dispensable. 
Indeed, sgs1 alleles with point mutations in the helicase domain have been shown to be 
capable of performing some functions of the wild-type allele, including those carried out 
during meiosis and checkpoint activation(Miyajima, Seki et al. 2000; Bjergbaek, Cobb et 
al. 2005). 
In contrast to two previous reports,(Yamagata, Kato et al. 1998; Heo, 
Tatebayashi et al. 1999) which both used the same yeast strain that constitutively 
expressed BLM from a GAPDH promoter and showed partial suppression of some 
sgs1Δ defects, including HU sensitivity, we found that neither BLM expression under 
control of the natural SGS1 promoter nor varying levels of BLM expression under control 
of a galactose-inducible promoter had any positive effect on the sgs1Δ mutant. That a 
single copy of BLM, when expressed under control of the native SGS1 promoter, cannot 
alleviate sgs1Δ defects initially suggested to us that BLM had no functionality in yeast. In 
fact, the strong increase in genome instability, accompanied by severe HU sensitivity 
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and some growth retardation upon overexpression of BLM, indicated that BLM 
expression is detrimental to yeast cells. The absence of any GCR accumulation upon 
Sgs1 overexpression suggests that increased accumulation of GCRs in 
BLM-overexpressing cells is not simply due to increased unwinding. Rather, we propose 
that BLM may possess helicase activity in yeast, leading to increased unwinding upon 
over-expression, but fails to elicit proper downstream responses, for example, due to 
lack of proper N-terminal protein-protein interactions, which ultimately leads to an 
overabundance of aberrantly repaired lesions. That endogenous levels of N-terminal 
segments of Sgs1 as short as 547 residues suppressed the slow growth phenotype and 
the severe HU sensitivity of BLM overexpressing cells argues in favor of a functional 
relationship between Sgs1 and BLM. For example, co-expression of Sgs1 and BLM 
could alleviate HU sensitivity in BLM overexpressing cells by acting as a bridge between 
BLM and Top3 (and/or other protein complexes interacting with the Sgs1 N- terminus), 
thereby linking enzymatic activity to appropriate upstream and downstream events. 
Remarkably, even relatively short N-terminal fragments of Sgs1 are sufficient for the 
suppression of the increased HU sensitivity of BLM overexpressing cells, further 
supporting the importance of the Sgs1 N-terminus with its role in mediating interaction 
with other DNA metabolic factors. HU resistance comparable to wild-type cells and 
significantly reduced GCR accumulation of cells expressing a chimeric fusion of the 
Sgs1 N- terminus, which is devoid of enzymatic function and dispensable for helicase 
activity and ssDNA binding in vitro, and the BLM C-terminus, which contains 
helicase/RQC and HRDC domains, are consistent with helicase activity of BLM in yeast 
and a biologically significant, functional interaction between BLM and Sgs1. That fusion 
of the Sgs1 and BLM segments provides HU resistance as well as co-expression of BLM 
and Sgs1 polypeptides from separate alleles in the same cell may indicate that the 
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N-terminus of Sgs1 can physically interact with BLM. Our findings also suggest that it is 
the inability of the N-terminus of BLM to interact with or be modified by yeast proteins 
that leads to the inability of BLM to function in yeast. A previous report that BLM 
expression in yeast alleviates several sgs1Δ phenotypes, including partial suppression 
of HU sensitivity(Yamagata, Kato et al. 1998; Heo, Tatebayashi et al. 1999), could be 
explained by the fact that, in the earlier study, BLM was expressed from a GAPDH 
promoter, whereas here it was expressed either from the native SGS1 promoter or from 
a galactose-inducible promoter. However, in light of the findings presented here, there 
could also be an alternative explanation. Since the GAPDH promoter-BLM construct 
appears to have been inserted into the middle of the wild-type SGS1 gene, an 
N-terminal segment of Sgs1 could have been expressed from the native SGS1 promoter 
in addition to BLM being expressed from the GAPDH promoter. As shown here for 
haploids expressing the chimera and for diploids co-expressing the N-termini of Sgs1 
and full-length BLM, such co-expression of an N- terminal Sgs1 segment from the native 
SGS1 promoter and BLM from the GAPDH promoter could be an explanation for the 
reported increase in HU resistance of BLM-expressing cells compared to sgs1Δ cells. 
Of the five human RecQ-like DNA helicases, BLM is considered to be most 
closely related to Sgs1. Even though we show here that BLM cannot suppress any 
defects of the sgs1Δ mutant, the functional chimera does provide evidence for a 
functional relationship between the two RecQ-like helicases and provides a model 
system for the further characterization of BLM functional domains in yeast. In fact, all 
BS-associated missense mutations and numerous polymorphisms are located within the 
770-residue C-terminal fragment of BLM that is part of the chimera, so that they are now 
accessible to further functional and mutational characterization in yeast. The in vivo 
functionality of the Sgs1-BLM chimera also demonstrates the remarkable utility of protein 
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disorder prediction as a tool for the construction of functional mutants. It will be 
interesting to see whether domains of any of the other human RecQ-like helicases, are 
capable of forming functional chimeras with the Sgs1 N-terminus. 
Materials and Methods  
Yeast strains and media 
All strains are derived from KHSY802, a derivative of S288C. Yeast strains 
expressing truncations of Sgs1 helicase were constructed by HR-mediated integration of 
PCR products, replacing the desired 3’-segment of SGS1 on chromosome VIII with a 
myc epitope coding sequence (from pFA6a-13Myc.His3MX6,(Longtine, McKenzie et al. 
1998)  a gift from Mark Longtine, University of Washington) in-frame with the SGS1 
coding sequence. The expression of all truncation alleles and the myc-epitope-tagged 
wild-type allele of SGS1 was confirmed by Western blot analysis. All gene replacements, 
insertions, and truncations were performed via the standard LiAc protocol,(Gietz and 
Woods 2006) using PCR products with at least 50 nt on each end, which matched the 
chromosomal target locus. A PCR fragment containing BLM cDNA (Open Biosystems) 
and a HIS3 cassette was amplified by PCR from plasmid pKHS293 using primers that 
include 50-nt homology to the chromosomal SGS1 locus to express BLM from the native 
SGS1 promoter (PSGS1). This PCR product was fused to the native chromosomal SGS1 
promoter by HR-mediated integration(Gietz and Woods 2006). A PCR fragment coding 
for a 13Myc epitope tag was amplified from pFA6a-13Myc-kanMX6 (Longtine, McKenzie 
et al. 1998)   and integrated in-frame at the 3’-end of cDNAs or sgs1 alleles for detection 
of protein expression by Western blot analysis. In strains KHSY3350 and KHSY3218, 
galactose-inducible promoters amplified from plasmids pFA6a-kanMX6-PGAL1 and 
pFA6a-TRP1- PGAL1, (Longtine, McKenzie et al. 1998)   respectively, were used to 
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replace the native SGS1 promoter. To construct KHSY3355, we amplified the 3’-terminal 
2313 bp of BLM cDNA linked to a HIS3 cassette by PCR from plasmid pKHS293 and 
used them to replace the 3‘-terminal 2400 bp of SGS1 in KHSY802. The accuracy of 
PCR-derived SGS1 or BLM integrations was confirmed by sequencing. Amino acid 
changes C1047F and F1056A in Sgs1 were made by site-directed mutagenesis 
(QuikChange, Stratagene) of pKHS360 and integrated at the sgs1∷HIS3 locus in 
KHSY1338. All yeast strains used in this study are listed in Table 2.S1. Cells were grown 
in YPD consisting of 10 g/l yeast extract (Fisher Scientific), 20 g/l Bactopeptone (BD 
Diagnostic Systems), and 2% glucose (Fisher Scientific), unless indicated otherwise. For 
plates, agar (BD Diagnostic Systems) was added at a concentration of 20 g/l. 
Western blot analysis 
Cells were grown to an OD600 = 0.5 in YPD, and whole-cell extracts were 
prepared from 5 ml of culture (" 3.5 × 107 cells) by standard trichloroacetic acid (TCA, 
Fisher Scientific) extraction to confirm expression of myc- epitope-tagged BLM and 
SGS1 alleles(Foiani, Liberi et al. 1999). Five microliters of TCA extract was separated on 
10% polyacrylamide gels, transferred to a PVDF membrane (Bio-Rad), probed with 
anti-c-myc monoclonal antibody (9E10, Covance Research Products), and visualized by 
chemiluminescence (ECL Plus, GE Healthcare). To confirm expression of SGS1 and 
BLM from the GAL1 promoter, we used the same Western blot procedure, but cells were 
grown overnight in yeast- peptone (YP) [(10 g/l yeast extract (Fisher Scientific), 20 g/l 
Bactopeptone (BD Diagnostic Systems)] supplemented with 2% sucrose (Fisher 
Scientific), diluted to an OD600=0.2 in YP supplemented with either 2% sucrose 
(uninduced sample) or 2% galactose (induced sample), and harvested for TCA 
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extraction when cultures reached OD600 = 0.5. Molecular weight marker (Broad Range) 
was from Bio-Rad. 
Sensitivity to DNA-damaging agents HU and MMS 
Cell cultures were grown in YPD to an OD600 = 0.5, and 10-fold serial dilutions 
were spotted on YPD supplemented with 0.05% MMS (Sigma Aldrich) or with 50 mM or 
100 mM HU (US Biological), as indicated. For experiments that included strains 
expressing BLM or Sgs1 from the GAL1 promoter (Figure 2. 5), cultures were grown in 
YP-2% sucrose instead of YPD and spotted on YP-1% sucrose + 1% galactose (to 
induce gene expression) supplemented with 100 mM HU or without HU as the growth 
control. 
GCR rate measurements 
Rates of accumulating GCRs in YPD were determined as previously described.83 
For GCR rate measurements of yeast strains expressing BLM or Sgs1 from the GAL1 
promoter, the same procedure was followed, except that media were supplemented with 
2% galactose to induce gene expression. Briefly, 10 ml of YP-2% galactose was 
inoculated with a single colony, which had been grown on YPD agar for 3 days. After 3 
days of growth in liquid media at 30 °C with vigorous shaking, cells were plated on GCR 
plates(Schmidt, Pennaneach et al. 2006) supplemented with 2% galactose instead of 2% 
glucose, and 10-6 dilutions were plated on YPD to obtain the viable cell count. Colonies 
on GCR plates were counted after 5 days of incubation at 30 °C. For GCR rate 
measurements in the presence of varying BLM expression levels (Table 2.2), 0.1% or 
0.5% galactose instead of 2% galactose was added to liquid YP media and to GCR 
plates, and sucrose was supplemented to reach a total of 2% sugar in the media. We 
calculated 95% confidence intervals according to Nair (Nair 1940). 
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Random spore analysis 
Diploids heterozygous for the desired mutant alleles were grown overnight at 30 
°C in YPD, washed, transferred to 0.1% potassium acetate (Fisher Scientific), and 
incubated for 5 days at 30 °C with vigorous shaking. Asci were incubated in the 
presence of 500µg/ml zymolase (MP Biomedicals) in 1 M sorbitol (Fisher Scientific) for 
20 min at 30 °C and enriched for haploid spores as previously described(Rockmill, 
Lambie et al. 1991). Spores were plated on YPD, incubated at 30 °C, and genotyped by 
spotting on synthetic drop-out media (US Biological) to detect the presence of TRP1 and 
HIS3 marker cassettes linked to the mutant alleles. The presence of mutant alleles 
linked to the kanMX6 cassette was detected by the ability of haploids to grow on YPD 
supplemented with 200 µg/ml G418 (Axxora LLC, San Diego, CA). 
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Figures and Tables 
 
Figure 2.1. C-terminal truncations of Sgs1 used in this study.   
(A) Full-length Sgs1 contains a DEAH-helicase domain, an RQC domain and an HRDC 
domain in its C-terminal half; interaction sites with Top3, Top2, Srs2, Rad51 and Rad16 
are indicated. C-terminal truncations ranging in size from 200 residues to 1428 residues 
were constructed by fusion to a myc-epitope tag. All truncations were introduced to the 
endogenous SGS1 locus on chromosome VIII. (B) Expression of wild-type Sgs1 and 
truncation alleles from the endogenous SGS1 promoter (PSGS1) was confirmed by 
Western blotting, using a myc-antibody. 
  52 
 
Figure 2.2. Sensitivity of truncation alleles to the DNA damaging agents HU and 
MMS.  
Ten-fold dilutions of exponentially growing cultures (OD600 = 0.5) were spotted on YPD 
for viable cell count and on YPD containing 100mM HU or 0.05% MMS, followed by 
incubation at 30oC. (A) Haploid cells expressing sgs1 alleles lacking 300 or more 
residues from the C-terminus are as sensitive to HU and MMS as the null allele. (B). 
Additional incremental 20-amino-acid deletions reveal that cells expressing sgs1 alleles 
lacking up to 240 residues are as resistant to HU and MMS as wild-type cells whereas 
those lacking 260 or more residues are as sensitive as the sgs1Δ mutant. (C) Combining 
the srs2Δ mutation with sgs1ΔC260 and sgs1ΔC300 mutations (lacking part of the RQC 
domain) causes a synthetic fitness defect (very slow growth), whereas combination with 
the sgs1ΔC200 allele (lacking the HRDC domain and Rad51 interaction site) does not.  
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Figure 2.3. Effect of zinc-binding domain mutations on Sgs1 function in vivo.  
(A) Zinc-binding domain is conserved from bacterial to human RecQ-like helicases. At 
least six different missense mutations in the zinc-binding domain are associated with 
Bloom’s syndrome. (B) C1047F and F1056A mutations were introduced into Sgs1 and 
expression was confirmed by Western blot using antibody against the C-terminal 
myc-epitope. (C) Mutation of the highly conserved F1056 does not impair Sgs1 function 
whereas the C1047F leads to an increase in sensitivity to HU and MMS, but not to the 
level seen in the sgs1Δ mutant. 
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Figure 2.4. BLM expression does not suppress sgs1Δ  defects and BLM 
overexpression is detrimental to yeast cells.  
(A) Galactose-inducible expression of myc-epitope tagged Sgs1 and BLM in yeast cells 
grown in 1% sucrose/1% galactose. (B) Cells expressing BLM from the SGS1 promoter 
on chromosome VIII are as sensitive to HU as cells lacking Sgs1. Replacement of the 
natural SGS1 promoter with a galactose-inducible promoter leads to BLM 
overexpression and increased HU sensitivity. Ten-fold dilutions of cells were spotted on 
media containing 1% sucrose/1% galactose with and without 100 mM HU. (C) 
Gross-chromosomal rearrangements (GCRs) accumulate in BLM-overexpressing cells 
(PGALBLM) in a dosage-dependent manner, whereas cells overexpressing Sgs1 do not 
accumulate GCRs. Cells were grown in media containing indicated concentrations of 
galactose supplemented with sucrose to reach a total of 2% sugar. As controls, GCR 
rates of the sgs1Δ mutant and a strain overexpressing Sgs1 were determined in 2% 
galactose.   
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Figure 2.5. HU sensitivity of diploid cells expressing mutant alleles of SGS1 and 
BLM.  
(A) Ten-fold dilutions of exponentially growing diploids expressing truncation alleles of 
Sgs1 in the presence of a wild-type allele were spotted on YPD media with and without 
100 mM HU. (B) Ten-fold dilutions of exponentially growing diploids expressing 
truncation alleles of Sgs1 in the absence of a wild-type allele were spotted on YPD 
media with and without 100 mM HU. (C) Ten-fold dilutions of exponentially growing 
diploids overexpressing BLM from a GAL1 promoter inserted at the native SGS1 locus 
and expressing truncation alleles of Sgs1 under control of the native SGS1 promoter on 
the other allele were spotted on media containing 1% galactose and 1% sucrose with or 
without 100 mM HU.  
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Figure 2.6. Construction of a functional chimerical protein composed of the 
N-terminus of Sgs1 and the C-terminus of BLM.  
(A - B) Protein disorder prediction of Sgs1 (red) and BLM (black) using the IUPred 
algorithm. Values above 0.5 indicate a disordered residue whereas values below 0.5 
indicate ordered residues; amino acid residue numbers (1-1447) are indicated on the 
abscissa. Black lines above the graph show a simplified order and disorder distribution 
along the length of the protein with values above 0.5 being assigned a “1” and values 
below 0.5 being assigned a “0”. The vertical red line indicate the site in Sgs1, BLM and 
the chimera where the disordered N-terminal segment transitions into the ordered 
helicase domain at residue 647/648. This site was chosen as the fusion site for the 
chimera. (C) Disorder prediction for the Sgs1-BLM chimera in which the N-terminal 647 
residues of BLM (black) were replaced with the N-terminal 647 residues of Sgs1 (red). 
(D) Ten-fold dilutions of exponentially growing haploids were spotted on YPD with or 
without 100 mM HU. (E) The C-terminus of the Sgs1-BLM chimera was fused to a 
myc-epitope tag and expression was confirmed by Western blotting. (F) A diploid 
heterozygous for the rrm3Δ mutation and the sgs1ΔC800-blmΔN647 allele expressing 
the chimera was sporulated and random spores were plated on YPD and genotyped. An 
open circle indicates the haploid double mutant, and the open square and pentagon 
indicate haploid sgs1ΔC800-blmΔN647 and rrm3Δ single mutants, respectively.       
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Table 2.1. Accumulation of gross-chromosomal rearrangements in cells 
expressing mutant alleles of SGS1. 
 
1 All sgs1 truncations (sgs1ΔC) are C-terminally fused to a myc-epitope tag. 
2 We calculated 95% confidence intervals (CI) according to Nair (Nair 1940). 
3 The sgs1ΔC800-blmΔN647 allele expresses a chimeric protein that consists of the 
N-terminal 647 residues of Sgs1 and the C-terminal 770 residues of human BLM. 
  
Relevant Genotype1 GCR Rate 
(Canr 5-FOAr x 10-10) 
95% CI2 
(Canr 5-FOAr x 10-10) 
wild-type 1.1 < 1 – 6.2 
sgs1Δ  251 80-310 
sgs1ΔC200 7 <6-23 
sgs1ΔC220 31 5-41 
sgs1ΔC240 10 <6-27 
sgs1ΔC260 159 85-362 
sgs1ΔC280 244 166-387 
sgs1ΔC300 145 76-204 
sgs1ΔC400 106 60-180 
sgs1ΔC500 102 53-252 
sgs1ΔC600  152 26-283 
sgs1ΔC700 189 49-271 
sgs1ΔC800 133 71-225 
sgs1ΔC1428  206 97-273 
sgs1-C1047F 64 35-131 
sgs1-F1056A  <16 <10-26 
mec3Δ  sgs1ΔC200  11 < 7 - 22 
mec3Δ  sgs1ΔC300  1003 691-1500 
mec3Δ  sgs1ΔC800  758 645-895 
mec3Δ  sgs1ΔC800-blmΔN643  361 330-419 
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Table 2.2. Effect of BLM expression on GCR accumulation in the sgs1Δ  mutant. 
Relevant Genotype1 
Galactose 
concentration in media 
GCR Rate 
(Canr 5-FOAr x 10-10) 
95% CI2 
(Canr 5-FOAr x 10-10) 
wild-type 0% 1.1 < 1 – 6.2 
PSGS1BLM  0% 70 56-151 
PGALBLM 0% 61 30-153 
PGALBLM 0.1% 335 233-576 
PGALBLM 0.5% 382 170-777 
PGALBLM 2% 1832 1090-2910 
PGALSGS1 2% < 11 < 9-12 
sgs1Δ  2% 54 23-104 
 
1 Human BLM cDNA was inserted at the endogenous SGS1 locus, fused to the native 
SGS1 promoter (PSGS1) or fused to a galactose-inducible promoter (PGAL). In PGALSGS1, 
the native SGS1 promoter region was disrupted by fusing the SGS1 ORF to a 
galactose-inducible promoter. If strains expressing BLM or SGS1 genes from the 
galactose-inducible GAL1 promoter were grown in less than 2% galactose (to lower 
protein expression levels) media was supplemented with sucrose to reach a total sugar 
concentration of 2%. 
2 We calculated 95% confidence intervals (CI) according to Nair 
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Abstract 
Bloom’s syndrome (BS) is an autosomal recessive disorder caused by mutations in the 
RecQ-like DNA helicase BLM, which functions in the maintenance of genome stability. 
Using a humanized model of Saccharomyces cerevisiae that expresses a chimera of the 
N-terminus of yeast Sgs1 and the C-terminus of human BLM from the chromosomal 
SGS1 locus, we have functionally evaluated 27 BLM alleles that are not currently known 
to be associated with BS. We identified nine alleles with impaired function when 
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assessed for hypersensitivity to the DNA-damaging agent hydroxyurea (HU). Six of 
these alleles (P690L, R717T, W803R, Y811C, F857L, G972V) caused sensitivity to HU 
that was comparable to known BS-associated or helicase-dead alleles, suggesting that 
they may cause BS and, in the heterozygous state, act as risk factors for 
cancerogenesis. We also identified three alleles (R791C, P868L, G1120R) that caused 
intermediate sensitivity to HU; while unlikely to cause BS, these partial loss-of-function 
alleles may increase risk for cancers or other BS-associated complications if a person is 
homozygous or compound heterozygous for these alleles or if they carry a known 
BS-associated allele. 
Introduction 
Bloom’s syndrome (BS) is a rare genetic disorder with 264 affected individuals 
worldwide currently included in the Bloom’s syndrome registry (Ellis, Sander et al. 2008). 
BS is characterized by proportional dwarfism, erythema on sun-exposed skin, hyper- or 
hypopigmented areas of skin, immunodeficiency, and subfertility (Bloom 1954; German J 
& Ellis NA. Bloom syndrome. In: Vogelstein and Kinzler 1998). Persons with BS have a 
striking predisposition to cancer development and increased risk for early-onset type-II 
diabetes (German J & Ellis NA. Bloom syndrome. In: Vogelstein and Kinzler 1998). Life 
expectancy is short, ranging from 1-49 years, with a mean age at death of 27 (German 
and Passarge 1989; Ellis, Sander et al. 2008).  
BS is caused by mutations in the BLM gene whose 22 exons encode a 3’-5’ DNA 
helicase that is related to RecQ of Escherichia coli and Sgs1 of Saccharomyces 
cerevisiae (Ellis, Groden et al. 1995; Bennett and Keck 2004). Nineteen recurring and 45 
unique mutations in BLM have been identified as causative of BS (German, Sanz et al. 
2007). BlmAsh, which occurs at a frequency of ~ 0.5% in the Ashkenazi Jewish 
  61 
population, is the most common BS-associated mutation - a frameshift caused by 
deletion of six nucleotides and insertion of seven different nucleotides (Ellis, Roe et al. 
1994; Ellis, Ciocci et al. 1998; Li, Eng et al. 1998; Straughen, Johnson et al. 1998). Most 
other BS-associated mutations are also frameshifts or point mutations that lead to 
premature termination of BLM upstream of or within the helicase domain, causing 
complete loss of function. However, thirteen missense mutations - seven in the helicase 
domain and six in the RecQ C-terminal (RQC) domain - have also been identified in 
persons with BS (German, Sanz et al. 2007). Five of these missense mutations have 
been characterized in vitro and were found to impair BLM’s ability to bind and hydrolyze 
ATP or to bind DNA (Guo, Rigolet et al. 2007). Although a crystal structure of the BLM 
helicase core has not yet been reported, modeling of known BS-associated mutations 
onto the crystal structure of E. coli RecQ has revealed molecular and structural 
explanations for these defects (Guo, Rigolet et al. 2007). Crystal structures of other 
RecQ-like DNA helicases, most notably those of the helicase core of human RecQL1 
and the winged-helix (WH) domain of WRN in a complex with DNA, have revealed that 
even domains that show no significant sequence identity, such as the WH-domains, are 
structurally and functionally conserved within the RecQ helicase family (Pike, Shrestha 
et al. 2009; Kitano, Kim et al. 2010). Normal BLM function also depends on its physical 
interaction with topoisomerase IIIα and Rmi1/Rmi2. Together they form the so-called 
BRT complex, which is involved in dissolving homologous recombination intermediates 
as noncrossovers (reviewed in reference (Hickson 2003). Interactions with Rad51, Mlh1, 
p53 and ATM have also been reported (Wang, Cortez et al. 2000; Wu, Davies et al. 
2001). Thus, BS cells are hypersensitive to DNA damaging agents, show elevated rates 
of mitotic recombination, especially between sister chromatids, but also between 
homologous chromosomes, and they accumulate abnormal replication intermediates 
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(Chaganti, Schonberg et al. 1974; Groden, Nakamura et al. 1990; Lonn, Lonn et al. 
1990; Groden and German 1992). Evidence that heterozygosity for BS-associated 
mutations is associated with increased cancer risk comes from a study that showed a 
greater than two-fold increase in colorectal cancer risk in carriers of the blmAsh mutation, 
though this association is somewhat uncertain (Gruber, Ellis et al. 2002; Cleary, Zhang 
et al. 2003). Associations between noncoding single nucleotide polymorphisms (SNPs) 
in BLM and breast cancer and to a lesser extent bladder cancer, malignant melanoma, 
acute myeloid leukemia and myelodysplastic syndromes have also been reported 
(Broberg, Huynh et al. 2009; Ding, Yu et al. 2009), and it has been suggested that these 
noncoding SNPs may be linked to functional SNPs in exons of BLM. However, it is 
unknown which, if any, of the 75 currently known coding BLM variants alter BLM 
function. Here, we have employed an S. cerevisiae system that expresses a chimera 
composed of the N-terminus of Sgs1 and the C-terminus of BLM under control of the 
chromosomal SGS1 promoter to functionally evaluate 27 variants of the BLM gene that 
are not currently known to be associated with BS. 
Results 
Identification of Total Loss-of-Function BLM Alleles not Currently 
Associated with BS  
Like BS cells, yeast cells lacking Sgs1 are hypersensitive to DNA-damaging 
agents (Mullen, Kaliraman et al. 2000). Deletion of the C-terminal 800 residues of Sgs1 
eliminates the HRDC (Helicase and RNAase D C-terminal), helicase and RQC domains, 
the latter two of which make up the helicase core of Sgs1. Hydroxyurea (HU) sensitivity 
of cells expressing this Sgs1 truncation is suppressed by replacing the missing 
C-terminal 800 residues of Sgs1 with the C-terminal half of human BLM (residues 
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648-1417) (Mirzaei, Syed et al. 2011) (Figure 3. 1 A and B). Figure 3.1B shows that the 
function of this chimera depends on enzymatic activity contributed by BLM since 
mutating the conserved lysine in the Walker A motif of BLM (K695R) or introducing 
mutations known to cause BS (C1036F, C1055S, D1064V) inactivated the chimera, 
causing severe sensitivity to HU. The region of BLM included in the chimera contains 41 
of the 75 missense mutations from dbSNP that are not currently known to be associated 
with BS and two additional, rare variants (c.2069C>T, P690L; c.3970C>T, H1324T) 
reported by German et al. (German, Sanz et al. 2007). Using PolyPhen (Adzhubei, 
Schmidt et al. 2010), we first ranked these 43 variants according to their probability to 
impair BLM function (Table 3.S1). The 11 variants predicted to be ‘probably damaging’ 
(score > 2.0) and the 11 variants predicted to be ‘possibly damaging’ (score > 1.5) were 
selected for in vivo analysis (Table 3.1). In addition, we chose the three highest ranked 
variants with a score < 1.5 (‘benign’) and two lower ranked variants for a total of 27 
amino acid changes to be functionally evaluated in vivo (Table 3.1, Figure 3. 1A). These 
27 variants were introduced into BLM cDNA and stably integrated at the chromosomal 
SGS1 locus. Expression of the BLM variants from the endogenous SGS1 promoter 
ensured cell-cycle-regulated expression and copy number control.  
By assessing the ability to grow in the presence of HU, we identified six total 
loss-of-function BLM alleles that are currently not associated with BS: P690L, R717T, 
W803R,  Y811C, F857L and G972V (Figure 3. 2). Expression of these BLM variants 
caused cells to be as sensitive to HU as cells expressing the helicase-dead K695R allele 
(Figure 3. 2) or known BS-associated alleles (Fig 1B). Yeast cells expressing these 
alleles were also hypersensitive to the alkylating agent methyl methanesulfonate (MMS) 
and 4-nitroquinoline 1-oxide (4NQO), which induces bulky DNA adducts (Figure 3. S1). 
Three of these six mutations affect residues in conserved helicase motifs (Figure 3. 3A); 
  64 
P690 maps to the Walker A motif, R717 to motif Ia and G972 to motif VI. W803 is 
located in a highly conserved aromatic-rich (AR) loop that follows the Walker B motif. 
Y811 and F857 are located between motifs II and III, and motifs III and IV, respectively. 
Only W803R affects a residue that is conserved in all five human RecQ homologs (BLM, 
WRN, RecQL1, RecQL4, RecQL5), whereas the others affect residues that differ in at 
least one of them. The arginine at position 717 is not conserved, with leucine or 
isoleucine being present at those positions in the other four human RecQ-like helicases, 
in Sgs1 and in RecQ. While the structure of the helicase domain of BLM has not been 
solved, those of E. coli RecQ and human RecQL1 were recently reported (Bernstein, 
Zittel et al. 2003; Pike, Shrestha et al. 2009). Based on ClustalW2 alignments P690, 
R717, W803 Y811, F857, G972 of BLM correspond to P114, I141, W227, Y235, F281 
and N397 of RecQL1 with no significant gaps in the alignment (Figure 3. 3A). Modeling 
the BLM residues onto the RecQL1 structure revealed that P690, R717, W803 and Y811 
are located in the first of the two RecA-like lobes of the helicase domain, whereas G972 
is located in the second lobe, with F857 in the loop connecting the two lobes (Figure 3. 
3C and D). Notably, all six affected residues are located near the surface of the deep 
cleft between the two lobes. Residues exposed along this cleft, including those that 
make up the conserved helicase motifs, are critical for ATP-binding and hydrolysis as 
well as single-strand DNA binding (Korolev, Yao et al. 1998; Velankar, Soultanas et al. 
1999; Bernstein, Zittel et al. 2003; Zittel and Keck 2005; Guo, Rigolet et al. 2007; Pike, 
Shrestha et al. 2009). 
Identification of Partial Loss-of-Function BLM Alleles  
In addition to total loss-of-function alleles we identified three alleles (R791C, 
P868L, G1120R) that caused slight growth inhibition on HU, suggesting a partial loss of 
function (Table 3.1, Figure 3. 2). Cells expressing these alleles also showed slightly 
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increased sensitivity to 4NQO, and to a lesser extent to MMS (Figure 3. S1). These 
partial loss-of-function mutations affect residues in the helicase core; however, they are 
not on the surface of the cleft between the two lobes. Instead, R791 borders the stretch 
of four hydrophobic residues that precedes the invariant aspartic acid (D795) and 
glutamate (E796) residues of the Walker B motif (Figure 3. 3 A and D) whereas P868 is 
furthest from the cleft in a loop that follows the first β-sheet of lobe 2 (Figure 3. 3E). The 
third affected residue, G1120, is located in the α2-α3 loop of the WH-domain and 
appears to be the only BLM variant that exhibits impaired function due to a missense 
mutation in this domain (Figure 3. 3 B, F and G). The WH-domain of RecQ-like helicases 
has recently been implicated in DNA recognition and strand separation (Pike, Shrestha 
et al. 2009; Kitano, Kim et al. 2010). Although there is no significant sequence identity 
between the WH-domains of RecQ helicases, ClustalW2 and structure-based 
alignments show that G1120 is conserved in Sgs1, RecQ and all four human RecQ-like 
DNA helicases that possess an RQC domain (Figure 3. 3B, Figure 3. S2 B) (Kitano, Kim 
et al. 2010). When we changed G1120 to a different residue (G1120E) we observed the 
same partial defect, further supporting the importance of G1120 for BLM function (Figure 
3. S3).  
Although predicted by PolyPhen to be ‘probably damaging’, the H1014R and 
H660Y alleles did not cause hypersensitivity to HU. None of the BLM alleles predicted to 
be ‘possibly damaging’ or predicted to be ‘benign’ impaired BLM function in the HU 
sensitivity assay (Table 3.1, Figure 3. 2). Of the 17 amino acid changes that did not 
impair BLM function, 13 are located in domains for which crystal structures or solution 
structures have been determined in at least one member of the RecQ-like DNA helicase 
family (Figure 3. S4). Seven of these amino acid changes map to the helicase domain 
and affect residues along the periphery of lobe 1 or lobe 2 away from the cleft between 
  66 
the lobes where the conserved helicase motifs are located (Figure 3. S4 A). Three other 
amino acid changes are located in the zinc-binding subdomain (Figure 3. S4 B) and two 
are located in the α3-α4 loop of the WH subdomain, which in contrast to the α2-α3 loop, 
where the partially defective G1120R mutation is located, is not known to be involved in 
DNA binding (Figure 3. S4 C). Finally, one amino acid change that did not impair BLM 
function maps to the HRDC domain (Figure 3. S4 D).    
Corresponding Amino Acid Changes Impair Sgs1 Function  
Of the five human RecQ-like DNA helicases, BLM is most closely related to 
Sgs1. Alignments between both proteins show 50% identity across the helicase core 
where the affected residues in all nine functionally impaired BLM variants are located. To 
determine if the functional impairment was limited to BLM or if the equivalent mutations 
also affected Sgs1 function we constructed nine sgs1 alleles that corresponded to the 
nine partially or fully impaired BLM alleles (Fig 4 A, Figure 3. S2). Identifying the 
equivalent residues in Sgs1 was unambiguous except for the proline residue at position 
868, which in BLM is located in a lysine-rich loop (868PKKPKK873) recently suggested to 
interact with DNA (Kitano, Kim et al. 2010). This proline is not present in Sgs1 and in the 
absence of a crystal structure of Sgs1 it is unclear if the loop is conserved. However, 
since the positive charge of the loop has been suggested to be functionally important for 
DNA binding we decided to mutate the first of three lysines in this region (K881) to 
leucine. The nine mutations were introduced into the SGS1 gene on a CEN/ARS 
plasmid expressed under control of the native SGS1 promoter and then tested for their 
ability to complement the HU hypersensitivity of an sgs1Δ mutant (Figure 3. 4 B). The 
W816R and Y824C alleles could not suppress the HU hypersensitivity of the sgs1Δ 
mutant whereas P701L, F870L and G1115R partially suppressed it, indicating impaired 
function of these five sgs1 alleles. The I732T, R804C, K881L and G983V alleles 
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appeared to fully suppress HU sensitivity of the sgs1Δ mutant, suggesting they retained 
activity that was similar to that of the SGS1 wild-type allele. Taken together, five of the 
six amino acid changes that caused a total loss of BLM function also impaired Sgs1 
function, whereas one of the three partial loss-of-function mutations did (Table 3.2). 
Notably, all BLM mutations that affected residues also conserved in Sgs1 and E. coli 
RecQ impaired Sgs1 function whereas those that are not conserved in E. coli RecQ, 
Sgs1 and BLM did not (Figure 3. 4 A, Figure 3. S2, Table 3.2). 
Genetic Interactions between BLM Variants in Diploid Cells  
To assess possible genetic interactions between BLM alleles we constructed 
diploids with various combinations of wild-type, partial loss-of-function and total 
loss-of-function alleles (Figure 3. 5, Figure3. S5). As expected, diploids homozygous or 
compound heterozygous for total loss of function alleles were most sensitive to HU. 
However, while we expected that diploids homozygous or heterozygous for wild-type 
alleles would not be hypersensitive to HU regardless of the status of the second allele, 
we observed that diploids heterozygous for total loss-of-function and wild-type alleles 
(Figure 3. 5, rows 4-7) were more sensitive to HU than diploids that were biallelic for 
wild-type alleles (Figure 3. 5, rows 1-3). We made similar observations when we 
included additional total loss-of-function alleles (K695R, C1055S) in the analysis (Figure 
3. S5). HU sensitivity of diploids homozygous for the partial loss-of-function P868L allele 
or heterozygous for P868L and one of the total loss-of-function alleles fell between that 
of diploids biallelic for wild-type or total loss-of-function alleles (Figure 3. S5). These 
findings could be explained by insufficient wild-type BLM protein or a lower activity of 
multimeric BLM helicase complexes that consist of a mixture of wild-type and 
nonfunctional monomers.  
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Discussion  
In this study we have used S. cerevisiae to functionally evaluate 27 BLM variants 
that are not currently associated with BS. The mutant BLM alleles were chromosomally 
expressed from the endogenous SGS1 promoter. The advantage over plasmid based 
approaches or expression from inducible or constitutive promoters is that BLM 
expression in this system is cell cycle regulated and copy number controlled. Similar to 
Sgs1, BLM appears in S-phase, is maintained at similar levels in G2/M, but has mostly 
disappeared by the time cells re-enter G1 (Dutertre, Ababou et al. 2000). Regulation of 
BLM expression by the chromosomal SGS1 promoter was critical since the goal of our 
study was to evaluate BLM variants that are not known to cause BS. Therefore, the 
experimental system had to be designed such that besides wild-type and null alleles it 
could also detect partial loss-of-function alleles, which impair BLM function, but at a level 
too weak to cause BS. The subtle defects exhibited by such weak alleles may be 
compensated for and thus go undetected in overexpression systems or in the absence 
of appropriate cell cycle regulation.  
Using this approach, we identified six total loss-of-function BLM alleles (P690L, 
R717T, W803R, Y811C, F857L, G972V) and three partial loss-of-function alleles 
(R791C, P868L, G1120R). While biochemical analysis will uniquely identify the specific 
defect of each of these BLM variants, previous structure-function analyses of RecQ and 
other helicases as well as the in vitro characterization of known BS-associated mutations 
allow us to make some predictions. For example, although the P690L mutation does not 
affect one of the highly conserved GK(T/S) residues of motif I (Walker A), its location 
within this motif most likely leads to loss of function because of an inability to bind ATP 
and/or Mg2+. The R717T mutation affects a variable residue of motif Ia. The effect of 
mutations in motif Ia has not yet been investigated, primarily because none of the 
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missense mutations known to cause BS are located in this motif. However, structural 
analyses have revealed that residues from motif Ia engage in ssDNA binding (Korolev, 
Hsieh et al. 1997; Kim, Morgenstern et al. 1998; Korolev, Yao et al. 1998; Velankar, 
Soultanas et al. 1999), and replacing the positively charged arginine with a neutral 
threonine may weaken ssDNA binding in this critical region. The third loss-of-function 
variant, W803, is located in an AR-loop that was originally described in the PcrA and 
shown to be critical for coupling ATP hydrolysis to DNA binding and unwinding 
(Dillingham, Soultanas et al. 1999; Velankar, Soultanas et al. 1999; Dillingham, 
Soultanas et al. 2001). This AR-loop is conserved in RecQ-like helicases, including BLM, 
Sgs1 and E. coli RecQ. The loss of function caused by mutating Y811, another aromatic 
residue just outside the AR-loop, is likely due to a similar inability to coordinate ATP 
hydrolysis with DNA binding/unwinding. F857 is located between motifs III and IV in the 
flexible loop that connects the two RecA-like lobes that make up the helicase domain. A 
mutation on this side of the interlobe cleft, which accommodates the ATP binding site, 
may interfere with ATP binding/hydrolysis. In SF-1 helicases, an ‘arginine-finger’ motif VI 
in lobe 2 also reaches into this site to interact with ATP (Soultanas, Dillingham et al. 
1999; Velankar, Soultanas et al. 1999), and it is plausible that the conserved arginine 
residues in motif VI of RecQ helicases (R978, R982 of BLM), which also reach into the 
ATP-binding site (Killoran and Keck 2006), serve the same function. Mutation of G972, 
which is located near this ‘arginine finger’, could therefore impair coordination between 
lobe 2 and ATP binding in lobe 1.  
Besides total loss-of-function mutations we identified three BLM alleles that retain 
partial activity (R791C, P868L, G1120R). Instead of being at or near the surface of the 
interlobe cleft where residues of the conserved motifs are exposed, the R791C and 
P868L mutations affect residues within or adjacent to internal β-sheets (Figure 3. 3 D 
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and E). However, R791 is close to the invariant D795 of the DExH motif II (Walker B) 
and, thus, the partial loss of function is most likely due to decreased ATP hydrolysis. In 
contrast, since the residue of REQL1 equivalent to P868 of BLM is not near the interlobe 
cleft its mutation is unlikely to affect the function of the conserved helicase motifs. 
Instead, its location near the bottom of lobe 2 where the zinc-binding domain adjoins the 
helicase domain (Figure 3. 3 E) may weaken the interaction between these two 
domains, which is thought to be important for DNA binding and protein stability. In fact, 
P868 is the first residue in a lysine-rich loop (residues 869-873) that has been suggested 
to play a role in stable DNA binding by BLM (Guo, Rigolet et al. 2007). Unlike R791C 
and P868L, the G1120R mutation is located in the RQC domain of the helicase core. It is 
the only known BLM variant whose defect is due to a missense mutation in the 
WH-subdomain. A recent analysis of the crystal structure of the WH-domain of WRN 
complexed with DNA indicates that in RecQ-like helicases two loops, one between the 
α2 and α3 helices and one between the β2 and β3 strands, are involved in 
sequence-independent DNA binding and strand separation, respectively, and undergo 
conformational changes upon DNA binding (Kitano, Kim et al. 2010). The importance of 
the conserved glycine in the α2-α3 loop is likely to stem from its low propensity (the 
lowest next to proline) for α-helix formation and, thus, its ability to maintain the loop 
structure and provide the flexibility needed for the conformational change (loop 
extension) and exposure of residues for DNA binding. Mutation analysis has confirmed 
the importance of the β-wing for DNA binding and helicase activity in WRN and RECQ1 
(Pike, Shrestha et al. 2009; Kitano, Kim et al. 2010). The identification of the partially 
defective G1120R and G1115R alleles now also provides in vivo support for the 
functional importance of the α2-α3 loop in BLM and Sgs1, respectively. Similarly, 
impairment of Sgs1 and BLM by the equivalent F870L and F857L mutations, 
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respectively, suggests functional importance in both helicases of the β7- β8 loop where it 
reaches into the interlobe cleft. Equivalent mutations in or near the AR-loop and the 
Walker A motif also impaired the function of both BLM and Sgs1. However, K881L 
(P868L in BLM) did not impair Sgs1 function, suggesting that the lysine-rich loop in lobe 
2 of BLM and its role in helicase function is not conserved in Sgs1. Indeed, this finding 
provides in vivo support for the recent proposal that the lysine-rich loop and its function 
may be unique to BLM (Guo, Rigolet et al. 2007).      
With the exception of the blmAsh allele, which occurs at a frequency of ~ 0.5% in 
the Ashkenazi Jewish population, alleles known to cause BS are very rare (< 0.1%) 
(Ellis, Roe et al. 1994; Li, Eng et al. 1998; German, Sanz et al. 2007). Indeed, most BS 
mutations have only been found in a single individual with BS (German, Sanz et al. 
2007). It is therefore likely that additional BS alleles exist in the human population that 
have, due to their rarity and the autosomal recessive pattern of inheritance of BS, not yet 
been identified in a person with BS. We propose that the six total loss-of-function alleles 
may be candidates for new BS mutations. Based on the recent finding that the frequency 
of P868L in the human population is ~ 4.6 % (Wirtenberger, Frank et al. 2006), we 
further propose that partially defective BLM variants (R791C, P868L, G1120R) are 
unlikely to be associated with full-scale BS as the predicted homozygosity for the P868L 
allele in the human population far exceeds the incidence of BS.  
Whether carriers for disease-causing BLM mutations also exhibit genome 
instability and are at increased risk for cancerogenesis is only beginning to be 
investigated. In one study, heterozygosity for the most common BS-associated mutation, 
blmAsh, was associated with increased colorectal cancer risk, although this increase was 
not seen in another study (Gruber, Ellis et al. 2002; Cleary, Zhang et al. 2003). Evidence 
of a gene dosage effect (haploinsufficiency) for BLM in colorectal tumorigenesis in mice 
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also indicates that heterozygosity for BLM plays a role in cancer predisposition (Goss, 
Risinger et al. 2002). Similarly, we observed diploids heterozygous for loss-of-function 
BLM alleles were more sensitive to DNA-damaging agents than wild-type diploids. This 
hypersensitivity could be due to haploinsufficiency or decreased activity of helicase 
complexes that consist of mixtures of wild-type and mutant BLM monomers. The 
possibility that the defect may be specific to expression being controlled by the SGS1 
promoter and may not apply to protein levels expressed from the endogenous BLM 
promoter also cannot be excluded.  
Besides the possibility of increased cancer risk for carriers of loss-of-function 
BLM mutations, hypomorphic BLM alleles - those that are partially functional and 
therefore do not cause all the clinical features of BS - may be associated with increased 
cancer risk. With the identification of the P868L polymorphism as a hypomorphic BLM 
allele candidate, it will now be possible to determine if such an association exists. A 
recent report, which found an allele-dosage-dependent effect of P868L on rectal cancer 
risk, does indeed point towards this possibility (Frank, Hoffmeister et al.). With an 
estimated 1 in 10 individuals being carriers of P868L (Wirtenberger, Frank et al. 2006) 
and, thus, ~ 1 in 500 individuals being predicted to be homozygous, an association 
between P868L homozygosity and an elevated risk for cancer (or other risks associated 
with genome instability, such as hypersensitivity to chemotherapeutics or other 
genotoxic agents), would be significant. Despite the evidence from our yeast system, it 
will remain unclear if R791C and G1120R are also hypomorphic alleles like P868L until 
the frequency of these alleles in the human population is determined. Notably, carriers of 
a known BS mutation (or one of the total loss-of-function alleles identified here) who also 
carry a hypomorphic allele such as P868L, i.e. who have no fully functional BLM allele, 
might also be at higher risk for cancers commonly associated with BS, such as 
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leukemia, lymphoma or epithelial cancers (German 1997), or they may exhibit a BS-like 
disorder, characterized by milder expression or later onset of a combination of 
BS-associated symptoms.  
Methods 
Yeast strains, plasmids and media  
Strains are derived from RDKY3615 (MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, 
lys2Bgl, hom3-10, ade2Δ1, ade8, hxt13::URA3). Diploids were constructed by mating 
haploids with the desired BLM allele. BLM cDNA was purchased from Open Biosystems 
(clone MGC286) and the HIS3 cassette from pRS303 was inserted into a SpeI site 
downstream of BLM. Variants were introduced into the cDNA by site-directed 
mutagenesis. A PCR product comprising nucleotides 1942 to 4251 of BLM and the HIS3 
marker cassette was used to replace nucleotides 1942 to 4341 of the chromosomal 
SGS1 ORF in RDKY3615 by recombination-mediated integration (Gietz and Woods 
2006), leading to expression of a fusion of the N-terminus of Sgs1 and the C-terminus of 
BLM (Sgs1-BLM). In-frame fusion at nucleotide 1941, the integrity of the integrated BLM 
cDNA sequence and the presence of the desired variant were confirmed by sequencing. 
Mutations in plasmid-borne SGS1 were introduced by site-directed mutagenesis and 
confirmed by sequencing of SGS1. Yeast strains and plasmids used in this study are 
listed in Tables S2 and S3. Yeasts were cultured in liquid yeast extract/peptone/dextrose 
(YPD) with shaking at 30°C or grown on YPD agar at 30°C.  
Sensitivity to DNA damaging agents  
Cell cultures were grown overnight in YPD (or in synthetic media lacking leucine to 
maintain pRS415 derived plasmids), diluted to OD600 = 0.2 and incubated until they 
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reached OD600 = 0.5-0.6. Tenfold dilutions were spotted on YPD and YPD supplemented 
with HU, MMS or 4NQO as indicated.  
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Figures and Tables 
 
Figure 3.1. Location of 27 BLM variants evaluated in this study  
(A) The C-terminal 770 residues of BLM were fused to the 647 N-terminal residues of 
Sgs1 to construct a chimera (Sgs1-BLM) that confers resistance to hydroxyurea (HU) in 
cells lacking Sgs1. Conserved domains are indicated by black boxes (helicase motifs) 
and by horizontally (RQC) or vertically (HRDC) striped boxes (12). Disorder scores are 
from IUPRED, with > 0.5 predicting disorder and < 0.5 predicting order (B) HU sensitivity 
of yeast cells expressing the Sgs1-BLM chimera, the helicase-dead Sgs1-BLM-K695R 
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Figure 3.2. HU sensitivity of yeast cells expressing BLM variants  
Variants were chromosomally expressed from the endogenous SGS1 promoter and 
ten-fold dilutions of exponentially growing cultures were spotted on YPD with HU or 
without HU. Variants that cause sensitivity equivalent to that of the helicase-dead variant 
(K695R) are shown in red (total loss of function), those that grow as well as wild-type in 
black and those that cause HU sensitivity intermediate between wild-type and the 
helicase-dead variant in blue (partial loss of function). The asterisk marks a BLM variant 
listed in dbSNP that was originally reported as a missense mutation (6), but 
subsequently identified to be a deletion of exons 11 and 12, resulting in a premature 
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Figure 3.3. Location of nine missense mutations found in this study to impair BLM 
function  
(A) ClustalW2 alignment between the helicase domain of human BLM and RecQL1. 
Identical residues are shaded gray. Total and partial loss-of-function mutations are red 
and blue, respectively. Helicase motifs and an aromatic-rich (AR) loop are indicated by 
horizontal lines. (B) Structure-based alignment of WH-domains (partial) of BLM, RecQL1 
and WRN, adapted from Kitano et al. (13). Structurally important residues are underlined 
and functionally important residues in the α2-α3 loop and β-wing are shown in bold. The 
glycine in the G1120R mutation is shaded blue. (C-F) Residues affected in BLM variants 
are highlighted in the crystal structure of RecQL1 (14). (C) Location of the six total 
loss-of-function mutations (pink spheres) along the cleft between the lobe 1 (blue) and 2 
(green). ADP is shown as an orange stick model and Mg2+ is shown as a yellow sphere. 
(D) R791 is located in lobe 1, with the nearby, invariant residue D795 (Walker B) shown 
as a red stick model. (E) The residue corresponding to P868 is located at the base of 
lobe 2 where the zinc-binding domain (yellow) adjoins. The loop connecting lobes 1 and 
2 and the β-sheets flanking this loop are indicated in red. (F) G1120 is located in the 
WH-domain (grey). The α2-α3 loop and β-wing are shown in green. (G) Location of the 
residue equivalent to G1120 in the WH-domain of WRN crystallized with DNA (13). The 
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Figure 3.4. HU hypersensitivity of sgs1 mutants with amino acid changes 
corresponding to those that impair BLM function  
(A) ClustalW2 alignment of Sgs1, human BLM and E. coli RecQ. Amino acid changes in 
Sgs1 are indicated in red if the corresponding BLM mutation causes total loss of 
function, or in blue if the corresponding BLM mutation causes partial loss of function. (B) 
sgs1 mutant alleles were expressed from pRS415 and the native SGS1 promoter to test 
for their ability to suppress HU hypersensitivity of sgs1Δ cells. Empty vector (pRS415) 
and vector expressing wild-type Sgs1 (pRS415-SGS1) served as negative and positive 
controls, respectively.  
  
Sgs1 1076 ANVINEERDVTEPAKKIVKLVESIQN-------------ERVTIIYCQDVFKGSRSSKIVQANHDTLEEHGIGK 
BLM 1068 KTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHN 
RecQ 405 CLDPPKQYDGSTDAQIALSTIGRVN--------------QRFGMGYVVEVIRGANNQRIRDYGHDKLKVYGMGR 
RECQL1 480 KDSAFERKNITEYCRDLIKILKQAEELN-----------EKLTPLKLIDSWMGKGAAKLRVAGVVAPTL----- 
WRN 950 DDSEDTSWDFGPQAFKLLSAVDILG--------------EKFGIGLPILFLRGSNSQRLADQYRRHSLF-GTGK 
 
 
Sgs1 1137 SMQKSEIERIFFHLITIRVLQEYSIMNNSGFASSYVKVGPNAKKLLTGKMEIKM 
BLM 1143 AERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENS 
RecQ 465 DKSHEHWVSVIRQLIHLGLVTQN--IAQHSALQL-TEAARPVLAESSLQLAVPR 
RECQL1 539 --PREDLEKIIAHFLIQQYLKEDYSFTAYATISYLKIGPKANLLNNEAHAITMQ 
WRN 1009 DQTESWWKAFSRQLITEGFLVEVSRYNKFMKICALTKKGRNWLHKANTESQSLI 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEP FLKQS NRTN YYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMS NRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 


















Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 S MQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 S IVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
RecQ 78 S MKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 NKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 LPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
Sgs1 659 TYPWSDEVLYR HEVFKLPGFRPNQLEAVN TLQGKDVFVLMPTGGGKSLCYQLPAVVK G THG TIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAIN ALLGEDCFILMPTGGGKSLCYQLPACVSP--- GVTV ISPLR 
RecQ 8 VLNLESGAKQVL ETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN--- GLTVVVSPLI  
 
 
Sgs1 733 SLMQDQVEHLLNKNI ASMF SRGTAEQRR TF--NLFINGLLD VYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIVDQ QKLTS DIPATYL GDKT SEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLEN YERKLLAR 
RecQ 78 SLMKDQV LQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH--- L AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKEL FF REYPDI M ALT TA EQVRMDIIHNLELK PVFLKQSFN T LYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKF SV VMAL TANPRVQKDILTQ KI RPQVFSMSFN H LK Y 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQ R RFPTL FMALT TA DTTRQDIVRL G NDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-T N IFE CDAVKSRFKNQTGIIYCHSKK CEQTSAQMQRNGIKCAYYHAGMEPD RLSVQKAWQ-ADE 
BLM 870 VLPKK VAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAA YH GLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQ MRYVQEQRGKS IIYCNSRAKVEDTAAALQSKGISAAAYH GLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQV CATV FGMGIDKP VRF YHFTVPRTLEGYYQETGRA D NYSYCITYF 
BLM 942 CQVICATI FGMGIDKP VRF IHASLPKSVEGYYQESGRA D EISHCLLFY
RecQ 289 LQIVVAT FGMGINKP VRF VHFDIPRNIESYYQETGRA D LPAEAMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
gs1 733 SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFV MPTGGGKSLCYQLPAV KSGKTHGTTI IS LI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLG DCF LMPTG GKSLCYQLPACVSP----GVTVVIS LR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTV SGRDCL VMP G GKSLCYQIPALLLN----GLTV S LI  
 
 
Sgs1 733 SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMIS SEQCKRAISR YAD K AR 
BLM 722 SLIVDQV KLTSLDIPATYLTGDKTDSEATN YL LS KDPIIKLLYVTPEKICA NRLIST ENLYERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNF EH----L-AHWNPV   
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELK PVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNM RQK PSVPVMALTATANPRV KDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 AVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATAD TTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 NKK-TK TIFEICDAV SR KNQTGIIYCHS KSCEQTSAQMQRNGIKCAYYHAGMEPDERL VQKAWQ-ADE 
BLM 870 LPKKPKKVAFDCLEWIRKHHPYDSGII C SRRECDTMA T QRDGLAALAYHAGLSDSA D VQQKWINQDG 
RecQ 219 LMEKFKP--- DQLMRYVQEQRGKSGIIYCNSRA VEDTAAA QSKGISAAAYHAGLEN V D QEKFQ-RDD 
 
 
Sgs1 951 IQVI TVAF GI KPDVRFVYHFTVPRTLEGYYQETGRA R GNYSYCITY  
BLM 942 CQVICATIAF MGIDKP VRFVIHASLPKSVEGYYQESGRA R GEISHCLLFY 
RecQ 289 LQ VV TVAF MGI KPNVRFVVHFDIPRNIESYYQETGRA RDGLPAEAMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFI MPTGGGKS CYQL ACVSP----GVTVVISP R 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIR LYI PERLMLDNFL H---- -AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNK -TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHA MEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKKVAFDCLEWIR HPYDSGIIYCLSRRECDTMADTLQRD LAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHA LENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAF MGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQI VATVAFGMGINKPNVRFV HFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 LMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAI RL ADGKLAR 
BLM 722 S IVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTP KICASNRLISTLENL ERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTRE QL--EVMTGCRTGQ RLLYIAPERLMLDNFLEH----L-AHWNPV   
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKF SVPVMALTATANPRVQKDI TQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQ SSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTIFEICDA KSRFKNQTGIIYCHSKKSC QTSAQMQRNG KCAYYH GMEPDE LSVQKAWQ-ADE 
BLM 870 V PKKPKKVAFDCLEWIRKHHPYD GIIYCLSRRECDTMADTLQRDGLAAL YH GLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRY Q QRGK GIIYCNSRAKVEDTAAALQSKGISAA YH GLENNV A VQEKFQ-R D 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIH SLPKSVEGYYQESGRAGRDGEISHCL FY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYY ETGRAGRD LPA AMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESG KQVLQETFGYQQFRPGQEEI DTVLSG DCLVV PTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 SLMQD VEHLLNK IKASMFSSR TAEQR QTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIV QVQKLTSL IP TYLTGDKTDSE TNIYL LSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
Rec  78 SLMKDQVDQLQANGVAA CLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVD AHCVSNW HDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVID AHCVSQW HDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVD AHCISQW HDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAV AT QGKDVFVL PTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SF HTKEMMKIFHKKFGLHNFRTNQLEAINAA LGEDCFILMPTG GKSLCY LPACVSP----GVT V LR 
RecQ 8 V LESG KQVLQE FGY QF PGQEEIIDTVL GRDCLVVMPTGGGK LCYQ PAL LN----GLTVV S LI  
 
 
Sgs1 733 SLMQ QVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIV V KLT LDIPATY TGDKT SEATNIYLQLS KDPIIK LYVTP KICAS LISTLENLYE KLLAR 
RecQ 78 SLMKDQVDQLQA GVAAAC NSTQTR QQL--EVMTGC TGQI LLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVDE HCVSNWGHDFRPDYKEL FFKREYPDIPMIALTATASEQVRMDIIHNLEL EPVFLKQSFNRTNLYYE 
BLM 796 VID AHCVSQWGHDFRQD KRM MLRQ FPSVPVMA T T NPRVQK LTQL ILRP VFSMSFNRHNLKY  
RecQ 145 AVDEAHCIS W HDFRPEYAALGQLRQRFPT PFMALT T DDTTRQD LGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTI EICDA KSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKK A DCLEWIR HHPYDSGIIYCLS REC TMADTLQRDGLAALAYHAGLSDSA DEVQQKWINQDG 
RecQ 219 L EKF ---LDQLMRYVQEQRGKSGIIYCNS AKVEDT AALQSKGISAAAYHAGLENNV DVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
Sgs1 59 TY WSD VLYRL EV K PG P T Q K V V V KSGKTH T I I
BLM 648 SF HTKEMMKIFHKK LHN TN L A NAA L E FIL S L CVSP V I P R
RecQ 8 VLNLESGAKQVLQE FGYQQFRPGQEEII TVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVS LI  
 
Sgs1 33 MQD EH LNKN K SMFSSRG A QRRQTF--NL INGLLD V IS M S EQCKR ISR ADGK
BLM 22 IV QK TSLDIP TY TGDK SEATNIYLQLSKKDPI K VT KICAS R ISTLE YER LLAR
RecQ 78 SLMKDQVDQLQANGV AACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
Sgs1 805 I V E N P LKFFKREY DI MI L A ASEQ RMD IHN ELKE VFLK T Y E
BLM 796 FVI Q G QD KRMNM SV V A AN RVQK LTQ KILR QVFSM N H LK Y
RecQ 145 AVDEAHC S WGH FRPEYAA GQLRQRFPT PFMALTATADDTTRQD VRLLGLNDPLIQISSFDRPNIRYM  
 
Sgs1 9 NK -T NTIFEICD VKSRFKN T H KKS EQTSAQM N IKCAY MEPDE LS KA Q-A E
BLM 870 VLP KPKKVAF C EWIRKHHPYD L RREC TMADT RD LA L SD A DE Q WINQ G
RecQ 219 LMEKFKP---L QLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNV DVQEKFQ-RDD 
 
Sgs1 51 I V Y FTV RTL T NY Y ITYF
BLM 942 C VIC I D D I ASL KSV G S EISHCL
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
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Figure 3.5. Examination of sensitivity to HU Diploids heterozygous or 
homozygous for total loss-of-function alleles 
Diploids heterozygous or homozygous for total loss-of-function alleles (W803R, C1036F) 
are more sensitive to HU than diploids homozygous for alleles exhibiting wild-type 
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Table 3.1. Coding, nonsynonymous BLM variants functionally evaluated in this 
study. 
Mutation Domain PolyPhen Score HU  
I658T HD 1.860 - 
H660Y HD (motif 0) 2.211 - 
P690L HD (motif I) 2.724 +++ 
P707S HD 1.951 - 
R717T HD (motif Ia) 2.008 +++ 
Q752H HD 1.921 - 
K755E HD 1.493 - 
S778C HD 1.773 - 
R791C HD (motif II) 2.495 + 
W803R HD (AR loop) 3.757 +++ 
Y811C HD 2.616 +++ 
T843I* HD 1.796 + 
F857L HD 2.001 +++ 
P868L HD 2.724 + 
K873N HD 1.649 - 
G972V HD (motif VI) 2.397 +++ 
Y995H RQC (zinc) 1.716 - 
H1014R RQC (zinc) 2.360 - 
A1043D RQC (zinc) 1.440 - 
G1120R RQC (WH) 2.172 + 
K1133E RQC (WH) 1.550 - 
E1143K RQC (WH) 1.554 - 
V1198M - 0.375 - 
E1213K HRDC 1.470 - 
H1324T - 1.098 - 
R1331G - 1.787 - 
Q1387K - 1.569 - 
 
Amino acid changes in BLM were identified in dbSNP and mapped to BLM. HD, helicase 
domain; AR, aromatic-rich; RQC, RecQ C-terminal domain with zinc-binding and 
winged-helix (WH) subdomains; HRDC, helicase and RNaseD C-terminal domain; HU, 
hydroxyurea sensitivity. Polymorphisms Phenotyping (PolyPhen) scores (Adzhubei, 
Schmidt et al. ; Adzhubei, Schmidt et al. 2010) estimate the probability of 
nonsynonomous mutations to affect protein function (>2, probably damaging; <2, 
possibly damaging; <1.5, benign). HU refers to Figure 3. 2 (+++ as sensitive as 
helicase-dead K695R, + intermediate sensitivity between wild-type and K695R, – 
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equivalent to wild-type). BLM variants P690L and H1324T were reported by German et 
al. (German, Sanz et al. 2007). The asterisk indicates a variant originally reported in 
dbSNP as a missense mutation, but later identified as deletion of exons 11 and 12, 
resulting in a premature stop codon (Ellis, Groden et al. 1995; German J & Ellis NA. 
Bloom syndrome. In: Vogelstein and Kinzler 1998).  
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Table 3.2. HU hypersensitivity conferred by sgs1 alleles coding for amino acid 
changes equivalent to those impairing BLM function.  




BLM Sgs1 Domain BLM Sgs1 
P690L P701L HD (motif I) +++ ++ 
R717T I732T HD (motif Ia) +++ - 
R791C R804C HD (motif II) + - 
W803R W816R HD (AR loop) +++ +++ 
Y811C Y824C HD +++ +++ 
F857L F870L HD +++ ++ 
P868L K881L HD + - 
G972V G983V HD (motif VI) +++ - 
G1120R G1115R RQC (WH) + ++ 
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Supplemental Figures and Tables 
 
Figure 3.S1. Sensitivity of cells expressing BLM alleles to DNA damaging agents  
Sensitivity of cells expressing total and partial loss of function BLM mutations to the 
alkylating agent MMS and the UV mimic 4NQO, which induces bulky DNA adducts. Total 
loss-of function mutations are indicated in red and partial loss of function mutations are 
indicated in blue. The helicase-dead K695R allele was included as a total 
loss-of-function control.   
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Figure 3.S2. Mutations in Sgs1 corresponding to six total and three partial 
loss-of-function mutations in BLM   
The amino acid changes in Sgs1 are shown in red if the corresponding amino acid 
change BLM caused a total loss of function, or in blue if the corresponding amino acid 
change in BLM caused a partial loss of function. (A) ClustalW2 alignment between the 
helicase domain of Sgs1, human BLM and E. coli RecQ. Identical residues are shaded 
gray. Total and partial loss-of-function mutations are indicated in red and blue, 
respectively. (B) Structure-based alignment of the WH-domain of Sgs1, E. coli RecQ and 
human BLM, RecQL1 and WRN, adapted from Kitano et al. (Kitano, Kim et al. 2010). 
Structurally important residues are underlined and functionally important residues in the 
α2-α3 loop and β-wing are indicated in bold.  
  
Sgs1 1076 ANVINEERDVTEPAKKIVKLVESIQN-------------ERVTIIYCQDVFKGSRSSKIVQANHDTLEEHGIGK 
BLM 1068 KTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHN 
RecQ 405 CLDPPKQYDGSTDAQIALSTIGRVN--------------QRFGMGYVVEVIRGANNQRIRDYGHDKLKVYGMGR 
RECQL1 480 KDSAFERKNITEYCRDLIKILKQAEELN-----------EKLTPLKLIDSWMGKGAAKLRVAGVVAPTL----- 
WRN 950 DDSEDTSWDFGPQAFKLLSAVDILG--------------EKFGIGLPILFLRGSNSQRLADQYRRHSLF-GTGK 
 
 
Sgs1 1137 SMQKSEIERIFFHLITIRVLQEYSIMNNSGFASSYVKVGPNAKKLLTGKMEIKM 
BLM 1143 AERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENS 
RecQ 465 DKSHEHWVSVIRQLIHLGLVTQN--IAQHSALQL-TEAARPVLAESSLQLAVPR 
RECQL1 539 --PREDLEKIIAHFLIQQYLKEDYSFTAYATISYLKIGPKANLLNNEAHAITMQ 
WRN 1009 DQTESWWKAFSRQLITEGFLVEVSRYNKFMKICALTKKGRNWLHKANTESQSLI 
Sgs1 659 TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI 
BLM 648 SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR 
RecQ 8 VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI  
 
 
Sgs1 733 SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR 
BLM 722 SLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR 
RecQ 78 SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL  
 
 
Sgs1 805 IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE 
BLM 796 FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY 
RecQ 145 LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM  
 
 
Sgs1 879 VNKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE 
BLM 870 VLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG 
RecQ 219 LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD 
 
 
Sgs1 951 IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF 
BLM 942 CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY 
RecQ 289 LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY 
B 
A  motif 0 motif I motif Ia
motif II
AR loop motif III
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Figure 3.S3. Intermediate sensitivity to HU of yeast cells expressing the G1120E 
allele  
Ten-fold dilutions of exponentially growing cultures were spotted on YPD with 100 mM 
HU or without HU (-HU). Total loss-of- function allele G972V is shown in red, those 
comparable to the wild-type chimera are shown in black and the allele intermediate 







- HU 100 mM HU 
G1120E 
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Figure 3.S4. Location of 13 residues whose mutation did not to impair BLM 
function  
(A) Residues in the crystal structure of human RecQ1 (14) that are equivalent to mutated 
residues in BLM variants that exhibit wild-type function are indicated by yellow spheres. 
For reference, residues (from Fig 3C) whose mutation leads to total loss of BLM function 
are indicated in red. Lobe 1 and 2 of the helicase domain are shown in blue and green, 
respectively. The Mg2+ ion and ADP are shown as a pink sphere and stick model, 
respectively. (B) Three residues in the zinc-binding subdomain of the RQC domain 
whose mutation did not impair BLM function are indicated by yellow spheres. The 
location of the residues was modeled onto the crystal structure of the helicase core of E. 
coli RecQ (Bernstein, Zittel et al. 2003). The conserved cysteine residues coordinating 
the zinc ion (pale brown) are shown in grey. (C) Two residues whose mutation did not 
impair BLM function are located in the α3-α4 loop (dark blue) of the WH-subdomain and 
are shown in yellow. For reference, location of the partial loss-of-function mutation 
G1120R in the α2-α3 loop (from Figure 3. 3G), is indicated in red. The α2-α3 loop and 
β-wing are highlighted in green. Residues were modeled onto the structure of human 
WRN crystallized with double stranded DNA (13). (D) One missense mutation that did 
not affect BLM function, E1213K, maps to a residue near the N-terminus of the HRDC 
domain. The solution structure of the HRDC domain of human BLM is shown (Kim and 

























  87 
 
Figure 3.S5. Sensitivity to HU of diploid cells homozygous or heterozygous for 
BLM alleles 
Sensitivity to HU of diploid cells homozygous or heterozygous for BLM alleles that 
exhibit wild-type function (wild-type, V1198M), partial loss of function (P868L) or total 
loss of function (K695R, W803R, C1055S, C1036F) in haploid cells. Ten-fold dilutions of 
exponentially growing cultures were spotted on YPD with 100 mM HU or on media 





























- HU 100 mM HU 
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Table 3.S1. Coding, nonsynonymous mutations in the human BLM gene 3’ half, 
which encodes the helicase, RQC and HRDC domains, ranked according to their 
Polymorphism Phenotyping (PolyPhen) score (28). 
 




rs148394770 exon 12 T>C 3.757 W803R 
c.2069C>T exon 8 C>T 2.724 P690L 
rs11852361 exon 13 C>T 2.724 P868L 
rs145029382 exon 12 A>G 2.616 Y811C 
rs55880859 exon 11 C>T 2.495 R791C 
rs150475674 exon 15 G>T 2.397 G972V 
rs145022945 exon 16 A>G 2.360 H1014R 
rs139688226 exon 8 C>T 2.211 H660Y 
rs139773499 exon 17 G>A 2.172 G1120R 
rs28406486 exon 9 G>C 2.008 R717T 
rs182115037 exon 13 T>G, T>A 2.001 F857L 
rs146077918 exon 9 C>T 1.951 P707S 
rs61752785 exon 10 G>C 1.921 Q752H 
rs187379039 exon 8 T>C 1.860 I658T 
rs137853152* exon 12 C>T 1.796 T843I 
rs150631940 exon 21 A>G 1.787 R1331G 
rs139610577 exon 11 C>G 1.773 S778C 
rs142723411 exon 15 T>C 1.716 Y995H 
rs146723808 exon 13 G>C 1.649 K873N 
rs183438014 exon 22 C>A 1.569 Q1387K 
rs140387675 exon 18 G>A 1.554 E1143K 
rs145027663 exon 18 A>G 1.550 K1133E 
rs142551229 exon 10 A>G 1.493 K755E 
rs28385142 exon 19 G>A 1.470 E1213K 
rs2229035 exon 16 C>A 1.440 A1043D 
rs149754073 exon 11 C>T 1.435 L788F 
rs151309611 exon 14 C>T 1.435 L896F 
rs144021705 exon 17 C>T 1.373 T1074I 
rs150034914 exon 22 G>A 1.370 R1407K 
rs139115275 exon 22 G>A 1.348 S1375N 
rs1801256 exon 19 T>A 1.323 S1209T 
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Table 3.S1 continued 
rs150784889 exon 17 G>A 1.249 G1104D 
rs138329850 exon 15 A>C 1.245 E985D 
rs190652985 exon 21 A>G 1.112 K1329E 
c.3970C>T exon 21 C>T 1.098 H1324T 
rs7167216 exon 21 G>T, G>C 1.090 V1321L 
rs144964365 exon 20 C>G 1.089 P1257A 
rs191789336 exon 10 G>A 0.986 V765I 
rs189925962 exon 15 A>G 0.960 I947V 
rs28385141 exon 19 G>A 0.835 V1205I 
rs142928725 exon 19 G>A 0.375 V1198M 
rs141269464 exon 17 G>A 0.176 G1104S 
rs7167216 exon 21 G>A 0.115 V1321I 
 
dbSNP ID and data on base substitutions and amino acid changes are from NCBI 
database dbSNP. Polymorphism Phenotyping (PolyPhen) scores were calculated with 
PolyPhen software (28). c.2069C>T and c.3970C>T were reported in reference 5. An 
asterisk indicates a variant listed in dbSNP that was reported as a missense mutation, 
but subsequently identified to be a deletion of exons 11 and 12, resulting in a premature 
stop codon (3,6). 
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Table 3.S2. Yeast strains used in this study. 
Strain Genotype Amino acid change in BLM 
RDKY3615 
MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, 
hom3-10, ade2Δ1, ade8, YEL069C::URA3 
- 
KHSY1338 RDKY3615, sgs1Δ::HIS3 - 
KHSY3355 RDKY3615, sgs1ΔC800-blmΔN647.HIS3 - 
KHSY3610 RDKY3615, sgs1ΔC800-blmΔN647-A2084G.HIS3 K695R 
KHSY3819 RDKY3615, sgs1ΔC800-blmΔN647-G3164C.HIS3 C1055S 
KHSY3820 RDKY3615, sgs1ΔC800-blmΔN647-A3191T.HIS3 D1064V 
KHSY3953 RDKY3615, sgs1ΔC800-blmΔN647-G3107T.HIS3 C1036F 
KHSY4072 RDKY3615, sgs1ΔC800-blmΔN647-A3041G.HIS3 H1014R 
KHSY4073 RDKY3615, sgs1ΔC800-blmΔN647-C3128A.HIS3 A1043D 
KHSY4074 RDKY3615, sgs1ΔC800-blmΔN647-G3427A.HIS3 E1143A 
KHSY4076 RDKY3615, sgs1ΔC800-blmΔN647-G3592A.HIS3 V1198M 
KHSY4077 RDKY3615, sgs1ΔC800-blmΔN647-G3637A.HIS3 E1213K 
KHSY4079 RDKY3615, sgs1ΔC800-blmΔN647-C3970T.HIS3 H1324T 
KHSY4085 RDKY3615, sgs1ΔC800-blmΔN647-T1973C.HIS3 I658T 
KHSY4087 RDKY3615, sgs1ΔC800-blmΔN647-C2070T.HIS3 P690L 
KHSY4089 RDKY3615, sgs1ΔC800-blmΔN647-G2150C.HIS3 R717T 
KHSY4093 RDKY3615, sgs1ΔC800-blmΔN647-C2371T.HIS3 R791C 
KHSY4096 RDKY3615, sgs1ΔC800-blmΔN647-T2407C.HIS3 W803R 
KHSY4098 RDKY3615, sgs1ΔC800-blmΔN647-A2432G.HIS3 Y811C 
KHSY4099 RDKY3615, sgs1ΔC800-blmΔN647-T2571A.HIS3 F857L 
KHSY4100 RDKY3615, sgs1ΔC800-blmΔN647-A2263G.HIS3 K755E 
KHSY4102 RDKY3615, sgs1ΔC800-blmΔN647-G2915T.HIS3 G972V 
KHSY4103 RDKY3615, sgs1ΔC800-blmΔN647-C2333G.HIS3 S778C 
KHSY4105 RDKY3615, sgs1ΔC800-blmΔN647-T2983C.HIS3 Y995H 
KHSY4147 RDKY3615, sgs1ΔC800-blmΔN647-A3397G.HIS3 K1133E 
KHSY4148 RDKY3615, sgs1ΔC800-blmΔN647-C2603T.HIS3 P868L 
KHSY4233 RDKY3615, sgs1ΔC800-blmΔN647-C1978T.HIS3 H660Y 
KHSY4234 RDKY3615, sgs1ΔC800-blmΔN647-C2119T.HIS3 P707S 
KHSY4237 RDKY3615, sgs1ΔC800-blmΔN647-G2256C.HIS3 Q752H 
KHSY4239 RDKY3615, sgs1ΔC800-blmΔN647-C2528T.HIS3 T843I 
KHSY4241 RDKY3615, sgs1ΔC800-blmΔN647-G2619C.HIS3 K873N 
KHSY4247 RDKY3615, sgs1ΔC800-blmΔN647-A3991C.HIS3 R1331G 
KHSY4249 RDKY3615, sgs1ΔC800-blmΔN647-A4159T.HIS3 Q1387K 
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Table 3.S2 continued 
KHSY4314 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, 
his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/ 




KHSY4316 KHSY4314, Wild-type / A2084G.HIS3 -/K695R 
KHSY4318 KHSY4314, Wild-type / T2407C.HIS3 -/W803R 
KHSY4320 KHSY4314, Wild-type / C2603T.HIS3 -/P868L 
KHSY4322 KHSY4314, Wild-type / G3592A.HIS3 -/V1198M 
KHSY4324 KHSY4314, Wild-type / G3164C.HIS3 -/C1055S 
KHSY4326 KHSY4314, A2084G.HIS3 / A2084G.HIS3 K695R/K695R 
KHSY4328 KHSY4314, A2084G.HIS3 / T2407C.HIS3 K695R/W803R 
KHSY4330 KHSY4314, A2084G.HIS3 / C2603T.HIS3 K695R/P868L 
KHSY4332 KHSY4314, A2084G.HIS3 / G3592A.HIS3 K695R/V1198M 
KHSY4334 KHSY4314, A2084G.HIS3 / G3164C.HIS3 K695R/C1055S 
KHSY4336 KHSY4314, T2407C.HIS3 / T2407C.HIS3 W803R/W803R 
KHSY4338 KHSY4314, T2407C.HIS3 / C2603T.HIS3 W803R/P868L 
KHSY4340 KHSY4314, T2407C.HIS3 / G3592A.HIS3 W803R/V1198M 
KHSY4342 KHSY4314, T2407C.HIS3 / G3164C.HIS3 W803R/C1055S 
KHSY4344 KHSY4314, C2603T.HIS3 / C2603T.HIS3 P868L/P868L 
KHSY4346 KHSY4314, C2603T.HIS3 / G3592A.HIS3 P868L/V1198M 
KHSY4348 KHSY4314, C2603T.HIS3 / G3164C.HIS3 P868L/C1055S 
KHSY4350 KHSY4314, G3592A.HIS3 / G3592A.HIS3 V1198M/V1198M 
KHSY4352 KHSY4314, G3592A.HIS3 / G3164C.HIS3 V1198M/C1005S 
KHSY4353 KHSY4314, G3164C.HIS3 / G3164C.HIS3 C1055S/C1055S 
KHSY4590 RDKY3615, sgs1ΔC800-blmΔN647-G3359A.HIS3 G1120R 
KHSY4596 KHSY4314, G3107T.HIS3 / G3107T.HIS3 C1036F/C1036F 
KHSY4598 KHSY4314, G3107T.HIS3 / Wild-type -/C1036F 
KHSY4600 KHSY4314, G3107T.HIS3 / A2084G.HIS3 C1036F/K695R 
KHSY4602 KHSY4314, G3107T.HIS3 / T2407C.HIS3 C1036F/W803R 
KHSY4604 KHSY4314, G3107T.HIS3 / C2603T.HIS3 C1036F/P868L 
KHSY4606 KHSY4314, G3107T.HIS3 / G3592A.HIS3 C1036F/V1198M 
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Table 3.S3. Plasmids used in this study. 
Plasmid ID Description Source 
pRS415 CEN/ARS, LEU2 reference (5) 
pKHS481 pRS415-SGS1  reference (4) 
pKHS560 pRS415-sgs1-P701L  this study 
pKHS562 pRS415-sgs1-I732T this study 
pKHS564 pRS415-sgs1-R804C this study 
pKHS566 pRS415-sgs1-W816R this study 
pKHS567 pRS415-sgs1-Y824R this study 
pKHS569 pRS415-sgs1-F870L  this study 
pKHS572 pRS415-sgs1-K881L  this study 
pKHS574 pRS415-sgs1-G983V  this study 
pKHS577 pRS415-sgs1-G1115R  this study 
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IDENTIFICATION OF RECQL1 AND RECQL4 BINDING 
PARTNERS USING A YEAST 2-HYBRID SCREEN 
 
 
Note to reader: Unpublished data. Hamed Mirzaei and Kristina H. Schmidt designed 




Of the five RecQ homologs found in humans, defects in BLM, WRN, and RecQL4 
result in disorders in which DNA repair and genome integrity are compromised. 
Investigation of BLM and WRN proteins have led to the identification of several 
interacting partners that link the RecQ-like family to a number of pathways (Figure 4.1). 
BLM has been shown to physically interact with RPA (Brosh, Li et al. 2000), p53 (Wang, 
Tseng et al. 2001), Rad51 (Wu, Davies et al. 2001), TopIIIα (Wu, Davies et al. 2000), 
BRCA1, BRCA2, and ATM (Wang, Cortez et al. 2000) in the HR pathway, in addition to 
interacting with MLH1 in the mismatch repair pathway (Pedrazzi, Perrera et al. 2001). 
Likewise, WRN has been shown to physically interact with RPA (Brosh, Orren et al. 
1999), p53 (Blander, Kipnis et al. 1999), PCNA (Lebel, Spillare et al. 1999), Fen1 
(Brosh, Driscoll et al. 2002), Pol∂ (Kamath-Loeb, Loeb et al. 2001), and base excision 
repair (BER) components (Mol, Parikh et al. 1999) during BER and DSB repair. WRN 
has also been demonstrated to bind the heterodimeric Ku70/Ku80 complex (Cooper, 
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Machwe et al. 2000) involved in NHEJ repair.  In addition, BLM and WRN have been 
shown to colocalize within the nucleus, and physically interact (von Kobbe, Karmakar et 
al. 2002). Less is known about which proteins physically interact with RecQL1 and 
RecQL4. Moreover, among the few known interacting proteins it is mostly unclear where 
on RecQL1 and RecQL4 these interactions take place. Nevertheless, RecQL1 has been 
shown to physically interact with importin-α (Seki, Tada et al. 1997), TopIIIα (Johnson, 
Lombard et al. 2000), RPA (Cui, Klima et al. 2003; Cui, Arosio et al. 2004), Exo1, 
mismatch repair factors MSH2/MSH6, MLH1/PMS2 (Doherty, Sharma et al. 2005), and 
most recently PARP1 (Sharma, Phatak et al. 2012) (Figure 4.1). Similarly, RecQL4 has 
been shown to physically interact with PARP1 (Woo, Futami et al. 2006), BLM (Singh, 
Popuri et al. 2012), MCM10 and the MCM2-7 complex (Xu, Rochette et al. 2009) (Figure 
4.1).  
Additionally, among all the reported cases of RTS, only 60% are as a result of a 
mutation in RecQL4, and the remaining 40% are a result of unknown defects (Wang, 
Levy et al. 2001). Identification of new interacting proteins of RecQL4 could implicate 
new genetic pathways and gene candidates, which are causative of RTS. 
At the time of this study no group had attempted a genome-wide screen in 
search for protein interacting partners for RecQL1 or RecQL4. We utilized a 
yeast 2-hybrid assay for identification of novel protein-protein interactions for RecQL1 
(Chapter 4.1) and RecQL4 (Chapter 4.2) by implementing two approaches. First, we 
screened the yeast open reading frames (ORF) library. We reasoned that since BLM 
and WRN are at least partially functional in yeast (Yamagata, Kato et al. 1998; Heo, 
Tatebayashi et al. 1999; Mirzaei, Syed et al. 2011; Mirzaei and Schmidt 2012), RecQL1 
and RecQL4 might be able to interact with the yeast proteome. Second, we screened a 
human cDNA library.  
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Results5:  
Chapter 4.1. A screen for RecQL1 interacting proteins 
Screen of a yeast ORF library for potential RecQL1 binding 
partners in yeast 
To assess the interaction of RecQL1 with the yeast proteome, we utilized an 
arrayed library of yeast ORFs that was constructed by the Fields laboratory (Uetz, Giot 
et al. 2000). As described by Uetz, et al. (2000), this library contains approximately 
6,000 yeast ORFs with each expressed in a separate yeast strain, allowing for efficient 
and high-throughput screens.  
The yeast 2-hybrid method used in this screen utilizes a GAL system in which a 
GAL1 promoter is fused to a HIS3 ORF. Transcriptional activation of the GAL1 promoter 
results in expression of the HIS3 gene. The prey plasmid pOAD (pKHS487, Appendix C) 
harbors the GAL4 activation domain (AD) and the bait plasmid pBDC (pKHS392, 
Appendix C) harbors the GAL4 DNA binding domain (DBD). A physical interaction 
between the bait and prey proteins brings the DBD and the AD in close proximity of each 
other. Interaction between the DBD and AD at the GAL1 promoter results in transcription 
of the HIS3 reporter gene (Uetz, Giot et al. 2000). Yeast colonies are then selected for 
on synthetic complete agar plates minus histidine (SC-HIS), with the subsequent growth 
in the absence of histidine as an indication for a putative protein-protein interaction 
between bait and prey. 
                                                
5 General methods and media are described in the Chapter 8. 
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Construction of the yeast ORF prey library 
The arrayed yeast ORF prey library was obtained from the Fields lab (Uetz, Giot 
et al. 2000). It was generated by first linearizing the pOAD plasmid using a double 
restriction enzyme digestion (PvuII and NcoI) to avoid religation, and then cloning yeast 
ORFs into the plasmid by recombinational cloning in yeast. Each ORF was amplified by 
PCR from yeast using a gene-specific primer pair that possessed a common 
20-nucleotide tail specific to the Forward and Reverse primers. After the initial step of 
the ORF amplification, the common tails served as priming sites for a second round of 
amplification. The 70-nucleotide long primers used in the second round of amplification 
were comprised of 20 nucleotides homologous to the common nucleotide tail generated 
by the first round of amplification and 50 nucleotides homologous to the pOAD plasmid 
where the ORF was to be integrated. The amplicon from the second round of 
amplification and the linearized plasmid were subsequently co-transformed into the 
yeast strain PJ69-4a  (KHSY3558, Appendix A). This yielded an arrayed library of 
approximately 6,000 independent clones, each expressing a different yeast ORF cloned 
in-frame with the GAL4 AD in the pOAD plasmid. This prey library was stored in sixteen 
384-well plates. 
Construction and verification of RECQL1 bait plasmid and bait 
reporter strain6 
To construct the bait plasmid, we adopted a similar method used by the Fields 
laboratory in construction of the prey library. Briefly, the bait plasmid pBDC (pKHS392, 
Appendix C) was linearized using a double restriction enzyme digestion (PvuII and NcoI) 
and RECQL1 cDNA was amplified by PCR from genomic DNA isolated from strain 
                                                
6 This section only pertains to strains used in the screen of the yeast ORF library 
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KHSY2046 (Appendix A) using primer pairs F1562/R15637 (Appendix B). These primers 
contained 20 nucleotides homologous to RECQL1 and 50 nucleotides homologous to 
the integration site of plasmid pKHS392. Using standard LiAc-mediated transformation8 ` 
were co-transformed into yeast strain KHSY2331 (Appendix A). Yeast strain KHSY2331 
is NHEJ-deficient due to deletion of DNA ligase 4 (lig4∆). Lig4 is required for completion 
of repair by NHEJ by ligating the two ends of the DSB. Utilizing this strain eliminated the 
possibility of the pKHS392 plasmid re-circularizing by the NHEJ repair pathway and 
forces circularization mediated by integration of RECQL1 through the HR pathway.  
Yeast strains harboring pKHS392-RECQL1 plasmids were positively selected for 
by spreading transformed cells on synthetic complete agar plates minus tryptophan 
(SC-TRP). The resulting yeast strain KHSY3554 (Appendix A) was used to obtain 
genomic DNA, which also contained the pKHS392-RECQL1 bait plasmid. The 
pKHS392-RECQL1 bait plasmid was separated from genomic DNA by electroporation of 
isolated genomic DNA into electro-competent E.coli9 cells using a MicroPulser (Bio 
LabTM). Subsequently, plasmid DNA was isolated from E.coli cells using QIAPrep 
Miniprep Kit (Qiagen) and sequenced to confirm that the RECQL1 cDNA is mutation free 
and integrated in-frame with the GAL4 DBD. Sequencing of the RECQL1 cDNA in 
pKHS392 was carried out using primers F1274, F1300, F1301, F1276, F1277, and 
R1278 (Appendix B). The resulting bait plasmid pKHS401 (Appendix C) was then 
transformed into the strain PJ69-4α  (KHSY3559, Appendix A) containing the reporter 
constructs, using standard LiAc-mediated transformation (Schiestl and Gietz 1989). The 
resulting yeast strains KHSY3604, KHSY3605, and KHSY3606 (Appendix A) harboring 
                                                
7 F=forward, R=reverse 
8 Standard LiAc-mediated transformation is described in Chapter 8 
9 Protocol for preparing electro-competent E.coli cells is described in Chapter 8. 
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pKHS401 expressed RECQL1 cDNA fused to the GAL4 DBD and were used as bait in 
the yeast 2-hybrid screen of the yeast proteome.  
To confirm expression of RecQL1 from bait strains KHSY3604, KHSY3605, and 
KHSY3606, Trichloroacetic Acid (TCA) mediated whole cell protein extracts were 
analyzed by Western blot as described in the Chapter 8. The resulting membrane was 
probed with an anti-DBD monoclonal antibody (Santa Cruz), and as shown in Figure 4.2, 
all three constructs express RecQL1 stably and abundantly. 
Prior to conducting the screen, the bait strains KHSY3604, KHSY3605, and 
KHSY3606 were tested for auto-activation of the HIS3 reporter gene (Figure 4.3). To do 
so, each strain was tested on three separate agar plates: SC-TRP, synthetic complete 
media lacking histidine and tryptophan (SC-HIS-TRP), and SC-HIS-TRP media 
supplemented with 3 mM of 3-Amino-1,2,4-triazole (3-AT, MP Biomedicals), here after 
referred to as SC-HIS-TRP+3AT. The SC-TRP medium only controls for the presence of 
the bait plasmid, while the SC-HIS-TRP medium assesses activation of the HIS3 
reporter gene. The 3-AT supplemented in SC-HIS-TRP+3AT is a competitive inhibitor of 
histidine and at low concentrations will degrade potential expression of HIS3, thus 
counteracting the effects of a “leaky” HIS3 promoter. As a positive control for 
auto-activation, we utilized a pBDC-BLM construct, which we found to auto-activate the 
HIS3 reporter gene (unpublished data). For a negative control, we utilized strain 
KHSY3989 (Appendix A). KHSY3989 is a reporter strain containing an empty bait 
plasmid. The test confirmed that pKHS392-RECQL1 (pKHS401) does not auto-activate 
the HIS3 reporter gene (Figure 4.3). 
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Screen of the yeast ORF prey library for RecQL1 interacting 
proteins  
In this screen, the bait strain KHSY3604 was mated to each of the 6,000 prey 
strains and the resulting diploid cells were assessed for their ability to activate the HIS3 
reporter gene. All mating, plating, and replica-plating of yeast strains on various selective 
media were preformed on a Singer® instruments screening robot (RoToR). Briefly, on 
day one, the yeast prey library was spotted from 16 individual 384-plates onto 16 
synthetic complete agar plates lacking leucine (SC-LEU) and incubated at 30°C for two 
days. Plating on SC-LEU allowed for continuous selection of the prey plasmid, which 
harbors a LEU2 cassette. The bait strain KHSY3604 was streaked out on an SC-TRP 
agar plate and incubated at 30°C overnight. On day two, a scoop of cells from the 
SC-TRP agar plate were inoculated in 10 ml of liquid SC-TRP media and incubated 
overnight in an orbital shaker at 30°C at 250 rpm. On day three, this culture was poured 
onto the surface of an agar plate and spotted on a YPD agar plate on a 384-spot grid 
followed by overnight incubation. On day four, the 384 individual colonies of KHSY3604 
were mated to colonies on the 16 prey plates by mixing and pinning onto a fresh YPD 
plate. The 16 resulting plates were then incubated at 30°C overnight and subsequently 
(on day five) replica-plated onto synthetic complete agar plates lacking leucine and 
tryptophan (SC-LEU-TRP). SC-LEU-TRP media allowed for continuous selection of 
diploids with both bait and prey plasmids. After two days of incubation, the colonies were 
replica-plated onto synthetic complete agar plates lacking leucine, tryptophan and 
histidine (SC-LEU-TRP-HIS) to positively select for diploid yeast strains that can activate 
the HIS3 reporter gene. To increase stringency of our selection against any false 
positives that were as a result of “leaky” HIS3 expression, the colonies on all 16 plates 
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were also replica-plated on SC-LEU-TRP-HIS agar plates supplemented with 3 mM 
3-AT (SC-LEU-TRP-HIS+3AT). This yeast 2-hybrid screen was performed in duplicate. 
Upon completion of the first replicate of the screen, we identified 37 putative 
interactions (Table 4.1). After completion of the second replicate of the screen, we 
identified 13 putative interactions (Table 4.2). Among our protein hit lists were HIS3 and 
GAL4 and although these are not candidates for interaction with RecQL1, they indicate 
that the yeast 2-hybrid was conducted correctly and the system is functional. Presence 
of the HIS3 ORF will allow growth on SC-LEU-TRP-HIS+3AT agar plates without the need 
for activation of the reporter gene. Similarly, the GAL4 ORF can interact with the reporter 
construct and activate expression of the HIS3 gene resulting in growth on 
SC-LEU-TRP-HIS+3AT agar plates albeit no physical interaction with the bait protein. 
Nevertheless, after combining the protein hit lists, we did not observe any protein that 
appeared in both replicates of the screen, suggesting that RecQL1 does not interact with 
the yeast proteome present in the yeast prey library. Figures 4.4 and 4.5 show the 16 
SC-LEU-TRP-HIS+3AT plates resulting from the first and second replicate of our screen, 
respectively.  
Construction and verification of the RecQL1 bait strain10 used to 
screen the human testis cDNA library for RecQL1 interacting 
proteins  
To screen the human proteome for RecQL1 binding partners, we utilized the 
Clontech Matchmaker® Gold Yeast Two-Hybrid System and the Clontech Mate & Plate™ 
Human Testis cDNA library. The testis cDNA library was specifically chosen since 
RecQL1 is abundantly expressed in this tissue (Kitao, Ohsugi et al. 1998).  
                                                
10 This section only pertains to strains used in the screen of human testis cDNA library 
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Since both yeast 2-hybrid systems employed in this chapter utilized a GAL1 
reporter, we were able to use the same bait plasmid (pKHS401) described earlier for 
both screens. However, for the screen of the human testis cDNA library we utilized the 
yeast strain AH109 (KHSY3130, Appendix A), which was part of the Clontech 
Matchmaker® Gold Yeast Two-Hybrid System kit. This strain contains four independent 
reporter genes, allowing for a more stringent screening and elimination of false positives 
(Figure 4.6). Using standard LiAc-mediated transformation (Schiestl and Gietz 1989), 
bait plasmid pKHS401 was introduced into strain KHSY3130 resulting in strains 
KHSYR1-1, KHSYR1-2, and KHSYR1-3. 
To confirm expression of RecQL1 from the bait strains KHSYR1-1, KHSYR1-2, 
and KHSYR1-3, TCA-mediated whole cell protein extracts were analyzed by Western 
blot. The resulting membrane was probed with an anti-DBD monoclonal antibody (Santa 
Cruz) and as shown in Figure 4.2, all three bait strains express RecQL1 stably and 
abundantly. Additionally, the three bait strains were evaluated for auto-activation as 
described earlier and this test confirmed that in none of the bait strains the reporter 
constructs are activated. 
Screen of the human testis cDNA library for RecQL1 interacting 
proteins  
The yeast 2-hybrid screen was carried out as outlined in the Clontech 
Matchmaker® Gold Yeast Two-Hybrid System manual. On day one, the bait strain 
KHSYR1-1 was cultured overnight in 100 ml of SC-TRP liquid media. After reaching the 
desired optical density (OD600=0.6), the overnight culture was spun down and subdivided 
into eight aliquots. Using standard LiAc-mediated transformation (Schiestl and Gietz 
1989), each aliquot was transformed with 600 ng of plasmid DNA from the Clontech 
Mate & Plate™ Human Testis cDNA library. To calculate transformation efficiency, one 
  102 
half of an aliquot was plated on SC-LEU-TRP media. The remaining 7.5 aliquots were 
plated on eight separate 150 mm SC-LEU-TRP-HIS+3AT agar plates, thus selecting for 
colonies that activate the HIS3 reporter gene. All agar plates were incubated at 30°C. 
SC-LEU-TRP agar plates were incubated for two days and SC-LEU-TRP-HIS+3AT agar 
plates were incubated for 14 days. Over half a million transformants were estimated to 
have been screened by adding the total number of transformants obtained on SC-LEU-
TRP agar plates.  
Colonies that appeared on the SC-LEU-TRP-HIS+3AT agar plates were 
re-streaked on fresh SC-LEU-TRP-HIS+3AT agar plates and incubated for an additional 
two days. Each streak was then suspended in 40% glycerol and collected at -80˚C for 
future analysis of these candidates of protein-protein interaction. A total of 96 candidates 
were obtained from this screen. To verify the prey bait interaction in these 96 
candidates, 20 µl of thawed stock was suspended in 100 µl of SC-LEU-TRP liquid media 
followed by two days of incubation at 30˚C. The 96 candidates were then spotted on 
SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar plates. The 
SC-LEU-TRP agar plates controlled for the presence of both bait and prey plasmids, the 
SC-LEU-TRP-HIS agar plates provided low stringency selection of protein-protein 
interactions, and the SC-LEU-TRP-HIS+3AT agar plates provided a more stringent 
selection of protein-protein interactions. From the original 96 candidates, 20 grew on all 
three agar plates (Table 4.3).  
Analysis of RecQL1 putatively interacting candidates 
In order to identify the cDNA insert present in each isolate, we rescued the prey 
plasmid as described in Chapter 8. Rescued plasmids were sequenced using primer 
F1975 (Appendix B), which specifically binds to the sequence upstream of the cDNA 
insert in the prey plasmid. The sequences were analyzed using NCBI’s BLAST 
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database. From the NCBI BLAST analysis we identified sequences from the following 
genes:  
• AIMP2 (aminoacyl tRNA synthetase complex-interacting multifunctional 
protein 2) 
• RAN (RAs-related Nuclear protein) 
• RANBP9 (ran-binding protein 9) 
• The KPNA family (karyopherin alpha family)  
o KPNA1, KPNA2, KPNA4, KPNA5 and KPNA6  
• ZGLP1 (zinc finger, GATA-like protein 1) 
• TRAF3IP1 (TNF receptor-associated factor 3 interacting protein 1)  
• C10ORF137 (EDRF1; Erythroid differentiation-related factor 1) 
• RECQL1 
Since complete sequence of the cDNA insert for genes AIMP2, TRAF3IP1 and 
C10ORF137 could not be obtained by using primer F1975, we designed specific primers 
for additional sequencing. Complete sequencing of these genes were carried out using 
primers: F2012 and R2013 for AIMP2, F2118 and R2119 for TRAF3IP1, and F2120 and 
R2121 for C10ORF137 (Appendix B, Table 4-3). 
The 20 candidates were also examined for expression of the human cDNA insert. 
To do so, TCA-mediated whole cell protein extract was analyzed by Western blot by 
probing the membrane with anti-AD monoclonal antibody (Santa Cruz). The activation 
domain and a linker sequence connecting it to the cDNA insert, has a molecular weight 
of approximately 30kDa. Thus, for this study we chose those candidates that produced a 
band larger than 40kDa11 as determined by Western blot analysis (Figure 4.7).  
                                                
11 A follow-up study of those candidates that produced a band between 30 and 40kDa will be conducted. 
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Among the candidates, TRAF3IP1 (candidate A6) and C10ORF137 
(candidate A7) produced a band with a molecular weight of approximately 50kDa. 
Candidates F5 (KPNA1), F6 (KPNA4), A8 (KPNA5), F4 (KPNA5), C6 (KPNA6), and A12 
(RANBP9) produce a band with a molecular weight between 80 and 125kDa (Figure 
4.7).  
Verification of candidates suggest C10ORF137 and TRAF3IP1 as 
strong candidates for interaction with RecQL1 
To verify that activation of the reporter gene is due to a legitimate interaction 
between the bait protein and the prey peptide and not due to auto-activation by the prey 
plasmid, we retested our candidates (Figure 4.8). Each rescued prey plasmid was 
transformed into strain KHSY3989 and the bait strains KHSYR1-1 and spotted on 
selective media, SC-LEU-TRP, SC-LEU-TRP-HIS, SC-LEU-TRP-HIS+3AT, and 
SC-LEU-TRP-HIS+3AT minus adenine (SC-LEU-TRP-HIS-ADE+3AT).  In the first four 
columns (columns 1-4) 10 fold serial dilutions of strain KHSY3989 harboring a prey 
plasmid were spotted and on the second four columns (columns 5-8) 10 fold serial 
dilutions of strain KHSYR1-1 harboring the same prey plasmid were spotted (Figure 4.8). 
We observe that candidate A12 (RANBP9) is not able to activate the reporter genes. 
Candidate F4 (KPNA5) and F11 (RecQL1) appeared to activate the reporter genes even 
in the absence of the bait, indicating auto-activation. Candidates A11 (RAN), A9 and B10 
(TRAF3IP1), and A2, B8, F2, and F10 (AIMP2) were omitted from analysis since 
sequencing revealed that the insert is not in-frame with the GAL4 AD. Candidates A7 
(C10ORF137), A8 (KPNA5), B11 (KPNA6), and F5 (KPNA1) were able to activate all 
reporter genes in the presence of the bait (columns 5-8) but not in the absence of the 
bait (columns 1-4). Moreover, candidate A6 (TRAF3IP1) and F6 (KPNA4) were able to 
activate the reporter construct on SC-LEU-TRP-HIS media as well as the more stringent 
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SC-LEU-TRP-HIS+3AT media. However, they do not activate the reporter construct on the 
most stringent SC-LEU-TRP-HIS-ADE+3AT media. Similarly, candidate E12 (KPNA2) was 
only able to activate the reporter construct on the SC-LEU-TRP-HIS media and not on 
either of the SC-LEU-TRP-HIS+3AT or SC-LEU-TRP-HIS-ADE+3AT media. 
Discussion  
In this study we first sought to investigate the ability of the human RecQL1 
protein to interact with the yeast proteome in a yeast 2-hybrid screen and found that 
RecQL1 does not interact with any of the yeast ORFs in the arrayed library.  
Second, we sought to identify interactions of the RecQL1 protein with the human 
proteome by screening for interactions using a testis cDNA library. Among the 
candidates many were members of the KPNA family: KPNA1, KPNA2, KPNA4, KPNA5 
and KPNA6. In humans, there are a total of 6 KPNA genes, all of which appeared in our 
screen except for KPNA3. In eukaryotes, karyopherins encoded by these genes are 
involved in transporting molecules into the nucleus. KPNA4 (also known as Qip1) has 
previously been identified as a RecQL1 interactor (Seki, Tada et al. 1997), thus acting as 
a positive control in our screen. Since all the karyopherins are part of the same complex 
at the nuclear pore, we chose not to investigate the other KPNA candidates further. 
TRAF3IP1 is a protein that is conserved from worms to humans. The N-terminal 
region of this protein is a microtubule-binding domain, while 100 residues of the 
C-terminus constitutes the coiled-coil region that binds to TRAF3 (tumor necrosis factor 
receptor-associated factor 3). The less well-conserved central region of the protein is 
rich in lysine and glutamic acid residues and carries KKE motifs, which may be 
necessary for tubulin-binding (Ling and Goeddel 2000). Clone A6, which codes for 149 
residues of the C-terminal region of TRAF3IP1, contains the 100 residues encoding the 
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coiled-coil region that binds to TRAF3 and matches both reported isoforms of the protein 
(Figure 4.9). It has been shown that upon overexpression of both TRAF3 and TRAF3IP1 
in HeLa cells, TRAF3IP1 is able to recruit TRAF3 to the microtubule network (Ling and 
Goeddel 2000). In mice TRAF3 has been demonstrated to be required for postnatal 
development and a competent immune system (Xu, Cheng et al. 1996). Upon 
confirmation of the RecQL1/TRAF3IP1 interaction in a human system, further research 
is needed to determine if RecQL1 also has a role in development and immunity in a 
potential TRAF/TRAF3IP1 complex. 
C10ORF137 is an erythroid differentiation-related factor known as EDRF1. Clone 
A7, which encodes for 62 residues of C10ORF137, matches both reported isoforms of 
the protein (Figure 4.10). While little is known about C10ORF137 (EDRF1) function, it 
has been shown to regulate α- and γ-globin transcription by modulating DNA-binding 
activity of the GATA-1 transcription factor (Wang, Li et al. 2002). Additionally, a variant of 
C10ORF137 was found in a screen for predisposing mutations in somatic and germline 
candidate cancer genes for a group of 45 familial colorectal cancers (Gylfe, Sirkia et al. 
2010).  
Since a predisposition to cancer is also a phenotype of other human RecQ-like 
homolog defects (BLM, WRN, RecQL4), and since some variants of RecQL1 have been 
suggested to be associated with reduced pancreatic cancer survival (Li, Frazier et al. 
2006), a physical interaction between RecQL1 and C10ORF137 is plausible and may 
further point towards a role for RecQL1 in cancer prevention.  
In preparation for further investigation of these candidates, first the expression 
profile of TRAF3IP1 and C10ORF137 should be examined to make certain that they are 
present in the same cell cycle phases as RecQL1. Next, to confirm that TRAF3IP1 and 
C10ORF137 physically interact with RecQL1 the interactions have to be verified in a 
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human system. A standard co-Immunoprecipitation experiment could be used to test for 
interaction of the endogenous proteins. If co-immunoprecipitation of endogenous 
proteins does not yield the predicted result, overexpression of tagged proteins can be 
employed to investigate physical interaction.  However, an overexpression system alone 
is not sufficient to confirm a physical interaction and would have to be validated by a 
different method such as mass spectroscopy.  
 
Results:  
Chapter 4.2. Yeast 2-hybrid screen of RecQL4 
Screen of a yeast prey library for potential RecQL4 binding 
partners in yeast 
The same yeast 2-hybrid system and yeast ORF prey library described in Chapter 4.1 
was used for this screen.  
Construction and verification of RECQL4 bait plasmid and bait 
reporter strain12 
The bait plasmid and bait strain were constructed as described in Chapter 4.1.  
Briefly, the bait plasmid pKHS392 was linearized using a double restriction enzyme 
digestion (PvuII and NcoI) and RECQL4 cDNA was amplified by PCR using primer pairs 
F1564/R1565 from genomic DNA extracted from strain KHSY2177 (Appendix A).  Using 
standard LiAc-mediated transformation (Schiestl and Gietz 1989), linearized pKHS392 
plasmid and RECQL4 PCR amplicon were co-transformed into the NHEJ-deficient yeast 
strain KHSY2331. Transformants were spread on SC-TRP agar plates for positive 
                                                
12 This section only pertains to strains used in the screen of yeast ORF library 
  108 
selection of yeast strains harboring pKHS392-RECQL4. The resulting yeast strain 
KHSY3552 (Appendix A) was used to obtain genomic DNA, which also contained 
plasmid pKHS392-RECQL4. Plasmid DNA was rescued and sequenced for confirmation 
of mutation free integration of RECQL4 cDNA in-frame with the GAL4 DBD (using 
primers R1307, F1269, F1270, F1271, F1272, and F1230, Appendix B). The resulting 
bait plasmid pKHS402 (Appendix C) was then transformed into strain KHSY3559 using 
standard LiAc-mediated transformation (Schiestl and Gietz 1989), yielding bait strains 
KHSY3607, KHSY3608, and KHSY3609, which were utilized in the yeast 2-hybrid 
screen. Bait strains KHSY3607, KHSY3608, and KHSY3609 were examined for 
expression of RecQL4 from the bait plasmid. As described in Chapter 4.1, we utilized 
TCA-mediated whole cell protein extract analyzed by Western blot and the resulting 
membrane was probed with an anti-DBD monoclonal antibody (Santa Cruz). As shown 
in Figure 4.2, all three constructs express RecQL4 stably and abundantly. 
Furthermore, the bait strains KHSY3607 and KHSY3608 were tested for 
auto-activation of the reporter HIS3 gene as outlined in Chapter 4.1. This test confirmed 
that pKHS402 does not auto-activate the HIS3 reporter gene (Figure 4.3). 
Screen of the yeast ORF prey library for RecQL4 interacting 
proteins  
The yeast 2-hybrid screen was carried out as outlined in Chapter 4.1 using strain 
KHSY3607. 32 candidates were identified in the first replicate of the screen (Table 4.4). 
While in the second replicate we identified 17 candidates (Table 4.5). However, after 
combining the candidate hit list, we did not observe any protein that appeared in both 
screens, suggesting that RecQL4 does not interact with the yeast proteome present in 
the yeast prey library. Figures 4.11 and 4.12 illustrate the 16 SC-LEU-TRP-HIS+3AT agar 
plates for the first and second replicate of our screen, respectively. 
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Construction and verification of the RecQL413 bait strain used in 
screen of the human testis cDNA library for RecQL4 interacting 
proteins  
To screen the human proteome for RecQL4 binding partners, we utilized the 
same Clontech Matchmaker® Gold Yeast Two-Hybrid System and the Clontech Mate & 
Plate™ Human Testis cDNA library described in Chapter 4.1. The testis cDNA library 
was specifically chosen since RecQL4 is highly expressed in this tissue, similar to 
RecQL1 (Kitao, Ohsugi et al. 1998). 
The bait strain was constructed by introducing the bait plasmid pKHS402 into 
strain KHSY3130 using standard LiAc-mediated transformation (Schiestl and Gietz 
1989), resulting in strains KHSYR4-1, KHSYR4-2, and KHSYR4-3. To confirm 
expression of RecQL4 from the bait plasmid, TCA-mediated whole cell protein extract 
was prepared from all three strains and analyzed by Western blot. The resulting 
membrane was probed with an anti-DBD monoclonal antibody (Santa Cruz) and, as 
demonstrated in Figure 4.2, all three constructs express RecQL4 stably and abundantly.  
Screen of the human testis cDNA library for RecQL4 interacting 
proteins  
The yeast 2-hybrid screen was carried out as outlined in the Clontech 
Matchmaker® Gold Yeast Two-Hybrid System manual. In contrast to the procedure 
outlined in Chapter 4.1, colonies that activated the HIS3 reporter gene were selected for 
on SC-LEU-TRP-HIS agar plates instead on SC-LEU-TRP-HIS+3AT agar plates. This 
slight modification lowered the stringency of the initial screen thus generating a larger 
number of candidates.  We screened over 1.2 million colonies for protein-protein 
                                                
13 This section only pertains to strains used in the screen of human testis cDNA library 
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interaction as estimated by adding the total number of transformants obtained on 
SC-LEU-TRP agar plates. We obtained 1200 candidates on SC-LEU-TRP-HIS agar 
plates during this initial screen. To reduce the number of false positives, we re-evaluated 
the initial 1200 candidates on SC-LEU-TRP, SC-LEU-TRP-HIS, and 
SC-LEU-TRP-HIS+3AT agar plates. As described in Chapter 4.1 the SC-LEU-TRP agar 
plates controlled for the presence of both bait and prey plasmids, the SC-LEU-TRP-HIS 
agar plates provided low stringency selection for protein-protein interactions, and the 
SC-LEU-TRP-HIS+3AT agar plates provided a more stringent selection for protein-protein 
interactions. From the original 1200 candidates, 166 grew on all three agar plates 
(Appendix F). To confirm the expression of 166 human cDNA candidates TCA-mediated 
whole cell protein extract was evaluated by Western blot analyses and the resulting 
membrane was probed with anti-AD monoclonal antibody (Santa Cruz). As reasoned in 
Chapter 4.1 the activation domain and a linker sequence connecting it to the cDNA 
insert, has a molecular weight of approximately 30kDa. Thus, for this study14 we chose 
to evaluate those candidates that produced a band larger than 40kDa as determined by 
Western blot analysis. Among the candidates, 24 produced a band with a molecular 
weight larger than 40kDa (Appendix F, Figure F.3).  
To identify the cDNA insert present in each candidate, we rescued the 24 prey 
plasmids from yeast and sequenced the insert using primer F1975, which anneals to the 
sequence upstream of the insert in the prey plasmid. The resulting sequences were 
analyzed using NCBI’s BLAST database. From the NCBI BLAST analysis we identified 
the following 12 candidates to be in-frame with the GAL4 AD:  
1. 10A10 - DNAJ homolog subfamily C member 7 (DNAJC7)  
2. 10B7 - RAR-related orphan receptor C (RORC) 
                                                
14 A follow-up study of those candidates that produced a band between 30 and 40kDa will be conducted. 
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3. 13B2 - Glutamine synthase (GLUL) 
4. 13B6 - CDK-activating kinase assembly factor MAT1 (MNAT1) 
5. 12D8 - Zinc finger MYM-type 2 (ZMYM2) 
6. 10B8 - Mediator of DNA damage checkpoint protein 1 (MDC1) 
7. 12C2 - Clusterin (CLU) 
8. 13A7 - Proteasome subunit beta type 9 (PSMB9) 
9. 13A10 - Nischarin (NISCH), 
10. 13A11 - Inhibin alpha (INHA) 
11. 13A12 - Actin-like 7B (ACTL7B)  
12. 13B1 - Mitochondrial ribosomal protein L38 (MRPL38) 
Next we designed specific primers to cDNAs: DNAJC7 (F2287), RORC (F2288), 
CLU (F2289), MNAT1 (F2290), NISCH (F2291), ACTL7B (F2292), MRPL38 (F2293), 
and PSMB9 (F2294) for which complete sequence of the insert could not be obtained by 
using primer F1975 (Appendix B) Table 4.6 indicates the length of the section of the 
insert recovered from sequence analysis. 
Verification of candidates for interaction with RecQL4 
To verify that activation of the reporter gene is due to a legitimate interaction 
between the bait protein and the prey peptide and not due to auto-activation by the prey 
plasmid, we transformed the 12 candidate prey plasmids into strain KHSY3989 and 
strain KHSYR4-1 and spotted on selective media (SC-LEU-TRP, SC-LEU-TRP-HIS, and 
SC-LEU-TRP-HIS+3AT, Figure 4.13). 10 fold serial dilutions of strain KHSY3989 harboring 
a prey plasmid were spotted on the first four columns (columns 1-4) and 10 fold serial 
dilutions of strain KHSYR4-1 harboring the same prey plasmid were spotted on the 
second four columns (columns 5-8, Figure 4.13). We observed that candidates 10A10 
(DNAJC7), 10B7 (RORC), 13B2 (GLUL), 13B6 (MNAT1), and 12D8 (ZMYM2) were able 
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to activate HIS3 reporter gene in the presence of the bait plasmid pKHS402 but not in 
the absence of the bait plasmid. Moreover, candidates 10B7 (RORC) and 13B6 
(MNAT1) were able to activate the HIS3 reporter gene on SC-LEU-TRP-HIS and on the 
more stringent SC-LEU-TRP-HIS+3AT agar plates, suggesting a more robust interaction. 
In contrast, candidates 10B8 (MDC1), 12C2 (CLU), 13A7 (PSMB9), 13A10 (NISCH), 
13A11 (INHA), 13A12 (ACTL7B), and 13B1(MRPL38) were not able to activate the HIS3 
reporter gene (Table 4.6, Figure 4.13). The recovered cDNA insert section of (DNAJC7), 
(RORC), (GLUL), (MNAT1), and (ZMYM2) that were identified by sequencing is shown 
in Figure 4.14 aligned to the corresponding full-length cDNA. 
Discussion 
In this study we utilized a yeast 2-hybrid assay to conduct a genome-wide screen 
for novel protein-protein interactions for RecQL4. We screened a yeast prey library and 
a human prey library and found that RecQL4 does not interact with any of the yeast 
ORFs in the prey library. However, in our screen of the human testis cDNA library we 
identified (DNAJC7), (MNAT1), (GLUL), (RORC), and (ZMYM2) as interacting 
candidates. 
DnaJ homolog subfamily C member 7 (DNAJC7) is an HSP40 homolog and 
co-chaperone for the molecular chaperones HSP70. The Hsp40 family is defined by the 
presence of the J domain, a conserved 70-residue domain homologous to the first 73 
amino acids of the E.coli Hsp40 called DnaJ (Hennessy, Nicoll et al. 2005). Candidate 
10A10 encodes 280 residues of the N-terminal region of DNAJC7, which does not 
include the J domain this protein (Figure 4.14). However, the 280 residues includes the 
tetratrico peptide repeat (TPR) region that mediates protein-protein interactions. Proteins 
with TPR regions function in assembly of multiprotein complexes, but are not 
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promiscuous in their protein interactions (D'Andrea and Regan 2003). The J domain of 
DNAJC7 has been demonstrated to interact with cell-cycle checkpoint protein Rad9 
(Xiang, Kumano et al. 2001). Rad9 is hypothesized to function at the early stages of the 
cell-cycle checkpoint in a complex with Rad1 and Hus1 (Dufault, Oestreich et al. 2003; 
Singh, Nurmohamed et al. 2007; Sohn and Cho 2009). Moreover, Rad9 has been 
suggested to have a role in regulation of apoptosis by interaction with Bcl2 (Komatsu, 
Hopkins et al. 2000). RecQL4 has been suggested to be involved in DSB repair, 
oxidative damage repair and pre-replication assembly. Since DNAJC7 has been shown 
to interact with the cell-cycle checkpoint machinery it is plausible that an interaction 
between RecQL4/DNAJC7 could be at the interface of regulation of the cell-cycle phase 
in response to DNA damage.  
Candidate 13B6 (MNAT1) identified in our screen contained the complete cDNA 
sequence of MNAT1 as reported in NCBI. MNAT1 (CDK-activating kinase assembly 
factor MAT1), along with cyclin H and CDK7, forms the CDK-activating kinase enzymatic 
complex. This complex activates several cyclin-associated kinases and can associate 
with TFIIH to activate transcription by RNA polymerase II (Eki, Okumura et al. 1998). 
MNAT1 has been demonstrated to interact with the tumor suppressor protein p53 (Ko, 
Shieh et al. 1997), and it has been shown to be required for efficient phosphorylation of 
p53 by CDK7-cyclin H, suggesting that MNAT1 functions as a factor for determining 
specific substrate for CDK7-cyclin H (Ko, Shieh et al. 1997).  
Previously, RecQL4 has been shown to interact with BLM (Singh, Popuri et al. 
2012) and BLM has been shown to interact with p53 (Wang, Tseng et al. 2001). We 
believe that it is plausible that MNAT1 and RecQL4 physically interact considering the 
fact that MNAT1 also interacts with p53 (Ko, Shieh et al. 1997). Moreover, all three 
mentioned proteins have been shown to directly be involved in the response or repair of 
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DSBs. We hypothesize that the interaction between MNAT1 and RecQL4 would have a 
role in regulation of transition between repair of DNA damage and apoptosis. 
Glutamine synthase (GLUL, candidate 13B2,) has been demonstrated to have a 
dynamic role in tumorigenesis in a tissue specific manner. GLUL catalyzes the synthesis 
of glutamine from glutamate and ammonia. This gene is expressed during early fetal 
stages, and plays an important role in controlling body pH by removing ammonia from 
circulation Glutamine is involved in cell proliferation, inhibition of apoptosis, and cell 
signaling. Increased glutamine catabolism in MYC-induced liver tumors in mice has been 
shown to be associated with decreased levels of glutamine synthetase. However, 
MYC-induced lung tumors result in increased expression of glutamine synthetase and 
accumulate glutamine (Yuneva, Fan et al. 2012). Tissue specificity is likely due to the 
metabolic profiles of tumors that depend on both the genotype and tissue of origin. RTS 
and RAPADILINO both have high instances of osteosarcoma and despite lung and liver 
tumors not being reported in these patients, regulation of tumorigenesis is an interface 
where it is plausible GLUL and RecQL4 to interact. 
Both (RORC) and (ZMYM2) have been identified as a transcription factors (He, 
Deftos et al. 1998; Ren and Cowell 2011). RORC is a member of the subfamily of 
nuclear receptors 1 (NR1) and has been shown to negatively regulate the Fas ligand, 
which subsequently regulates Interleukin 2 (IL-2) production in T-cells (He, Deftos et al. 
1998). ZMYM2 is a zinc finger protein; as such it contains a zinc-finger subdomain at the 
N-terminus that has been shown to enable dimerization of fibroblast growth factor 
receptor-1 (FGFR1) (Ren and Cowell 2011). ZMYM2-FGFR1 rearrangement have been 
linked to development of T-cell lymphomas (Ren and Cowell 2011). Since 
immunodeficiency and defects in development of T-cells have not been associated with 
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RecQL4 associated diseases, at this time it is unclear why RORC or ZMYM2 would be 
an interacting partner for RecQL4.  
As described in Chapter 4.1, validity of the protein interaction between RecQL4 
and our hits DNAJC7, MNAT1, and GLUL should next be verified by 
co-Immunoprecipitation experiment of the endogenous proteins in a human cell line.  
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Figures and Tables 
 
Figure 4.1 Known interacting proteins BLM, WRN, RecQL1 and RecQL4 
(A) Interacting proteins for BLM and WRN helicases. The proteins are shown in 
approximate location of the interaction site. (B) Proteins identified to physically interact 
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Figure 4.2 Evaluation of expression of RecQL1 and RecQL4 from bait plasmids by 
Western blot analysis  
Yeast cells were grown to an OD600 = 0.5 in SC-TRP, and whole- cell extracts were 
prepared from 5 ml of culture (3.5 × 107 cells) by standard TCA extraction to confirm 
expression of RecQL1 and RecQL4 from bait plasmids pKHS401 and pKHS402, 
respectively. 10 µl of TCA extract was separated on 10% SDS-PAGE, transferred to a 
PVDF membrane (Bio-Rad), probed with anti-DBD monoclonal antibody (Santa Cruz), 
and visualized by chemiluminescence (ECL Plus, GE Healthcare). Molecular weight 
marker (Broad Range) was obtained from Bio-Rad. All samples indicate abundant and 
intact expression of RecQL1 and RecQL4 proteins. Isolates KHSY3604, KHSY3605, and 
KHSY3606 (expressing RecQL1) and isolates KHSY3607, KHSY3608, and KHSY3609 
(expressing RecQL4) are bait constructs used in the screen of the arrayed yeast ORF 
library. In addition, isolates KHSYR1-1, KHSYR1-2, KHSYR1-3 (expressing RecQL1) 
and KHSYR4-1, KHSYR4-2, and KHSYR4-3 (expressing RecQL4) are bait constructs 
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Figure 4.3 Assessment of auto-activation of the HIS3 reporter gene by bait 
plasmid  
Three RecQL1 bait strains KHSY3604, KHSY3605, and KHSY3606 and two RecQL4 
bait strains KHSY3607 and KHSY3608 were evaluated on SC-TRP, SC-HIS-TRP and 
SC-HIS-TRP+3AT. Two different BLM bait constructs were used as positive control, and 
strain KHSY3559 (harboring empty bait plasmid) was used as negative control. As 
illustrated, neither RecQL1 nor RecQL4 constructs auto-activate the HIS3 reporter gene. 
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Figure 4.4 Plates 1-16 of the RecQL1 yeast 2-hybrid screen of yeast prey library 
(Replicate 1)  
The 16 SC-LEU-TRP-HIS+3AT agar plates were used to identify putative interactions 
between the RecQL1 bait strain KHSY3604 and the yeast prey library. We identified 37 
putative positive interactions listed in Table 4.1.  
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Figure 4.5 Plates 1-16 of the RecQL1 yeast 2-hybrid screen of yeast prey library 
(Replicate 2)  
The 16 SC-LEU-TRP-HIS+3AT agar plates were used to identify putative interactions 
between the RecQL1 bait strain KHSY3604 and the yeast prey library. We identified 13 
putative positive interactions listed in Table 4.2.  
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Figure 4.6 The reporter constructs of bait strain AH109 (KHSY3130, Clontech) 
The four reporter constructs present in the AH109 bait strain utilized in the Clontech 
Matchmaker® Gold Yeast Two-Hybrid System. The reporter constructs include the HIS3 
(in green) and ADE2 (in red) markers (James, Halladay et al. 1996) under the control of 
Upstream Activating Sequence (UAS) and promoter elements GAL1 and GAL2, 
respectivly. In addition, the lacZ (in blue) reporter is under the control of MEL1 UAS and 
promoter element. MEL1 is an endogenous GAL4-responsive gene. Utilizing four 
reporter genes allows for various degrees of stringency in selecting for putative protein 
interacting partners. This strain was utilized in the screen of the human testis cDNA 
library for both RecQL1 and RecQL4. 
 
  
GAL1 UAS GAL1 TATA HIS3 
GAL2 UAS GAL2 TATA ADE2 
MEL1 UAS MEL1 TATA LacZ 
MEL1 UAS MEL1 TATA MEL1 
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Figure 4.7 Western blot analyses of the 20 candidates identified in the screen of 
human testis cDNA library for RecQL1 interacting partners  
Cells were grown to an OD600 = 0.5 in SC-LEU-TRP, and whole- cell extracts were 
prepared from 5 ml of culture (3.5 × 107 cells) by standard TCA extraction to confirm 
expression of the activation domain and the testis cDNA ORF (Foiani, Liberi et al. 1999). 
10 µl of TCA extract was separated by 10% SDS-PAGE, transferred to a PVDF 
membrane (Bio-Rad), probed with anti-AD monoclonal antibody (Santa Cruz), and 
visualized by chemiluminescence (ECL Plus, GE Healthcare). Molecular weight marker 
(Broad Range) was obtained from Bio-Rad. The activation domain and a linker 
sequence connecting it to the cDNA insert has a molecular weight of approximately 
30kDa. In this study we were interested in candidates that encoded a peptide with a 
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Figure 4.8 Verification of the RecQL1 putative interacting partners 
Verification of candidates were carried out by transformation of each rescued prey 
plasmid into strain KHSY3989 and the bait strains KHSYR1-1 and spotted four different 
selective media: SC-LEU-TRP, SC-LEU-TRP-HIS, SC-LEU-TRP-HIS+3AT, and 
SC-LEU-TRP-HIS-ADE+3AT. SC-LEU-TRP agar plates select for presence of both the 
bait and prey plasmids, SC-LEU-TRP-HIS and SC-LEU-TRP-HIS+3AT agar plates select 
for activation of the HIS3 reporter gene at low and high stringency, respectively. 
SC-LEU-TRP-HIS-ADE+3AT agar plates are the most stringent by selecting for activation 
of HIS3 and ADE2 reporter genes. 10-fold serial dilutions of strain KHSY3989 harboring 
a prey plasmid was spotted on columns 1-4 and 10-fold serial dilutions of strain 
KHSYR1-1 harboring the same prey plasmid was spotted on columns 5-8. Candidates 
A12 (RANBP9) and A11 (RAN) cannot activate the reporter genes. Candidate F4 
(KPNA5) and F11 (RecQL1) appear to activate the reporter genes even in the absence 
of the bait, indicating auto-activation. Candidates, A9 and B10 (TRAF3IP1), and A2, B8, 
F2, and F10 (AIMP2) can activate the reporter genes but were omitted from analysis 
since sequencing revealed the insert to not be in-frame with the GAL4 AD. Candidates 
A7 (C10ORF137), A8 (KPNA5), B11 (KPNA6), and F5 (KPNA1) were able to activate all 
reporter genes in the presence of the bait (columns 5-8) but not in the absence of the 
bait (columns 1-4). Candidates A6 (TRAF3IP1) and F6 (KPNA4) can only activate the 
HIS3 reporter gene on SC-LEU-TRP-HIS and SC-LEU-TRP-HIS+3AT media. Candidate 
E12 (KPNA2) can only activate the HIS3 reporter gene on the SC-LEU-TRP-HIS media. 
Empty&vector& Bait&vector& Empty&vector& Bait&vector& Empty&vector& Bait&vector& Empty&vector& Bait&vector&
Empty&vector& Bait&vector& Empty&vector& Bait&vector& Empty&vector& Bait&vector& Empty&vector& Bait&vector&
        SC-LEU-TRP              SC-LEU-TRP-HIS       SC-LEU-TRP-HIS+3AT   SC-LEU-TRP-HIS-ADE 
A7 = C10orf137 
A11 = RAN 
A12 = RANBP9 
 B10 = TRAF3IP1
F5 = KPNA1 
E12 = KPNA2 
 F6 = KPNA4
A8 = KPNA5 
B11 = KPNA6 
F4 = KPNA5 
 F10 = AIMP2 
A2 = AIMP2 
A2 = AIMP2 
B8 = AIMP2 
F2 = AIMP2 
F10 = AIMP2 
A6 = TRAF3IP1 
A9 = TRAF3IP1 
B10 = TRAF3IP1 
A7 = C10orf137 
A11 = RAN 
A12 = RANBP9 
 
F11 = RECQ1 
 
        SC-LEU-TRP              SC-LEU-TRP-HIS       SC-LEU-TRP-HIS+3AT   SC-LEU-TRP-HIS-ADE 
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Colonies with different shades of red are indicative of inactive adenine pathway, while 
white colonies indicate activation of the ADE2 reporter gene.   
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Figure 4.9 cDNA insert fragment identified in the screen of the human testis cDNA 
library for RecQL1 interacting proteins 
 (A) We identified nucleotides 1626 to 2076 of the TRAF3IP1 cDNA from sequencing of 
Clone A6. This fragment encodes 149 amino acids of the C-terminus of the TRAF3IP1 
protein, which includes the 100 residue coiled-coil region shown to interact with TRAF3. 
(B) We identified nucleotides 3532 to 3717 of C10ORF137 cDNA from sequencing of 





1 1626 2076 






C-terminal coiled coil region and TRAF3 binding domain  
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Figure 4.11 Plates 1-16 of the RecQL4 yeast 2-hybrid screen of yeast prey library 
(Replicate 1).  
The 16 plates of SC-Leu-Trp-His+3AT were used to identify putative interactions between 
the RecQL4 bait strain KHSY3607 and the yeast prey library. Table 4.4 presents the 33 
putative positive interactions identified in this replicate.  
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Figure 4.12 Plates 1-16 of the RecQL4 yeast 2-hybrid screen of yeast prey library 
(Replicate 2).  
The 16 plates of SC-Leu-Trp-His+3AT were used to identify putative interactions between 
the RecQL4 bait strain KHSY3607 and the yeast prey library. Table 4.5 presents the 17 
putative positive interactions identified in this replicate. 
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Figure 4.13 Verification of RecQL4 putative interacting partners 
Each rescued prey plasmid is transformed into strain KHSY3989 and strains KHSYR1-1 
and spotted on three selective media. SC-LEU-TRP agar plates select for presence of 
both the bait and prey plasmids, SC-LEU-TRP-HIS and SC-LEU-TRP-HIS+3AT agar 
plates select for activation of the HIS3 reporter gene at low and high stringency, 
respectively. In columns 1-4, 10 fold serial dilutions of strain KHSY3989 harboring a prey 
plasmid were spotted and in columns 5-8, 10 fold serial dilutions of strain KHSYR4-1 
harboring the same prey plasmid are spotted. Candidates 10A10 (DNAJC7), 10B7 
(RORC), 13B2 (GLUL), 13B6 (MNAT1), and 12D8 (ZMYM2) are able to activate HIS3 
reporter gene in the presence of the bait plasmid pKHS402 but not in the absence of the 
bait plasmid. Candidates 10B7 (RORC) and 13B6 (MNAT1) are able to activate the HIS3 
reporter gene on SC-LEU-TRP-HIS and the more stringent SC-LEU-TRP-HIS+3AT agar 
plates suggesting a more robust interaction. Candidates 10B8 (MDC1), 12C2 (CLU), 
13A7 (PSMB9), 13A10 (NISCH), 13A11 (INHA), 13A12 (ACTL7B), and 13B1(MRPL38) 
are not able to activate the HIS3 reporter gene 
 
  
        SC-LEU-TRP              SC-LEU-TRP-HIS        SC-LEU-TRP-HIS+3AT 
10A10 = DNAJC7 
Empty vector Bait vector Empty vector Bait vector Empty vector Bait vector 
10B7 = RORC 
10B8 = MDC1 
 12C2 = CLU 
13A7 = PSMB9 
13A10 = NISCH 
13A11 = INHA 
 
 
13A12 = ACTL7B 
13B1 = MRPL38 
13B6 = MNAT1 
13B2 = GLUL 
Empty pOAD 
 12D8 = ZMYM2 
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Figure 4.14 cDNA insert fragment identified in the screen of the human testis 
cDNA library for RecQL4 interacting proteins 
 (A) Clone 10A10 contains nucleotides 1-700 of DNAJC7 cDNA encoding the 280 amino 
acids of the DNAJC7 protein. (B) Clone 13B6 contains the complete cDNA sequence of 
MNAT1. (C) Clone 10B7 contains nucleotides 174-953 of cDNA RORC encoding 260 
amino acids of the RORC protein (D) Clone 13B2 contains nucleotides 434-1122 of 
cDNA GLUL encoding 688 amino acids at the C-terminus of the GLUL protein. (E) Clone 
12D8 contains nucleotides 1402-2140 of cDNA ZMYM2 encoding 246 amino acids in the 
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Table 4.1 Thirty-seven candidates identified in the first replicate of the yeast 
2-hybrid screen for RecQL1 interacting proteins of the yeast proteome 
ORF Plate # 384 well # Name 
YBR005W 1 A 6 YBR005W 
YGL258W 1 M18 YGL258W 
YIL060W 1 P 5 YIL060W 
YGR026W 3 C17 YGR026W 
YCL009C 3 M10 ILV6 
YBR104W 3 P 5 YMC2 
YJL131C 5 A 8 YJL131C 
YJL139C 5 N 5 YUR1 
YJL138C 5 P 5 TIF2 
YLR016C 7 A 8 YLR016C 
YMR048W 7 F20 YMR048W 
YLR165C 7 L11 YLR165C 
YLR178C 7 M10 TFS1 
YLL045C 7 N 5 RPL8B 
YLL041C 7 P 5 SDH2 
YKR036C 9 C11 CAF4 
YLR381W 9 M18 YLR381W 
YJR036C 9 N 5 YJR036C 
YJR059W 9 P 5 PTK2 
YDR008C 11 A 6  
YDR133C 11 A 8 YDR133C 
YDR290W 11 C11 YDR290W 
YOR225W 11 M18 YOR225W 
YDR308C 11 N 5 SRB7 
YDR344C 11 P 5 YDR344C 
YDR171W 13 A 8 HSP42 
YDR414C 13 C11 ERD1 
YDR165W 13 N 5 YDR165W 
YPR054W 13 O22 SMK1 
YDR208W 15 A 6 MSS4 
YNL144C 15 C11 YNL144C 
YMR185W 15 L11 YMR185W 
YNL221C 15 M10 POP1 
YOR353C 15 M18 YOR353C 
YDR356W 15 N 5 NUF1 
YPL045W 15 O22 VPS16 
YDR359C 15 P 5 YDR359C 
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Table 4.2 Thirteen candidates identified in the first replicate of the yeast 2-hybrid 
screen for RecQL1 interacting proteins of the yeast proteome 
ORF Plate # 384 well 
# 
Name 
YGR026W 3 C17 YGR026W 
YER118C 3 P 8 SHO1 
YIL176C 4 B 2 YIL176C 
YDR155C 11 D 8 CPH1 
YOR074C 12 D16 CDC21 
YOR202W 12 K17 HIS3* 
YDR423C 13 I10 CAD1 
YNL189W 14 A12 SRP1 
YLR206W 14 D 9 ENT2 
YKL210W 15 D10 UBA1 
YPL248C 15 H21 GAL4* 
YNL216W 15 O10 RAP1 
YDR326C 16 O 6 YDR326C 
 
* HIS3 and GAL4 are not candidates for interaction with RecQL1 they are false positives. 
Presence of the HIS3 ORF will allow growth on SC-LEU-TRP-HIS+3AT agar plates 
without the need for activation of the reporter gene. Similarly, the GAL4 ORF can 
interact with the reporter construct and activate expression of the HIS3 gene resulting in 
growth on SC-LEU-TRP-HIS+3AT agar plates albeit no physical interaction with the bait 
protein.  
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Table 4.3 Summary of the results of the yeast 2-hybrid screen of the human testis 
cDNA library for RecQL1-interacting proteins 






A2 AIMP2 No + + + 25kDa 
A6 TRAF3IP1 Yes + + -­‐	   45kDa 
A7 C10ORF137 Yes + + + 50kDa 
A8 KPNA5 Yes + + + 125kDa 
A9 TRAF3IP1 No + + -­‐	   20kDa 
A10 ZGLP1 Yes n/a n/a n/a -­‐	  
A11 RAN No -­‐	   -­‐	   -­‐	   n/a 
A12 RANBP Yes -­‐	   -­‐	   -­‐	   100kDa 
B8 AIMP2 No + + + 25kDa 
B10 TRAF3IP1 No + + + -­‐	  
B11 KPNA2 Yes + + + 125kDa 
C6 KPNA6 Yes n/a n/a n/a 125 
E12 KPNA2 Yes + -­‐	   -­‐	   -­‐	  
F2 AIMP2 No + + + 20kDa 
F3 AIMP2 No n/a n/a n/a -­‐	  
F4 KPNA5 Yes AA AA AA n/a 
F5 KPNA1 Yes + + + 90kDa 
F6 KPNA4 Yes + + -­‐	   125kDa 
F10 AIMP2 No + + + 25kDa 
F11 RECQ1 N/A AA AA AA n/a 
 




5 Molecular weight as determined by Western blot analysis 
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Table 4.4 List of the 32 putative interactions identified in the first replicate of the 
yeast 2-hybrid screen for RecQL4 
ORF Plate # 384 well # Name 
YGL121C 1 C 3 YGL121C 
YGL117W 1 N 6 YGL117W 
YFL026W 2 O19 STE2 
YBL036C 3 C 3 YBL036C 
YGR026W 3 C17 YGR026W 
YCR094W 3 N 6 CDC50 
YGR280C 3 O19 YGR280C 
YHL003C 4 O19 LAG1 
YIR018W 5 C 3 YAP5 
YJL049W 5 N 9 YJL049W 
YKL096W 5 O19 CWP1 
YLR302C 6 J16 YLR302C 
YGL099W 6 O19 YGL099W 
YKL115C 7 C 3 YKL115C 
YKR087C 7 N 6 YKR087C 
YLR173W 8 J16 YLR173W 
YMR067C 8 O19 YMR067C 
YNL205C 9 N 6 YNL205C 
YNR012W 10 J16 URK1 
YPL117C 10 O19 IDI1 
YDR071C 11 N 6 YDR071C 
YOR277C 11 O19 YOR277C 
YOR174W 12 J15 MED4 
YDL175C 13 C 3 YDL175C 
YDR219C 13 N 6 YDR219C 
YPL236C 13 O19 YPL236C 
YOL164W 14 J16 YOL164W 
YOR359W 14 O19 YOR359W 
YDR430C 15 N 6 YDR430C 
YPL164C 15 O19 YPL164C 
YML048Wa 16 J16  
YOR086C 16 O19 YOR086C 
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Table 4.5 List of the 17 putative interactions identified in the second replicate of 
the yeast 2-hybrid screen for RecQL4 
ORF Plate # 384 well # Name 
YAL014C 1 A 4 YAL014C 
YAL008W 1 C 4 YAL008W 
YER121W 2 B10 YER121W 
YER148W 2 D24 SPT15 
YER109C 2 L 8 FLO8 
YGR026W 3 C17 YGR026W 
YGR048W 3 N17 UFD1 
YER028C 3 J 8 YER028C 
YCL016C 3 K10 YCL016C 
YGL035C 4 C18 MIG1 
YKL061W 4 L22 YKL061W 
YLR159W 6 P10 YLR159W 
YLR285W 7 P13 YLR285W 
YER114C 10 C16 BOI2 
YNR069C 14 E15 YNR069C 
YPL248C 15 H21 GAL4 
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Table 4.6 Summary of the results of the yeast 2-hybrid screen of the human testis 
cDNA library for RecQL4-interacting proteins 











10A10 DNAJC7 1-700 1486 + - 80 
10B7 ROROC 174-953 1494 + + 100 
13B2 GLUL 434-1122 1122 + - 70 
13B6 MANT1 1-804 804 + + 70 
12D8 ZMYM2 1402-2140 4134 + - 120 
10B8 MDC1 5905-6271 6271 - - 50 
12C2 CLU 55-719 1350 - - 90 
13A7 PSMB9 1-532 660 - - 50 
13A10 NISCH 3709-4430 4515 - - 80 
13A11 INHA 688-1101 1101 - - 50 
13A12 ACTL7B 577-1221 1248 - - 70 
13B1 MRPL38 1-710 1143 - - 80 
 
1 Recovered section of the insert identified by sequence analysis  
2 Length of the cDNA as reported in NCBI  
3 SC-LEU-TRP-HIS 
4 SC-LEU-TRP-HIS+3AT 
5 Molecular weight as determined by Western blot analysis 
 
  







GENETIC CHARACTERIZATION OF RECQL1 AND RECQL4 IN 
HUMANIZED SACCHAROMYCES CEREVISIAE  
 
 
Note to reader: Unpublished data. Experiments were designed by Hamed Mirzaei and 
Kristina H. Schmidt and were performed and analyzed by Hamed Mirzaei except for 
initial construction and integration of the RECQL5 gene in yeast, which was performed 
by Salahuddin Syed. All data analysis and figures were generated by Hamed Mirzaei. 
 
Rationale: 
As discussed in Chapter 1, the five human RecQ-like homologs are RecQL1, 
BLM, WRN, RecQL4, and RecQL5 (Umate, Tuteja et al. 2011). Three out five, BLM, 
WRN, and RecQL4, are associated with known syndromes. Syndromes associated with 
RecQ-like proteins present a variety of clinical symptoms ranging from skeletal 
abnormalities, proportionate dwarfism, elevated cancer predisposition, immune 
deficiencies, infertility or subfertility, facial dysmorphia, gastro intestine disturbance, 
patellar abnormalities, and premature aging (Bachrati and Hickson 2003). 
Despite the three disorders attributed to RecQL4 (outlined in Chapter 1), very 
little is known about the cellular function of this helicase, defects of which result in 
severe complication. RecQL4 is the only member among the human RecQ-like 
homologs to lack both the RQC and the HRDC domain (Figure 1.1 and Figure 5.4F). 
RecQL4 has been demonstrated to have ATPase and strand annealing activities similar 
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to other members of RecQ-like family (Sharma, Doherty et al. 2006), and while helicase 
activity is observed in purified RecQL4, it is extremely weak (Suzuki, Kohno et al. 2009; 
Xu and Liu 2009).  
RecQL4 is highly expressed in the thymus and testis (Kitao, Ohsugi et al. 1998). 
Interestingly, the expression profile of this protein through out the cell cycle is very 
similar to yeast Sgs1 and human BLM, which appear during S-phase and are maintained 
at similar levels in G2/M, but have mostly disappeared by the time cells re-enter G1 
(Dutertre, Ababou et al. 2000). Moreover, post-treatment with ionizing radiation, the 
N-terminus of RecQL4 has been shown to physically interact with the N-terminus of 
BLM, and stimulate its helicase activity at stalled replication forks during S-phase (Singh, 
Popuri et al. 2012). In addition to physical interaction with BLM, there is some evidence 
suggesting RecQL4 is involved in the repair of DNA double strand breaks (DSB) 
including its presence in a complex with Rad51 upon induction of DSBs, formation of foci 
in close proximity of PML bodies, and lastly RecQL4 deficient fibroblast cells are slightly 
more sensitive to gamma radiation and accumulate more ɣH2AX than RecQL4 proficient 
fibroblast cells (Petkovic, Dietschy et al. 2005; Singh, Karmakar et al. 2010). In contrast 
to BLM, RecQL4 demonstrates a nucleoplasmic localization both in presence and 
absence of DNA damaging agents (Bischof, Kim et al. 2001; Woo, Futami et al. 2006).  
However, in response to oxidative damage, RecQL4 does localize to the nucleolus. This 
pattern of localization in combination with evidence for physical interaction with PARP1 
has led to the hypothesis that this RecQ-like helicase aids in recovery from DNA 
damage as a result of oxidative stress (Diefenbach and Burkle 2005; Woo, Futami et al. 
2006).  
In recent years, mass spectrometry and co-immunoprecipitation analysis have 
shown interaction of RecQL4 with MCM10 and the MCM2-7 complex (Xu, Rochette et al. 
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2009). Furthermore this interaction is shown to be controlled by the cell cycle and limited 
to the G1 and S phases. This finding suggests that RecQL4 plays an important role in 
DNA replication (Xu, Rochette et al. 2009). 
Comparable to RecQL4, RecQL1 is highly expressed in the testis and thymus 
(Kitao, Ohsugi et al. 1998) and is one of the least studied human RecQ-like helicases. 
Among the human RecQ-like homologs, RecQL1 is the most abundant (Kawabe, 
Tsuyama et al. 2000) and is not associated with any disorder. Consequently, very little is 
known about the function of this helicase in humans. However, there is some evidence 
suggesting that this helicase functions in similar DNA metabolism pathways as other 
member of the RecQ-like family.  
RecQL1 can unwind many secondary DNA structures 15  in addition to the 
canonical 3’-5’ helicase activity and ssDNA annealing (Sharma, Sommers et al. 2005; 
Popuri, Bachrati et al. 2008). This helicase also demonstrates branch migration and 
processing of Holliday junctions (LeRoy, Carroll et al. 2005; Bugreev, Brosh et al. 2008; 
Popuri, Bachrati et al. 2008; Mazina, Rossi et al. 2012). RecQL1 has been shown to 
physically interact with DNA mismatch repair proteins (MSH2/MSH6 and MLH1/PMS2), 
Exo1(Doherty, Sharma et al. 2005), RPA (Cui, Arosio et al. 2004), Importin-α (Seki, 
Tada et al. 1997) and, TopIIIα (Johnson, Lombard et al. 2000). As in the case of 
RecQL4, mass spectrometry and co-immunoprecipitation analysis of RecQL1 illustrate 
interaction with PARP1 and suggest involvement in the oxidative stress response 
pathway (Sharma, Phatak et al. 2012). 
Due to the fact that very little is known about RecQL1 and RecQL4, we sought to 
characterize these proteins in a yeast system.  Since there are five RecQ-like homologs 
in humans, we sought to assess their ability to complement the yeast homolog Sgs1. 
                                                
15 Previously described in Chapter 1 
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Previously, it has been reported that BLM and WRN helicases are capable of partially 
complementing sgs1Δ defects when expressed in an sgs1Δ background (Yamagata, 
Kato et al. 1998; Heo, Tatebayashi et al. 1999). Yamagata et al. demonstrated that 
expression of BLM under the control of a GAPDH promoter fully suppressed premature 
aging, rDNA hyper-recombination, and HU sensitivity of the sgs1Δ mutant (Yamagata, 
Kato et al. 1998; Heo, Tatebayashi et al. 1999). Utilizing the same system, it was 
demonstrated that the WRN protein was able to complement sgs1Δ defects to a lesser 
extent in comparison to BLM (Yamagata, Kato et al. 1998).   
We reasoned that since BLM and WRN are able to complement some of sgs1Δ 
defects, RECQL1 and RECQL4 might be able to do the same at varying degrees. We 
hypothesized that RECQL1, which possesses all the same conserved domains as BLM 
(the 7 helicase motif, RQC, and HRDC domains), should be able to complement sgs1Δ 
defects in the same manner as BLM. In addition, we predicted that RECQL4 should be 
able to complement sgs1Δ defects to some level due its putative role in restart of stalled 
replication forks. However, RECQL4 complementation will probably be less than BLM, 
WRN or even RECQL1 since RECQL4 lacks both the RQC and the HRDC conserved 
domains and has questionable helicase activity.  
To test our hypothesis, RECQL1 and RECQL4 cDNAs were cloned 
independently in place of the yeast homolog SGS1. We examined the ability of RECQL1 
and RECQL4 to complement sgs1Δ defects, including hypersensitivity to the DNA 
damaging agent hydroxyurea (HU) and accumulation of gross chromosomal 
rearrangements (GCR) when expressed under the control of the SGS1 promoter and 
when overexpressed from a GAL1 inducible promoter. Taking advantage of the SGS1 
promoter ensured that RecQL1 and RecQL4 are copy number controlled and are 
expressed in the same cell phases as Sgs1, which corresponds to the expression profile 
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of BLM and RecQL4 in human cells. The GAL1 promoter allowed us to examine effects 
of overexpression of RecQL1 and RecQL4 in yeast in the event that expression from the 
SGS1 promoter was not sufficient.  
We further characterized RecQL1 and RecQL4 in our novel chimeric system, 
which was described in Chapter 2 (Mirzaei, Syed et al. 2011). In addition we investigated 
genetic interactions between RecQL1, RecQL4, RecQL5 and BLM in diploid yeast cells. 
Results16 
Construction of humanized yeast strains expressing RecQL1 and 
RecQL4 at the SGS1 locus 
For this investigation, we obtained RECQL1 and RECQL4 cDNAs as a clone in 
vector pOBT7 from Open Biosystems (p2823112 and p3634266, respectively, here on 
referred to as pKHS263 and pKHS264). It should be noted that there are two different 
isoforms for RecQL4, a 1208 amino acid protein, which possess a long N-terminal region 
and a 652 amino acid protein, with a very short N-terminal region. At the time of this 
study the short isoform was the only available isoform.  
In order to positively select for yeast strains expressing RecQL1 or RecQL4, a 
selectable marker had to be cloned downstream of the plasmid-borne RECQL1 and 
RECQL4 cDNAs. To achieve this, we utilized the HIS3MX6 cassette harbored in the 
pRS303 plasmid (Appendix C) (Sikorski and Hieter 1989). A two-step cloning process 
was adopted for efficient integration. In step one, the HIS3MX6 cassette was amplified 
by PCR from the pRS303 plasmid using primers F1236/R123717 (Appendix B) and 
cloned into vector pCR2.1-TOPO (Invitrogen), resulting in plasmid pKHS337 (Figure 
                                                
16 General methods and material are described in Chapter 8 
17 F= Forward, R=Reverse. 
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5.1A). The primer combination F1236/R1237 flanks the HIS3MX6 cassette and 
contains 5’ XhoI restriction sites. In step two, we took advantage of the unique XhoI 
restriction site present downstream of both RECQL1 and RECQL4 cDNA in the pOBT7 
plasmid (pKHS263 and pKHS264) and the engineered XhoI sites flanking the HIS3MX6 
cassette in the pKHS337 plasmid. We subjected all three plasmids to XhoI digestion 
followed by ligation of the HIS3MX6 cassette into the pOBT7 plasmid using DNA 
Ligation Kit Ver. 2.1 (Takara) per manufacturer instructions. Subsequently, ligation 
products were transformed into electro-competent E.coli cells18 and positively selected 
for on LB agar plates (Trypton 10g/L, Yeast extract 5g/L, and NaCl 5g/L) supplemented 
with 100ug/ml of Chloramphenicol (CMP). 
 Colony PCR was utilized to screen E.coli transformants for the presence of 
plasmids pKHS263 or pKHS264 harboring a HIS3MX6 cassette. Primer combinations 
F1229/R1032 and F1229/R1031 were used to analyze RECQL1 constructs while 
primers F1230/R1032 and F1230/R1031 were used to analyze RECQL4 constructs 
(Figure 5.1B, Appendix B). 
Plasmid DNA was isolated using QIAGEN’s QIAprep Spin Miniprep Kit (per 
manufacturer’s instructions) from E.coli transformants identified by the colony PCR 
screen. Subsequently, isolated plasmid DNA was subjected to HindIII digestion to take 
advantage of a unique restriction site that confirmed the presence of the HIS3MX6 
cassette and its relative orientation with respect to the RECQL1 or RECQL4 cDNA 
(Figure 5.1C). From the six isolates each that were analyzed by HindIII digestion, three 
RECQL1 constructs (pKHS338, pKHS339, and pKHS340) and three RECQL4 
constructs (pKHS344, pKHS345, and pKHS346) with the HIS3MX6 cassette in the 
opposite orientation from the cDNA were selected for yeast integration (Appendix C).  
                                                
18 Protocol for making electro-competent cells is described in Chapter 8. 
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To ensure that the expression of RECQL1 (and independently RECQL4) is copy 
number and cell cycle regulated, RECQL1 and RECQL4 cDNAs were integrated at the 
chromosomal SGS1 locus in frame with the start codon, thus being under the control of 
the SGS1 promoter. To construct the PSGS1.RECQL1.HIS3MX6 allele, we amplified the 
RECQL1.HIS3MX6 fragment by PCR from plasmid pKHS338 using the primer 
combination F1245/R1246 (Figure 5.1D, Appendix B). These primers are 70-nucleotides 
long and are comprised of 20-nucleotides homologous to the template DNA and 
50-nucleotides homologous to the integration site. Using standard LiAc-mediated 
transformation19 (Schiestl and Gietz 1989), the RECQL1.HIS3MX6 PCR amplicon was 
introduced into yeast strain KHSY1633 (Appendix A). The KHSY1633 strain is an sgs1Δ 
strain in which the SGS1 gene has been replaced with a kanMX6 cassette conferring 
resistance to G418-sulfate (Alexis Biochemicals). Transformants with stable genomic 
integration of RECQL1.HIS3MX6 were selected for by plating of cells on synthetic 
complete agar plates lacking histidine (SC-HIS).  
Colonies were then examined for loss of resistance to G418-sulfate followed by 
confirmation of RECQL1 cDNA integration at the SGS1 locus by PCR using primer 
combinations F1143/R1278 and F1229/R1032 (Figure 5.1E, Appendix B). The 
integrated RECQL1 cDNA was amplified by PCR from select verified yeast isolates and 
subsequently sequenced to confirm no mutations were incorporated during the 
transformation process. Sequencing of the genomic RECQL1 amplicon was carried out 
using primers R1278, F1274, F1300, F1301, F1276, and F1277 (Appendix B). Three 
independent clones KHSY2046, KHSY2047, and KHSY2048 (Appendix A) were 
obtained for further functional characterization by GCR analysis, and evaluation of 
sensitivity to HU.  
                                                
19 Standard LiAc-mediated transformation is described in Chapter 8 
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Similarly, RECQL4 was integrated at the chromosomal SGS1 locus, utilizing 
pKHS345 to generate the RECQL4.HIS3MX6 PCR fragment using the primer 
combination F1253/R1254 (Figure 5.1F, Appendix B). Confirmation of 
RECQL4.HIS3MX6 integration by PCR was carried out using primer combinations 
F1143/R1273 and F1230/R1032 (Figure 5.1G, Appendix B). Select verified yeast 
isolates were used to amplify genomic RECQL4 by PCR, which was subsequently 
sequenced using primers R1307, F1269, F1270, F1271, F1272, and F1230 
(Appendix B). While strain KHSY2177 was the only completely sequenced and 
confirmed isolate, additional clones were obtained by mating of KHSY2177 to wild-type 
strain KHSY802 (Appendix A). Briefly, diploid yeast strains are constructed by mixing 
strains of the opposite mating-type (MATa or MATα) (Herskowitz and Jensen 1991), 
which can then be sporulated to produce haploid cells (Rockmill, Lambie et al. 1991). By 
coupling generation of diploids and sporulation of diploids, strains with different 
genotypes could be combined to produce desired combinations of mutations in a haploid 
cell, or in the case of RECQL4, expressing cells to generate additional clones. 
To verify protein expression for both RECQL1 (KHSY2046) and RECQL4 
(KHSY2177) from the humanized yeast strains, a myc-epitope tag was fused to the 
3’ end of the cDNA, yielding strains KHSY2860 and KHSY2867, respectively 
(Appendix A).  
To fuse the myc-epitope tag to RECQL1 cDNA, the 13MYC.TRP1 cassette was 
amplified by PCR from plasmid pFA6a.13MYC.TRP1 (Appendix C) (Longtine, McKenzie 
et al. 1998) using primer combination F1281/R1283 (Figure 5.2A, Appendix B). Similarly 
to fuse the myc-epitope tag to RECQL4 cDNA, the 13MYC.TRP1 cassette was amplified 
by PCR using primer combination F1282/R1283 (Figure 5.2B, Appendix B). Next utilizing 
standard LiAc-mediated transformation (Schiestl and Gietz 1989), the 13MYC.TRP1  
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cassette amplicon for RECQL1 was transformed into strain KHSY2046, while the 
13MYC.TRP1 cassette amplicon for RECQL4 was transformed into strain KHSY2177. 
Transformed yeast cell with the stably integrated 13MYC.TRP1 cassette were selected 
for on synthetic complete agar plates minus tryptophan (SC-TRP). Fusion of the 
myc-epitope tag to the RECQL1 and RECQL4 cDNAs was first verified by PCR using 
primer combinations F1277/R1029 for RECQL1 (Figure 5.2A, C and D, Appendix B) and 
F1230/R1029 for RECQL4 (Figure 5.2B, Appendix B). Protein expression was then 
confirmed by standard Western blot analysis using monoclonal anti-myc antibody 
(Covance, Figure 5.2E) as described in Chapter 8.  
Expression of RecQL1 or RecQL4 in an sgs1Δ strain does not 
suppress accumulation of GCRs or reduce hypersensitivity to HU 
The GCR assay was carried out as previously described (Schmidt, Pennaneach 
et al. 2006). GCR rates were derived from 10 ml cultures of three or more independent 
strain isolates. Statistical significance of differences between median GCR rates were 
assessed by calculating 95% confidence intervals for all median GCR rates according to 
the method of Nair (Nair 1940). Previous studies by our laboratory and others have 
illustrated that an sgs1Δ strain has a moderate rate of GCR accumulation (Myung, Datta 
et al. 2001; Schmidt and Kolodner 2006; Mirzaei, Syed et al. 2011) (Table 5.1).  Our 
hypothesis was that RECQL1 humanized yeast strains could lower this rate by 
complementing Sgs1 function. However, unlike RecQL1or BLM, RecQL4 lacks both the 
RQC and the HRDC domains. Thus the RECQL4 humanized yeast strain was not 
expected to be able to lower the rate of GCR accumulation to the same degree. 
Measurements of the rate of GCR accumulation in PSGS1.RECQL1.HIS3MX6 and 
PSGS1.RECQL4.HIS3MX6 strains constructed above, illustrated that there are no 
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statistically significant differences between an sgs1Δ strain and an sgs1Δ strain 
expressing RecQL1 or RecQL4 under the control of an SGS1 promoter (Table 5.1).  
Since expression of the RecQL1 and RecQL4 proteins under control of the 
endogenous SGS1 promoter did not complement Sgs1 function, we next evaluated the 
effects of overexpression of these proteins from a GAL1 promoter on accumulation of 
GCRs in an sgs1∆ strain.  
We constructed yeast strains with galactose inducible RecQL1 and RecQL4. 
Briefly, TRP1.PGAL1 was amplified by PCR from the pFA6a.TRP1.PGAL1 plasmid 
(Appendix C) (Longtine, McKenzie et al. 1998) for integration upstream of RECQL1 and 
RECQL4 to replace the native SGS1 promoter in yeast strains KHSY2046 and 
KHSY2676, respectively. Using standard LiAc-mediated transformation (Schiestl and 
Gietz 1989), the TRP1.PGAL1 amplicon was introduced into yeast and selected for on 
SC-TRP agar plates as described earlier. Chromosomal integration of the GAL1 
promoter was confirmed by PCR utilizing primer combinations F1029/R1278 and 
F1030/R1278 for verification of TRP1.PGAL1.RECQL1.HIS3MX6 and primer combination 
F1029/R1273 and F1030/R1273 for verification of TRP1.PGAL1.RECQL4.HIS3MX6 
(Figure 5.2F and G, Appendix B). By this method, we generated four isolates that 
overexpressed RecQL1 (KHSY3726, KHSY3727, KHSY3728, and KHSY3729) and four 
isolates that overexpressed RecQL4 (KHSY3771, KHSY3772, KHSY3773, and 
KHSY3774) from a galactose inducible GAL1 promoter.  
To verify inducibility and protein expression levels of the 
TRP1.PGAL1.RECQL1.HIS3MX6 and TRP1.PGAL1.RECQL4.HIS3MX6 strains in the 
presence of galactose, myc-epitope tags were fused to the 3’ end of the cDNA as 
described earlier. However, since the GAL1 promoter is linked to a TRP1 cassette we 
utilized a 13MYC.kanMX6 cassette instead of a 13MYC.TRP1 cassette. The presence of 
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the 13MYC.kanMX6 cassette can be selected for on YPD media supplemented with 
200 µg/ml of active G418-sulfate. As before the cassette was amplified by PCR from 
pFA6a.13MYC.kanMX6 (Appendix C) (Longtine, McKenzie et al. 1998) using primer 
combination F1281/R1283 for fusion to RECQL1 cDNA and primer combination 
F1282/R1283 for fusion to RECQL4 cDNA. Using standard LiAc-mediated 
transformation (Schiestl and Gietz 1989), the 13MYC.kanMX6 cassette amplicon was 
introduced into yeast strain KHSY3726 and KHSY3771 and were selected for on YPD 
agar plates supplemented with 200 µg/ml of active G418-sulfate. RecQL1 and RecQL4 
expression in the resulting strains KHSY3730 (TRP1.PGAL1.RECQL1.HIS3MX6) and 
KHSY3775 and KHSY3776 (TRP1.PGAL1.RECQL4.HIS3MX6), was verified by Western 
blot analysis. In order to induce RECQL1 or RECQL4 cDNA under the control of the 
GAL1 promoter, the 2% dextrose in media was replaced with 2% galactose or 
1% sucrose and 1% galactose.  
For this experiment, we slightly modified the GCR assay. After the initial 
three-day incubation on YPD agar plates, a single colony was cultured in liquid 
YP-Galactose (yeast extract 10g/L, peptone20g/L, 2% galactose) instead of YPD. After 
reaching saturation, the cultures were spread on synthetic complete agar plates 
containing 5-FOA (1 g/L), and canavanine (60 mg/L), lacking arginine as before but the 
dextrose in the media was replaced with galactose (GCR/Gal agar plates).   
Measurement of the rate of accumulation of GCRs in strains overexpressing 
RecQL1 and RecQL4 from a GAL1 promoter illustrated there are no statistically 
significant differences between an sgs1∆ strain and an sgs1∆ strain overexpressing 
RecQL1 or RecQL4 (Table 5.1).  
Because there is no statistically significant difference in the rate of accumulation 
of GCRs between strains expressing RecQL1 or RecQL4 and an sgs1∆ strain, we chose 
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to evaluate GCRs in a cell cycle checkpoint deficient background. Previous studies have 
demonstrated that deletion of the DNA-damage checkpoint sensor MEC3 in an sgs1Δ 
background leads to a synergistic increase in the accumulation of the GCR rate 
(Schmidt and Kolodner 2006; Mirzaei, Syed et al. 2011). To generate mec3∆ sgs1∆ 
strains expressing RecQL1 or RecQL4, we first generated diploid heterozygous strains 
by crossing desired mutant strains. The resulting diploid strains were sporulated and 
genotyped on selective media for the presence of the desired combination of mutations, 
as described in Chapter 8. Briefly, strains KHSY2046 and KHSY2676 were crossed to a 
mec3∆ strain KHSY1346 (Appendix A), and the resulting heterozygous diploids were 
sporulated and genotyped producing double mutant (sgs1∆ mec3∆) yeast strains 
expressing RecQL1 or RecQL4. Double mutant strains KHSY2050, KHSY2051, and 
KHSY2052 (Appendix A) expressing RecQL1, and strains KHSY3568, KHSY3569, and 
KHSY3570 (Appendix A) expressing RecQL4 were analyzed for accumulation of GCRs.  
When comparing the rate of accumulation of GCRs of an sgs1∆ mec3∆ strain 
expressing RecQL1 or RecQL4 (under the control of an SGS1 promoter) to an sgs1∆ 
mec3∆ strain, we observed no statistically significant difference (Table 5.1). Thus 
concluding that neither RECQL1 nor RECQL4 can complement sgs1∆ defects as 
detected by the GCR assay. 
Next, we sought to examine whether strains expressing either RecQL1 or 
RecQL4 could reduce the hypersensitivity to HU observed in an sgs1∆ strain. We 
assessed the ability of strains expressing RecQL1 or RecQL4 under the control of a 
native SGS1 promoter and strains overexpressing these proteins from a GAL1 inducible 
promoter to reduce the hypersensitivity to HU observed in sgs1∆ cells. We reasoned that 
it was possible that the amount of RecQL1 or RecQL4 protein expressed from the SGS1 
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promoter might be insufficient to compensate for the absence of SGS1. This hypothesis 
was tested by evaluating strains overexpressing RecQL1 and RecQL4.  
To assess hypersensitivity to the DNA damaging agent HU, an overnight culture 
of the desired strain was diluted in YPD to OD600 = 0.2 and grown at 30°C to OD600 = 0.6. 
Next a series of 10-fold dilutions was prepared from the yeast culture, and 2 µl aliquots 
were spotted on YPD and on YPD containing different concentrations of HU. We 
assessed sensitivity to 10 mM, 20 mM, 50 mM, 100 mM, and 200 mM HU. When 
assessing hypersensitivity of strains expressing galactose inducible RecQL1 or RecQL4, 
we substituted 2% dextrose with 1% sucrose and 1% galactose. As controls, we utilized 
wild-type strain KHSY802 and sgs1∆ strain KHSY1633. In addition we used a PGAL1.BLM 
strain, which was previously found to be hypersensitivity to HU20 (Mirzaei, Syed et al. 
2011).  
We observed that cells expressing either RecQL1 or RecQL4 under the native 
SGS1 promoter are as hypersensitivity to HU as an sgs1∆ strain (Figure 5.3A). 
Moreover, overexpression of neither RecQL1 nor RecQL4 helped to reduce the 
observed hypersensitivity of an sgs1∆ strain to HU (Figure 5.3B). However, unlike yeast 
strains overexpressing BLM, overexpression of RecQL1 or RecQL4 did not result in 
elevated hypersensitivity to HU (Figure 5.3B). 
Construction of Sgs1-RecQL1 and Sgs1-RecQL4 chimeric 
proteins 
It has been previously reported from our laboratory that an Sgs1-BLM chimeric 
protein is able to partially suppress the deleterious phenotypes associated with an sgs1∆ 
strain (Mirzaei, Syed et al. 2011). This Sgs1-BLM21 chimera was generated by fusing the 
                                                
20 Described in Chapter 2 
21 For simplicity, Sgs1 [1-647]-BLM [648-1447] is simply referred to as Sgs1-BLM 
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N-terminal region of Sgs1 (amino acids 1-647), which is predicted to be disordered, to 
the C-terminus catalytic region of BLM (amino acids 648-1417), which is predicted to be 
ordered (Figure 5.4A, B, and C). Therefore, we sought to assess whether chimeric 
proteins comprised of Sgs1 and RecQL1 or Sgs1 and RecQL4 are able to complement 
sgs1∆ defects similar to the Sgs1-BLM chimera (Mirzaei, Syed et al. 2011). We 
hypothesized that RecQL1 would complement sgs1∆ defects because, similar to BLM 
and Sgs1, it possesses the RQC domain and the HRDC domain in addition to the 7 motif 
helicase domain. In contrast, we reasoned that RecQL4 would not complement sgs1∆ 
defects because it lacks both the RQC and the HRDC domains. 
The RecQL1 protein is 649 amino acids long and is only half the size of BLM due 
to a very short N-terminal region that extends from the helicase core (Figure 5.4F). We 
assessed disorder scores of RecQL1, BLM, and Sgs1 from a server for the prediction of 
intrinsically unstructured regions of proteins (IUPred, http://iupred.enzim.hu/) and 
observe that the majority of the RecQL1 protein is predicted to be structured, similar to 
the C-terminus of BLM (Figure 5.4H and I). Consequently, we chose to fuse the same 
647 residue long N-terminus of Sgs1 that was used in construction of the Sgs1-BLM 
chimera (Chapter 2) to the full-length RecQL1 protein resulting in a 1296-amino-acid 
long chimeric protein (Figure 5.4D). 
The cDNA of RECQL4 obtained from Open Biosystems encodes a protein that 
has a short N-terminal tail extending from the helicase core. The IUPred prediction of 
disorder scores for this RecQL4 isoform revealed little similarity to RecQL1 or the 
C-terminus of BLM (Figure5.4J). This was not unexpected since RecQL4 lacks both 
C-terminal RQC and HRDC domains that are present in BLM and RecQL1 (Figure 5.4F). 
Because this RecQL4 isoform lacks the long N-terminal tail, we decided to fuse the 
same 647 residue long N-terminus of Sgs1 used in construction of the Sgs1-BLM 
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chimera (Chapter 2) and the Sgs1-RecQL1 chimera to the full length RecQL4 yielding a 
1299-amino-acid long chimeric protein (Figure 5.4E). For construction of the 
above-mentioned chimeric proteins, RECQL1.HIS3MX6 and RECQL4.HISMX6 were 
amplified by PCR from plasmids pKHS338 and pKHS345, respectively. Primer 
combination F1690/R1246 where used for RECQL1.HIS3MX6 amplification (Appendix 
B) and F1688/R1246 were used for RECQL4.HISMX6 amplification (Figure 5.1D and F, 
Appendix B). 
Subsequently, standard LiAc-mediated transformation (Schiestl and Gietz 1989) 
was used to introduce each amplicon into yeast strain KHSY802, resulting in chimeric 
genes that are expressed under control of the native SGS1 promoter. Positive 
transformants were selected for the presence of RECQL1.HIS3MX6 and 
RECQL4.HIS3MX6 on SC-HIS agar plates. Select isolates were verified by PCR 
analysis for chromosomal integration of RECQL1.HIS3MX6 and RECQL4.HIS3MX6 at 
the SGS1 locus using primer combinations F1259/R1278 and F1259/R1273, 
respectively (Figure 5.4G). Subsequently, the SGS1 fusion site and RECQL1 were 
amplified by PCR and sequenced to ensure mutation free integration using primers 
F1260, R1278, F1274, F1300, F1301, F1276, and F1277 (Appendix B). Similarly, the 
SGS1 fusion site and RECQL4 were amplified by PCR and sequenced for mutation free 
integration using primers F1260, R1307, F1269, F1270, F1271, F1272, and F1230 
(Appendix B). The resulting strains were KHSY3686 expressing Sgs1 [1-647]-RecQL1 
and KHSY3687 expressing Sgs1 [1-647]-RecQL4 (here on referred to as Sgs1-RecQL1 
and Sgs1-RecQL4, Appendix A). Furthermore, as described earlier, in order to generate 
additional yeast strains expressing chimeric constructs and to obtain yeast strains 
expressing chimeric constructs in a mec3∆ background, we crossed strains KHSY3686 
and KHSY3687 to strain KHSY1346 followed by subsequent sporulation and genotyping. 
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Phenotypic characterization of yeast strains expressing 
Sgs1-RecQL1 and Sgs1-RecQL4 chimeric proteins 
Since the Sgs1-BLM chimera22 (Mirzaei, Syed et al. 2011) does not exhibit a 
statistically significant change in GCR rate in the Mec3-proficient strain (Table 5.1), we 
decided to only evaluate yeast strains expressing Sgs1-RecQL1 and Sgs1-RecQL4 
chimeric proteins in a mec3∆ strain. We assessed the rate of accumulation of GCRs of 
strains KHSY3704, KHSY3705, KHSY3706 (expressing Sgs1-RecQL1) and strains 
KHSY3707, KHSY3708, KHSY3709 (expressing Sgs1-RecQL4) (Appendix A). We found 
no statistically significant difference between the rate of accumulation of GCRs in an 
sgs1∆ mec3∆ strain and a mec3∆ strain expressing Sgs1-RecQL1 or Sgs1-RecQL4 
chimeric proteins in contrast to a mec3∆ strain expressing Sgs1-BLM chimeric protein 
(Table 5.1).   
Next, we evaluated yeast strains KHSY3686 and KHSY3687 for the ability of 
Sgs1-RecQL1 and Sgs1-RecQL4 chimeric proteins to suppress hypersensitivity to HU 
observed in an sgs1∆ strain. As a control, we utilized a yeast strain expressing the 
Sgs1-BLM chimera (Mirzaei, Syed et al. 2011) and a yeast strain expressing the 
helicase-deficient mutant of Sgs1-BLM chimera (Sgs1-BLM.HD, described in Chapter 3) 
(Mirzaei and Schmidt 2012). All strains were evaluated on YPD agar plates 
supplemented with three different concentrations of 50mM, 100mM, and 200mM of HU.  
We observed that, unlike the Sgs1-BLM chimera, neither Sgs1-RecQL1 nor 
Sgs1-RecQL4 chimeric proteins are able to suppress hypersensitivity to HU. Strains 
expressing either construct exhibit the same degree of sensitivity to HU as a yeast strain 
expressing Sgs1-BLM.HD chimeric mutant (Figure 5.5).   
                                                
22 Described in Chapter 2 
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Diploid yeast cells expressing various gene combinations of BLM, 
RECQL1, RECQL4, and RECQL5 hint to genetic interaction 
between some members of the human RecQ-like family  
Thus far, our findings have illustrated that yeast strains expressing RecQL1 and 
RecQL4 from the native SGS1 promoter or a GAL1 promoter are not able to 
complement defects observed in an sgs1∆ strain. Moreover, in Chapter 2 we 
demonstrated that BLM overexpression results in elevated hypersensitivity to HU, and 
that this phenotype can be rescued in a diploid strain expressing a single copy of SGS1 
from the other chromosome (PSGS1.SGS1/PGAL1.BLM) (Mirzaei, Syed et al. 2011).  
Here we wanted to evaluate whether diploid strains expressing RECQL1, 
RECQL4, or RECQL5 from the native SGS1 promoter can complement defects 
observed in an sgs1∆/sgs1∆ strain. Furthermore, if protein production from the SGS1 
promoter is not sufficient, will overexpression of these genes from a GAL1 promoter 
result in complementation or will it result in elevation of hypersensitivity as observed in 
the case of overexpression of BLM (Mirzaei, Syed et al. 2011)?  
 We reasoned that an investigation in a diploid yeast system would better mimic 
a mammalian system. Where these proteins might also act on homologous 
chromosomes in addition to sister chromatids. Thus, we expressed various combinations 
of RecQ-like genes in diploid yeast cells and evaluated hypersensitivity to the DNA 
damaging agent HU. 
For this analysis, we constructed two sets of diploid strains. In the first set, all 
RecQ-like genes were controlled under the SGS1 promoter, while in the second set the 
same genes were under the control of the inducible GAL1 promoter. This allowed us to 
evaluate effects of endogenous levels of protein and overexpressed levels on 
suppression of hypersensitivity to HU. The following gene combinations were evaluated: 
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RECQL1/RECQL1, RECQL4/RECQL4, RECQL5/RECQL5, RECQL1/RECQL4, 
RECQL1/RECQL5, RECQL4/RECQL5, BLM/RECQL1, BLM/RECQL4, and 
BLM/RECQL5. Multiple isolates for each gene combination were generated23. All diploid 
strains were spotted on YP-sucrose/galactose agar plates  (YPD media in which 
dextrose is replaced with 1% sucrose and 1%  galactose) supplemented with 50mM, 
100mM, or 200mM HU. We observed that all combinations of RecQ-like genes appear to 
be as sensitive as an sgs1∆/sgs1∆ strain, with the exception of the homozygous BLM 
strain, which appeared slightly more sensitive to HU (Figure 5.6A). When evaluating the 
sensitivity of the diploid yeast strains overexpressing RecQ-like gene combinations 
under the control of the GAL1 promoter, we observed three levels of sensitivity to HU. At 
level one, strains expressing PGAL1.RECQL4/PGAL1.RECQL4 or PGAL1.RECQL5 
/PGAL1.RECQL5 were as sensitive to HU as an sgs1∆/sgs1∆ strain. At level two, strains 
expressing PGAL1.RECQL1/PGAL1.RECQL1 were slightly more sensitive in comparison to 
an sgs1∆/sgs1∆ strain. At level three, strains expressing PGAL1.BLM/PGAL1.BLM were 
most sensitive (Figure 5.6B) as previously reported (Mirzaei, Syed et al. 2011). 
Moreover, in strains overexpressing a combination of PGAL1.RECQL4/PGAL1.BLM or 
PGAL1.RECQL5/PGAL1.BLM we observed that hypersensitivity to HU is reduced in 
comparison to strains that overexpress PGAL1.BLM/PGAL1.BLM (Figure 5.6B). This 
observation hints to a possible genetic interaction between RECQL4 and BLM, and 
RECQL5 and BLM.  The same phenotype was not observed in strains overexpressing 
PGAL1.RECQL1/PGAL1.BLM (Figure 5.6B). 
                                                
23 For complete list refer to Appendix A. 
  154 
Discussion  
The goal of this study was to evaluate yeast as a model for the functional 
characterization of the human RecQ-like helicases RECQL1 and RECQL4. Although 
BLM and WRN genes had been previously studied in a yeast system, this was the first 
attempt to evaluate RecQL1 and RecQL4 in a yeast system. Due to the fact that there 
are five RecQ-like homologs in humans, we sought to investigate redundancies in 
functionality among yeast and RecQ homologs by evaluating their ability to complement 
defects observed in an sgs1∆ strain (Yamagata, Kato et al. 1998; Heo, Tatebayashi et 
al. 1999; Mirzaei, Syed et al. 2011).  
We evaluated strains expressing RECQL1 or RECQL4 for their ability to lower 
the rate of accumulation of GCRs and/or the suppression of hypersensitivity to HU, 
which is observed in sgs1∆ strains. After examining strains expressing a single copy of 
RECQL1 or RECQL4 chromosomally integrated at the SGS1 locus and under the control 
of native SGS1 promoter and strains overexpressing chromosomally integrated RECQL1 
or RECQL4 under the control of an inducible GAL1 promoter, we observed that similar to 
BLM (Mirzaei, Syed et al. 2011), neither RECQL1 nor RECQL4 can complement defects 
observed in an sgs1∆ strain. This is possibly due to divergence of function between the 
yeast RecQ-like homolog, Sgs1, and human RecQL1 and RecQL4. Human RecQL1 and 
RecQL4 are not able to interact with the yeast proteome to carryout Sgs1-mediated 
functions. This hypothesis is supported by the fact that both RecQL1 and RecQL4 
constructs utilized in this study lack the long N-terminal tail found in Sgs1, which 
contains the Top3 binding site that is crucial for proper function (Watt, Louis et al. 1995; 
Bennett, Noirot-Gros et al. 2000; Johnson, Lombard et al. 2000; Fricke, Kaliraman et al. 
2001). 
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Next, we evaluated chimeric constructs of Sgs1-RecQL1 and Sgs1-RecQL4 for 
their ability to suppress hypersensitivity to HU and to lower the rate of accumulation of 
GCR. As demonstrated in Chapter 2, a chimeric Sgs1-BLM protein was able to suppress 
some of the defects observed in an sgs1∆ strain. However we found that strains 
expressing chimeric constructs of Sgs1-RecQL1 or Sgs1-RecQL4 exhibited the same 
level of hypersensitivity to HU as strains expressing the helicase-dead Sgs1-BLM 
chimera, or an sgs1∆ strain. Moreover, GCR analysis of Mec3-deficient strains 
expressing Sgs1-RecQL1 or Sgs1-RecQL4 showed no statistically significant difference 
in accumulation of GCR when compared to an sgs1∆, mec3∆ strain. 
Most likely, the inability of strains expressing RecQL4 or the Sgs1-RecQL4 
chimera to complement sgs1∆ defects can be attributed to the lack of both conserved 
RQC and HRDC domains. However, the same is not true for RecQL1. Although we were 
not surprised when the full length RecQL1 did not complement sgs1∆ defects, since it 
lacks the long N-terminal tail. We predicted that a chimeric Sgs1-RecQL1 protein would 
be functional. The observed lack of function indicates a significant separation of function 
between BLM and RecQL1.  
Lastly, we evaluated diploid yeast strains expressing various combinations of 
RECQL1, RECQL4, RECQL5, and BLM genes. While all diploid strains in which the 
RecQ-like homologs were controlled by the SGS1 promoter showed the same level of 
sensitivity to HU as an sgs1∆/sgs1∆ strain, different degrees of hypersensitivity to HU 
were detected when the same constructs were overexpressed.  We observed that 
strains expressing PGAL1.RECQL4/PGAL1.RECQL4 or PGAL1.RECQL5/PGAL1.RECQL5 
depicted the same degree of sensitivity to HU as an sgs1∆/sgs1∆ strain. In contrast, 
strains expressing PGAL1.RECQL1/PGAL1.RECQL1 showed a higher degree of sensitivity 
to HU when compared to an sgs1∆/sgs1∆ strain, but not as sensitive as a 
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PGAL1.BLM/PGAL1.BLM strain (previously demonstrated in Chapter 2). Again, the 
observed results can be explained by the fact that RECQL4 lacks the RQC and the 
HRDC domain while RECQL5 lacks the HRDC domain and both proteins have a very 
short N-terminal tail extending from the helicase core, which most likely renders these 
helicases mostly inactive in the yeast system. In contrast, the observed hypersensitivity 
of the PGAL1.RECQL1/PGAL1.RECQL1 strain suggests that RecQL1 is able to functionally 
interact in yeast (either with DNA substrates or other proteins), probably blocking 
alternative pathways from resolving the replication stress caused by exposure to HU.  
Previous studies from our laboratory have demonstrated that overexpression of 
BLM results in extreme hypersensitivity to HU (Mirzaei, Syed et al. 2011). Therefore, we 
predicted that strains expressing PGAL1.BLM/sgs1∆, PGAL1.BLM/PGAL1.RECQL1, 
PGAL1.BLM/PGAL1.RECQL4, or PGAL1.BLM/PGAL1.RECQL5 would be as sensitive as a 
strain expressing PGAL1.BLM/PGAL1.BLM. Contrary to our hypothesis, strains expressing 
PGAL1.BLM /PGAL1.RECQL4 or PGAL1.BLM /PGAL1.RECQL5 appeared to be less sensitive 
to HU when compared to the PGAL1.BLM/PGAL1.BLM strain. To explain this phenomenon, 
we hypothesize that BLM may be able to interact with DNA substrates (such as forks 
and HR intermediates) in yeast, but may be unable to interact with Sgs1 binding partners 
(yeast Top3, Top2, Srs2, Rad51, Rmi1, Rpa, Pol∂, and mismatch repair proteins) to 
allow for proper functionality. As a result overabundance of BLM may cause it to 
outcompete the endogenous yeast DNA repair pathways that could deal with stalled 
replication forks and DSBs caused by exposure to HU. In the case of the diploid strains, 
it is plausible that physical interactions between BLM and RecQL4 or RecQL5 results in 
sequestration of BLM, which in return will allow alternative pathways to engage in DNA 
repair, thus reducing the hypersensitivity observed in strains overexpressing BLM. 
Moreover, recently RecQL4 has been shown to physically interact with BLM (Singh, 
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Popuri et al. 2012). Although this interaction was shown to require the N-terminal region 
of both proteins it is plausible that RECQL4 possess a secondary binding domain to 
interact with BLM, and can interact when there is an overabundance of RecQL4. 
  Additionally, it is plausible that BLM interacts with downstream binding partners 
of Sgs1 but is unable to carry out Sgs1 related tasks resulting in extreme hypersensitivity 
to HU upon BLM overexpression. Consequently interaction between BLM and RecQL4 
or RecQL5 would result in release of downstream Sgs1 binding partners and a reduction 
of the hypersensitivity observed in overexpression of BLM.  
To further elucidate the cause of the extreme hypersensitivity to HU upon BLM 
overexpression in yeast additional investigation is required. Furthermore, the 
protein-protein interaction between BLM and RecQL4 (Singh, Popuri et al. 2012) and the 
possibility of interaction between RecQL5 and BLM merits further investigation. BLM has 
been previously shown to also physically interact with WRN, another RecQ-like helicase 
(von Kobbe, Karmakar et al. 2002), and immunocytochemistry studies using yeast 
strains overexpressing PGAL1.BLM/PGAL1.RECQL4 or PGAL1.BLM/PGAL1.RECQL5 will allow 
us to determine whether BLM colocalizes with RecQL4 and/or RecQL5 in yeast.   
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Figures and Tables 
 
Figure 5.1 Construction of PSGS1.RECQL1 and PSGS1.RECQL4 expressing yeast 
strains    
A) This diagram depicts the primer and XhoI restriction sites on the pCR2.1 TOPO 
plasmid used to clone the HIS3MX6 cassette, which was amplified by PCR from plasmid 
pRS303.   B) An illustration of the primer annealing sites used in colony PCR verification 
of the HIS3MX6 cassette linked to RECQL1 and RECQL4. C) An image of the gel 
electrophoresis of the HindIII digestion of pOBT7 plasmids harboring RECQL1.HIS3MX6 
or RECQL4.HIS3MX6. A HindIII digestion was used to confirm presence of the 
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to right starting with the marker, lanes 1-6 are digestion products of RECQL1.HIS3MX6 
constructs while lanes 7-12 are digestion products of RECQL4.HIS3MX6 constructs. In 
lanes 1-6, the presence of the smaller 1 kb band signifies a HIS3MX6 cassette in a 
reverse orientation in relation to RECQL1. In lanes 7-12, the presence of the smaller 
2 kb band signifies the HIS3MX6 cassette in reverse orientation in relation to RECQL4. 
Isolates 1, 2, and 4 for RECQL1 (pKHS338, pKHS339, pKHS340) and 10, 11, and 12 for 
RECQL4 (pKHS344, pKHS345, pKHS346) were selected for use in this study.  D) For 
construction of PSGS1.RECQL1.HIS3MX6, the RECQL1.HIS3MX6 fragment was 
amplified by PCR from plasmid pKHS338 using the primer combination F1245/R1246 
depicted here. E) An illustration of the annealing sites of primer combinations 
F1143/R1278 and F1229/R1032 used to verify integration of RECQL1 cDNA at the 
SGS1 locus. F) To construct PSGS1.RECQL4.HIS3MX6, the RECQL4.HIS3MX6 fragment 
was amplified by PCR from plasmid pKHS338 using the primer combination 
F1253/R1254 as depicted. G) An illustration of the annealing sites of primer 
combinations F1143/R1273 and F1230/R1032 used to verify integration of RECQL4 
cDNA at the SGS1 locus 
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Figure 5.2 Myc-tag epitope fusion and integration of GAL1 promoter in strains 
expressing RecQL1 and RecQL4 
(A) An illustration of the annealing sites of primers used to fuse the myc-epitope tag in 
the form of the 13MYC.TRP1 cassette to RECQL1 cDNA, in addition to primers used to 
confirm the integration by PCR. (B) An illustration of the annealing sites of primers used 
to fuse the myc-epitope tag in the form of 13MYC.TRP1 cassette to RECQL4 cDNA, in 
addition to primers used to confirm the integration by PCR. (C) An example of the gel 
electrophoresis of the PCR products used in verification of fusion of the 13MYC.TRP1 
cassette to the 3’ end of RECQL1. The primer combinations used for this experiment are 
as follows: lane 1 = F1277/R1144, lane 2 = F1277/R1032, lane 3 = F1277/R1029, 
lane 4 = F1030/R1144. (D) An illustration of the annealing sites for primers in the 
RECQL1 construct that myc was not successfully integrated. (E) Representative 
Western blot of strains expressing RecQL1 and RecQL4 fused with myc-tag epitope. 
This membrane was probed with monoclonal anti-myc primary antibody (Covance).  (F, 
G) An illustration of the annealing sites of primers used in integration of the GAL1 
promoter upstream of RECQL1 and RECQL4 in addition to primers used for confirmation 
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Figure 5.3 HU sensitivity of strains expressing PSGS1.RECQL1, PSGS1.RECQL4, 
PGAL1.RECQL1, and PGAL1.RECQL4  
(A) Ten-fold dilutions of exponentially growing haploid cells expressing RECQL1 and 
RECQL4 integrated at the native SGS1 locus under the control of the SGS1 promoter 
were spotted on YPD media with and without 100mM HU. (B) Ten-fold dilutions of 
exponentially growing haploids overexpressing RECQL1 and RECQL4 from a GAL1 
promoter inserted at the native SGS1 locus were spotted on media containing 
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Figure 5.4 construction of Sgs1-RecQL1 and Sgs1-RecQL4 chimerical protein 
An illustration of the protein disorder prediction of Sgs1 (red), BLM (blue), RecQL1 
(green), and RecQL4 (purple) using the IUPred algorithm. Values above 0.5 indicate a 
disordered residue whereas values below 0.5 indicate ordered residues; (A, B) predicted 
disorder plot of full-length Sgs1 and BLM proteins. (C,D, and E) The transition site 
between the two colors in each disorder prediction plot indicates the site where the 
disordered N-terminal segment of Sgs1 was fused to the C-terminal region of the 
corresponding RecQ-like protein yielding the chimeric protein. (F) Pictorial 
representation of the conserved domains of RecQ-like genes used in this study. (G) An 
illustration of the primer annealing sites used for verification by PCR of Sgs1-RecQL1 
and Sgs1-RecQL4 chimeric strains. (H, I, and J) A comparison of the predicted disorder 
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Figure 5.5 HU sensitivity of yeast cells expressing the Sgs1-RecQL1 and 
Sgs1-RecQL4 chimeric proteins 
Ten-fold dilutions of exponentially growing haploid cells were spotted on YPD media with 
and without 100mM HU. Yeast cells expressing the helicase-deficient mutant Sgs1-BLM 
chimera are denoted by Sgs1-BLM.HD   
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Figure 5.6 HU sensitivity of diploid cells expressing various combinations of 
RECQL1, RECQL4, RECQL5, and BLM genes  
(A) Ten-fold dilutions of exponentially growing diploids expressing various combinations 
of RECQL1, RECQL4, RECQL5, and BLM genes integrated at the native SGS1 locus 
under the control of the SGS1 promoter were spotted on YPD media with and without 
100 mM HU. (B) Ten-fold dilutions of exponentially growing diploids overexpressing 
various combinations of RECQL1, RECQL4, RECQL5, and BLM from a GAL1 promoter 
inserted at the native SGS1 locus were spotted on media containing 1% galactose and 
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Table 5.1 Rate of accumulation of Gross Chromosomal Rearrangements (GCR) 
 
1 We calculated 95% confidence intervals (CI) according to Nair (Nair 1940). 
2 The sgs1Δc800-BLMΔn647 allele expresses a chimeric protein that consists of the 
N-terminal 647 residues of Sgs1 and the C-terminal 770 residues of human BLM. 
3 The sgs1Δc800.RECQL1 allele expresses a chimeric protein that is comprised of the 
N-terminal 647 residues of Sgs1 and full-length RecQL1.   
4 The sgs1Δc800.RECQL4 allele expresses a chimeric protein that is comprised of the 
N-terminal 647 residues of Sgs1 and full-length RecQL4. 
5 All RecQ-like gene constructs are chromosomally integrated at the SGS1 locus under 
the control of the SGS1 promoter, except when a GAL1 inducible promoter was used 
denoted as PGAL1. 
  
Relevant genotype GCR rate (Canr 5-FOAr x 10-10) 
95% CI1 
(Canr 5-FOAr x 10-10) 
Wild type 1 <1-6.2  
sgs1Δ 96 58-206 
BLM 75 56-264 
2sgs1Δc800.BLMΔn647 24 11-65 
RECQL1 266 200-368 
RECQL4 89 65-200 
sgs1Δ, mec3Δ 1297 1120-2030 
sgs1Δ, BLM, mec3Δ 1728 1440-2090 
sgs1Δc800, mec3Δ 823 710-969 
sgs1Δc800.BLMΔn647, mec3Δ 361 330-419 
sgs1Δc800.BLMΔn647.HD 131 56-241 
sgs1Δ, RECQL1, mec3Δ 721 624-1130 
3sgs1Δc800.RECQL1,  mec3Δ 701 608-914 
sgs1Δ, RECQL4,  mec3Δ 954 720-1260 
4sgs1Δc800.RECQL4,  mec3Δ 742 450-1270 
5PGAL1.SGS1 11 9-12 
PGAL1.BLM 1832 1090-2910 
PGAL1.BLM.HD 390 231-509 
PGAL1.RECQ1 173 102-235 
PGAL1.RECQ4 99 64-212 
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The known functional domains of BLM include the helicase domain, the RQC 
domain and the HRDC domain (Bachrati and Hickson 2003; Hickson 2003; Umate, 
Tuteja et al. 2011). The helicase domain is responsible for the ATP hydrolysis (Walker, 
Saraste et al. 1982; Ye, Osborne et al. 2004) and single strand annealing activities of 
this protein (Korolev, Hsieh et al. 1997; Korolev, Yao et al. 1998; Dillingham, Soultanas 
et al. 2001). The RQC domain is comprised of the zinc-binding subdomain, which is 
responsible for structural stability (Bernstein, Zittel et al. 2003; Janscak, Garcia et al. 
2003) and the winged-helix subdomain, which is thought to aid in DNA unwinding as 
demonstrated in the WRN protein (Kitano, Kim et al. 2010). However, others have 
shown it is not required for unwinding activity (Gyimesi, Harami et al. 2012). The HRDC 
domain has DNA binding properties (Kim and Choi 2010), but the function of this domain 
is not yet fully understood. In Sgs1, the yeast homolog of BLM, the HRDC domain has 
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been shown to be dispensable when evaluating yeast strains expressing a truncated 
Sgs1 protein lacking the HRDC domain for accumulation of GCR or sensitivity to HU 
(Mullen, Kaliraman et al. 2000; Mirzaei, Syed et al. 2011). Moreover, biochemical 
analyses have shown that in BLM the HRDC domain is not required for its helicase 
activity (Gyimesi, Harami et al. 2012). 
Of the 32 exonic single-nucleotide variants that are causative of 
Bloom’s syndrome (BS), 13 are missense mutations and 19 possess a premature stop 
codon (Ellis, Groden et al. 1995; Foucault, Vaury et al. 1997; Barakat, Ababou et al. 
2000; German, Sanz et al. 2007). While premature stop codons are spread throughout 
the disease-associated BLM allele, all missense mutations are located in the helicase 
and RQC domains. The significance of both these domains for BLM function has been 
shown by many groups including ours (Guo, Rigolet et al. 2005; Huber, Duquette et al. 
2006; Sharma, Doherty et al. 2006; Mirzaei and Schmidt 2012).  
As demonstrated in Chapter 3, our laboratory has developed a novel chimeric 
system through which we have identified several additional amino acids that are critical 
for proper function of BLM (Mirzaei and Schmidt 2012). Here we sought to further 
investigate BLM in search for other functionally critical regions by conducting a random 
mutagenesis screen.   
Results 
Design of the random mutagenesis screen 
In Chapter 2 we illustrated that overexpression of BLM in yeast results in an 
extremely elevated rate of accumulation of GCRs (1.8x10-7 with 95% confidence 
intervals of 1.0 x10-7 - 2.9 x10-7, Table 2.2) (Mirzaei, Syed et al. 2011). For the random 
mutagenesis screen, we hypothesized that if overexpression of functional BLM results in 
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an elevated rate of accumulation of GCRs, inactivation of BLM as a result of a mutation 
in a crucial region should lead to loss of this phenotype. We therefore developed a 
system in which randomly mutagenize plasmid borne BLM cDNA was overexpressed in 
yeast, and these yeast strains were then assayed for accumulation of GCRs. The BLM 
cDNA was cloned into the plasmid pYES3 (Invitrogen, pKHS390, Figure 6.1, Appendix 
C) and randomly mutagenized utilizing an E.coli mutator strain (XL1 Red, Agilent 
technologies).  Mutagenized plasmids were subsequently transformed into yeast strain 
KHSY802 (appendix A). 
Constructions of pYES3-BLM and random mutagenesis 
For integration of BLM cDNA by recombinant cloning, plasmid pKHS390 was 
linearized using double restriction enzyme digestion (NotI and SacI, Figure 6.1) and BLM 
cDNA was amplified by PCR from genomic DNA extracted from strain KHSY1705 
(Appendix A) using primer pairs F1617/R1618 (Figure 6.1, Appendix B). These primers 
contained 20 nucleotides homologous to BLM cDNA and 50 nucleotides homologous to 
the pKHS390 plasmid backbone. Next, standard LiAc-mediated transformation (Schiestl 
and Gietz 1989) was used to co-transform the linearized plasmid and BLM amplicon into 
strain KHSY2331 (Appendix A). The Lig4-deficient strain KHSY2331 is impaired in 
NHEJ; thus, HR-mediated repair is utilized to recircularize the pKHS390 plasmid, 
resulting in integration of the BLM amplicon into this vector. Since the pKHS390 plasmid 
contains a TRP1 cassette, yeast transformants were selected for the presence of 
pKHS390-BLM on SC-TRP agar plates. Genomic DNA was isolated from the resulting 
yeast strain (KHSY3553, Appendix A) followed by rescue of plasmid DNA from the 
isolated genomic DNA. The recovered pKHS390-BLM plasmid DNA was sequenced for 
confirmation of mutation free, in-frame integration of BLM cDNA using primers R1189, 
F1559, F1424, F1420, F1422, F1417, R1520, F1418, R1067, and F1423 (Appendix B). 
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The resulting plasmid, pKHS404 (Appendix C), was then randomly mutagenized in the 
XL1 red mutator strain. 
The XL1 Red E.coli mutator strain (Greener, Callahan et al. 1997) has a mutation 
rate of approximately 5,000-fold higher than wild-type. The high mutation rate of this 
strain is due to deficiency in three of the primary DNA repair pathways. These cells are 
mutD, mutT, and mutS deficient. As a result, they lack 3´ to 5´ exonuclease activity of 
DNA polymerase III, resulting in loss proof reading, are impaired in their ability to 
hydrolyze 8-oxodGTP, resulting in compromised base excision repair, and have an 
error-prone mismatch repair pathway.  
In order to obtain mutagenized candidates of the BLM cDNA, we transformed the 
BLM overexpression vector pKHS404 into XL1 Red cells. Transformants were plated on 
LB agar plates supplemented with 100 mg/ml of ampicillin and incubated at 30˚C for 
30 hrs.  After the incubation period, approximately 200 colonies were picked at random 
from the agar plates, inoculated in one 10 ml culture of liquid LB media, and incubated 
overnight. Subsequently, plasmid DNA was isolated from the overnight culture using 
QIAPrep Miniprep Kit (Qiagen) and used in screening for loss of BLM function.  
GCR screen of yeast cells harboring mutagenized plasmid borne 
BLM 
Using standard LiAc-mediated transformation (Schiestl and Gietz 1989), the 
mutagenized pkhs404 plasmids were transformed into wild-type yeast strain KHSY802 
(Appendix A). Transformants were selected for by growth for three days at 30˚C on 
SC-TRP agar plates (Figure 6.2A). To induce expression of BLM from the GAL1 
promoter, while positively selecting for presence of the pkhs404 plasmid, colonies were 
picked at random from SC-TRP agar plates and streaked on SC/Gal-TRP agar plates 
(synthetic complete media minus tryptophan with 2% galactose instead of 2% dextrose). 
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All SC/Gal-TRP agar plates were incubated for four days at 30˚C (Figure 6.2B). Each 
streak was then patched as a 1” by 1” square on a fresh SC/Gal-TRP agar plate and 
incubated for another four days at 30˚C (this plate is referred to as the master plate, 
Figure 6.2C). The SC/Gal-TRP agar plates with patched candidates were then replica 
plated on GCR/Gal selective media and incubated for four days. The GCR/Gal agar 
plates used for this screen differed from those previously described [Chapter 8, 
(Schmidt, Pennaneach et al. 2006)], in that 2% galactose was substituted for 2% 
dextrose. Substitution of sugar allowed for continuous expression of BLM from the GAL1 
promoter. After the final incubation period, the number of colonies that appeared on 
each patch were counted and compared to the number of colonies from a patch with 
yeast strains harboring non-mutated pYES3-BLM plasmid (Figure 6.2D). 
 
Yeast strains expressing PGAL1.BLM from a 2µ-plasmid, have a GCR rate higher 
than chromosomally expressed PGAL1.BLM due to higher copy number (rate of 6.0x10-7, 
95% confidence intervals of 4.8x10-7 – 7.2 x10-7). Consequently a 1” by 1” patch of yeast 
strains harboring non-mutated pkhs404 plasmid produces between 14 to 60 colonies on 
GCR/Gal agar plates. Therefore, in this screen we were interested in patches that 
produced less than 14 colonies. Upon identification of a patch with less than 14 colonies, 
a small scoop of cells from the corresponding patch on the master plate was saved for 
future sequencing analysis of the BLM cDNA. Over 1,000 colonies were screened, which 
produced approximately 100 potential candidates. A complete record of all random 
mutagenesis experimental data is available in Appendix F.  
Analysis of candidate yeast strains harboring mutant pKHS404  
Plasmid DNA was rescued from each patch of interest and sequenced for 
identification of the BLM mutation using primers R1189, F1559, F1424, F1420, F1422, 
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F1417, R1520, F1418, R1067, and F1423 (Appendix B). Of the approximate 100 
candidates, the first 58 were sequenced (Figure 6.3, Table 6.1). From the sequenced 
candidates, 47 had incorporated a mutation in the BLM cDNA (a deletion or an insertion) 
resulting in a truncated protein and loss of the helicase domain. Two candidates (54-10 
and 47-3) had a mutation resulting in a stop codon that did not affect the helicase 
domain but instead disrupted the RQC domain. Three candidates (82-5, 15-4, and 
48-15) had mutations affecting the HRDC domain. We also identified six candidates that 
did not have a mutation in the BLM cDNA. Inactivation of BLM in these candidates is 
possibly due to a mutation affecting the GAL1 promoter. 
To further evaluate the mutations, we took advantage of the chimeric system 
described in Chapter 2 (Mirzaei and Schmidt 2012). Since the importance of the helicase 
domain is well established, we excluded all candidates with a mutation affecting the 
helicase domain from our analysis. Therefore, we examined alleles BLM-47-3 and 
BLM-48-15 in the chimeric system. First, we evaluated the effects of a frame shift at 
nucleotide 3028 as a result of a thymidine insertion affecting residues 1009 and onward 
(BLM-47-3). Second, a deletion of a cytosine at nucleotide 3918, causing a frame shift 
affecting residues 1306 and onward (BLM-48-15) was evaluated. Using site-directed 
mutagenesis24, the desired mutations were introduced into plasmid pKHS293 (harboring 
BLM.HIS3, Appendix C) and subsequently used in construction of the chimeric 
Sgs1-BLM, as described in Chapter 2 (Mirzaei and Schmidt 2012). The resulting yeast 
strains KHSY4082 and KHSY4083 expressing Sgs1-BLM-47-3, and strain KHSY4084 
expressing Sgs1-BLM-48-15 were verified by sequencing using primers F1260, R1520, 
F1418, F1419, R1067, and F1423 (Appendix B). Next, we evaluated yeast strains 
KHS4083 and KHSY4084 for hypersensitivity to HU (Figure 6.3). When compared to the 
                                                
24 Protocol for site-directed mutagenesis is outlined in Chapter 8 
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wild-type Sgs1-BLM chimera and the mutant helicase-deficient Sgs1-BLM chimera 
(Sgs1-BLM.HD), we observed that strain KHS4083 shows a total loss-of-function 
phenotype, while strain KHSY4084 shows a partial loss-of-function phenotype.  
Discussion  
Here we sought to identify new regions within the BLM protein that are crucial for 
its function. Utilizing the knowledge gained from previous studies in our laboratory 
(Mirzaei, Syed et al. 2011; Mirzaei and Schmidt 2012), we developed a screen, which 
would allow us to select for loss-of-function BLM mutants. Analysis of two of the newly 
identified mutations in our chimeric system revealed that the BLM-47-3 allele which has 
a frame shift at residue 1009 results in total loss-of-function of BLM protein, while the 
BLM-48-15 allele with a frame shift at residue 1306 yields a partially functional BLM 
protein.   
The phenotype observed in yeast cells expressing Sgs1-BLM-47-3 did not come 
as a surprise. The RQC domain is comprised of two subdomains: the zinc-binding and 
the winged helix (WH). In the zinc-binding subdomain, there are four highly conserved 
cysteine residues, which have been implicated to be responsible for coordination of the 
Zn2+ ion (Bernstein, Zittel et al. 2003; Janscak, Garcia et al. 2003; Guo, Rigolet et al. 
2005). Among the four cysteine residues, mutation of either C1036, C1055, or C1066 
have been identified to be causative of Bloom’s syndrome. BLM-47-3 allele inserted a 
thymidine at nucleotide 3028 (residue 1009) of BLM causing a frame shift and a 
premature stop codon at nucleotide 3064 (residue 1015). Truncation of the BLM protein 
at residue 1015 results in the loss of all three cysteine’s (C1036, C1055 and C1066) 
causes the loss-of-function phenotype. We have previously demonstrated (in Chapter 3) 
that a yeast strain expressing chimeric Sgs1-BLM with C1036, C1055F or C1066F 
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mutations are as sensitive to HU as a yeast strain expressing Sgs1-BLM.HD (Mirzaei 
and Schmidt 2012).  
Structural analyses of the HRDC domain of RecQ-like helicase have predicted 
the BLM HRDC domain to be between residues 1200 and 1315 (Wu, Chan et al. 2005; 
Kitano, Yoshihara et al. 2007; Kim and Choi 2010). The BLM-48-15 allele has a frame 
shift due to deletion of a cytosine at nucleotide 3918 (residue 1306). This deletion 
disrupts the HRDC domain by altering the primary sequence of the protein after residue 
1306, leading to a premature stop codon at nucleotide 4212 (residue 1404). Evaluation 
of this change in our chimeric system demonstrates a partial loss-of-function phenotype. 
This finding was unexpected since in this mutant the domains of the helicase core are 
not affected. Moreover, studies in yeast Sgs1 from our laboratory and others have 
previously shown that the HRDC domain of Sgs1 is dispensable when cells are 
evaluated for GCR and sensitivity to HU (Mullen, Kaliraman et al. 2000; Mirzaei, Syed et 
al. 2011). Moreover, in vitro studies of BLM have indicated the HRDC domain is not 
required for DNA unwinding (Gyimesi, Harami et al. 2012). However, the HRDC domain 
of BLM has been demonstrated to have an important role in dissolution of the double 
Holliday junctions (Wu, Chan et al. 2005; Kim and Choi 2010). The HRDC domain is 
widely assumed to assist BLM with binding to DNA, allowing for a more stable 
association between the helicase domain and the DNA (Kim and Choi 2010). The HRDC 
domain of Sgs1 has been suggested to regulate helicase function through additional 
contact with DNA (Liu, Macias et al. 1999). Furthermore, three dimensional structure 
analysis of BLM by NMR reveals that, similar to Sgs1 and RecQ of E.coli, the BLM 
HRDC domain preferentially binds single stranded DNA (Bernstein and Keck 2005; 
Kitano, Yoshihara et al. 2007).  
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Although it has been shown that in Sgs1 the HRDC domain is dispensable when 
evaluating yeast cells for sensitivity to HU (Mullen, Kaliraman et al. 2000; Mirzaei, Syed 
et al. 2011), we only observe a partial defect when evaluating yeast cells expressing 
Sgs1-BLM-48-15 for sensitivity to HU. One explanation for the phenotype observed in 
our chimeric system may be that BLM has evolved in a way that its function more so 
than Sgs1’s function depends on the interaction of the HRDC domain with DNA. Thus, 
deletion of the HRDC domain in BLM, but not Sgs1, would result in a partial 
loss-of-function phenotype when exposed to HU. Alternatively, the loss-of-function in 
yeast could be not due to the disruption of the HRDC domain but due to the change of 
the primary sequence downstream of this domain affecting a region not yet associated 
with proper BLM function. 
Previously, we identified G1120E as the most C-terminal single amino acid 
mutation to date to have an impact on BLM function (Mirzaei and Schmidt 2012). 
Residue 1120 resides in the winged helix subdomain of the RQC domain. Identification 
of allele BLM-48-15 with a frame shift at nucleotide 3918 (residue 1306) leading to a 
premature stop codon at nucleotide 4212 (residue 1404) suggests that there may be 
other regions even more C-terminal to that have an important role in suppressing 
sensitivity to DNA damaging agents.  
This study has demonstrated that the random mutagenesis system in yeast can 
be utilized to identify important regions within BLM, and evaluation of the remaining 42 
candidates might lead to the identification of additional novel mutations that impair BLM 
function.  Moreover, the novel allele, BLM-48-15, will be further evaluated in a BLM 
deficient human cell line for its ability to complement various cellular defects of Bloom’s 
syndrome cells.   
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Figures and Tables 
 
Figure 6.1 pKHS404 plasmid map   
Utilizing recombinant cloning, BLM cDNA was integrated downstream of the GAL1 
promoter in the plasmid pYES3 (Invitrogen), yielding plasmid pKHS404. Illustrated here 
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Figure 6.2 Patch assay for the analysis of accumulation of GCRs  
The previously described GCR assay (Schmidt, Pennaneach et al. 2006) was modified 
for the purposes of this screen. (A) Yeast transformants harboring mutagenized 
pKHS404 plasmids were positively selected for by plating on SC-TRP agar plates. (B) 
To induce BLM expression from the GAL1 promoter, colonies were picked at random 
from the transformation plate and streaked (1 cm long) on a SC/Gal-TRP plate followed 
by four days of incubation at 30˚C. (C) Each streak was then patched as a 1” by 1” 
square (indicated by blue lines) and incubated for four days. This plate is referred to as 
the master plate and is used to recover the mutated plasmid of interest. (D) The patched 
plates are then replica plated onto a GCR/Gal agar plate to screen for loss of 
accumulation of GCRs. Yellow lines indicate the limits of each patch while blue stars 
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Figure 6.3 BLM cDNA and relative location of mutations identified in the random 
mutagenesis screen to impair BLM function 
BLM cDNA in recovered plasmid pKHS404 was subject to sequence analysis in order to 
identify the mutation responsible for inactivation of the BLM protein. Illustrated here is a 
schematic representation of all the mutations identified in the sequenced samples. All 
blue stars represent the relative location of mutations leading to a premature stop codon.  
  
PGAL1.BLM Helicase  RQC HRDC NL
S 
blm47-3 blm48-15 
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Figure 6.4 HU sensitivity of yeast cells expressing Sgs1-BLM chimeric constructs 
with mutations identified in isolates 47-3 and 48-15 
Ten fold dilutions of exponentially growing haploid cells were spotted on YPD media with 
and without 100 mM HU. Total loss-of-function was based on a phenotype similar to that 
of yeast cells expressing the Sgs1-BLM.HD. A partial loss-of-function phenotype was 
assessed based on sensitivity to HU to a degree that was between that of a yeast strain 











  179 
Table 6.1 Mutations identified by sequencing of the BLM cDNA in the mutagenized 
pKHS404 plasmid 
Plate	  #1	   Isolate	  #2	   ID	  #3	   Nucleotide	  #	   Mutation	   Nucleotide	   Effected	  
Domain	  
4	   3	   4-­‐3	   1353	   insertion	   A	   helicase	  
6	   1	   6-­‐1	   563	   deletion	   A	   helicase	  
7	   5	   7-­‐5	   1544	   deletion	   A	   helicase	  
15	   4	   15-­‐4	   3400	   Insertion	  	   A	   HRDC	  
19	   5	   19-­‐5	   1544	   deletion	   A	   helicase	  
20	   5	   20-­‐5	   1523	   insertion	   A	   helicase	  
21	   2	   21-­‐2	   1526	   insertion	   A	   helicase	  
23	   5	   23-­‐5	   2610	   insertion	   A	   helicase	  
27	   2	   27-­‐2	   1251	   insertion	   A	   helicase	  
28	   4	   28-­‐4	   1523	   Insertion	  	   A	   helicase	  
30	   1	   30-­‐1	   2269	   insertion	   A	   helicase	  
31	   3	   31-­‐3	   2269	   insertion	   A	   helicase	  
38	   4	   38-­‐4	   2360	   deletion	   A	   helicase	  
41	   6	   41-­‐6	   1545	   insertion	   A	   helicase	  
41	   16	   41-­‐16	   1462	   insertion	   T	   helicase	  
43	   19	   43-­‐19	   2269	   insertion	   	   helicase	  
44	   4	   44-­‐4	   No	  BLM	  Mutations	  
45	   3	   45-­‐3	   1544	   deletion	   A	   helicase	  
45	   9	   45-­‐9	   1544	   deletion	   A	   helicase	  
46	   6	   46-­‐6	   1337	   insertion	   A	   helicase	  
46	   9	   46-­‐9	   1544	   deletion	   A	   helicase	  
46	   12	   46-­‐12	   1544	   deletion	   A	   helicase	  
46	   13	   46-­‐13	   2916	   insertion	   G	   helicase	  
46	   14	   46-­‐14	   1544	   deletion	   A	   helicase	  
46	   17	   46-­‐17	   1544	   deletion	   A	   helicase	  
46	   19	   46-­‐19	   563	   insertion	   A	   helicase	  
47	   3	   47-­‐3	   3064	   insertion	   T	   RQC	  
47	   6	   47-­‐6	   1544	   deletion	   A	   helicase	  
47	   17	   47-­‐17	   1544	   deletion	   A	   helicase	  
47	   18	   47-­‐18	   1544	   deletion	   A	   helicase	  
48	   15	   48-­‐15	   3918	   deletion	   C	   HRDC	  
49	   11	   49-­‐11	   No	  BLM	  Mutations	  
50	   5	   50-­‐5	   1544	   deletion	   A	   helicase	  
52	   18	   52-­‐18	   No	  BLM	  Mutations	  
52	   20	   52-­‐20	   1544	   deletion	   A	   helicase	  
53	   8	   53-­‐8	   2629	   insertion	   T	   helicase	  
53	   11	   53-­‐11	   2886	   insertion	   T	   helicase	  
53	   18	   53-­‐18	   1392	   insertion	   T	   helicase	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Table 6.1 continued  
54	   10	   54-­‐10	   3163	   deletion	   T	   RQC	  
55	   11	   55-­‐11	   1544	   deletion	   A	   helicase	  
56	   19	   56-­‐19	   1544	   deletion	   A	   helicase	  
57	   2	   57-­‐2	   2269	   insertion	   A	   helicase	  
57	   7	   57-­‐7	   874	   insertion	   T	   helicase	  
57	   13	   57-­‐13	   1070	   insertion	   A	   helicase	  
57	   14	   57-­‐14	   2269	   insertion	   A	   helicase	  
57	   20	   57-­‐20	   2609	   deletion	   A	   helicase	  
58	   18	   58-­‐18	   1544	   deletion	   A	   helicase	  
60	   7	   60-­‐7	   1544	   deletion	   A	   helicase	  
61	   4	   61-­‐4	   1544	   deletion	   A	   helicase	  
61	   5	   61-­‐5	   1544	   deletion	   A	   helicase	  
63	   2	   63-­‐2	   1544	   deletion	   A	   helicase	  
63	   3	   63-­‐3	   563	   insertion	   A	   helicase	  
72	   3	   72-­‐3	   No	  BLM	  Mutations	  
73	   14	   73-­‐14	   No	  BLM	  Mutations	  
78	   12	   78-­‐12	   No	  BLM	  Mutations	  
79	   9	   79-­‐9	   1544	   deletion	   A	   helicase	  
82	   5	   82-­‐5	   3380	   insertion	   C	   HRDC	  
  
1The plate # refers to the master plate from which the mutagenized plasmid was 
recovered. 
2The isolate # refers to the patch location on the master plate from which the 
mutagenized plasmid was recovered 
3ID # is the given name by which each isolate is identified. 
  







FINAL THOUGHTS AND FUTURE DIRECTIONS 
 
Final thoughts 
The maintenance of genome stability is a fundamental requirement of every living 
organism.  Failure to maintain the integrity of the genome from one generation to 
another can lead to chromosome aberrations that may manifest into developmental 
abnormalities, cancer progression, and premature aging. Highly conserved DNA repair 
mechanisms have evolved to protect the genome from a variety of genotoxic elements 
that lead to destabilization of genetic material. Genotoxic stress can manifest as a 
byproduct from cellular metabolism as in the generation of reactive oxygen species, or 
from environmental factors such as radiation and chemical toxicants. The RecQ-like 
family of helicases has proven to be critically involved in genome surveillance and DNA 
repair mechanisms.  
Since RecQ was discovered in E. coli 30 years ago, the role and function of 
RecQ-like helicases at the interface of replication and repair has been extensively 
investigated. However much is still unknown regarding the details of the molecular 
function of these proteins. A better understanding of the RecQ-like family may provide a 
means to develop a therapeutic approach to help individuals affected by syndromes 
associated with defects in BLM, WRN, and RecQL4. Further investigation of these 
proteins will lead to a better understanding of the mechanisms behind processes that 
result in accumulation of mutations, chromosomal instability, tumorigenesis and cancer.  
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In this dissertation we sought to further investigate BLM, RecQL1, and RecQL4 
by using yeast as a model. We constructed humanized yeast strains and evaluated the 
ability of these genes to complement defects observed in sgs1∆ mutants.  
Future directions 
Functional and mutational characterization of BLM 
In our characterization of BLM, we developed a novel chimeric yeast system 
(Chapter 2) that allowed us to investigate 41 known BLM variants found in the general 
population (Chapter 3). We identified six total loss-of-function BLM alleles that are 
currently not associated with BS: P690L, R717T, W803R,  Y811C, F857L and G972V. 
Furthermore, we identified three alleles (R791C, P868L, G1120R) that partially impaired 
BLM function. Although modeling of these mutations on the crystal structure of RecQL1 
and WRN have provided some insight on the probable cause of the impaired BLM 
function, further biochemical analysis will identify the specific defect for each of these 
BLM variants. Moreover, the effect that these newly identified alleles have in a human 
system is yet to be verified. Finally, as presented in Chapter 3, our studies investigated 
variants that mapped to the C-terminal region of BLM, which was used in construction of 
the chimeric protein. Consequently, none of the variants of the N-terminal region of BLM 
have yet to be evaluated. The following specific aims outline experiments to first 
characterize the nine BLM alleles identified in Chapter 3 in addition to evaluation of the 
remaining BLM variants in a human system:  
 
Aim 1: Evaluate BLM variants in BLM-/- human cell line for the presence of chromosomal 
abnormalities observed in BS cells. 
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1.1. Perform mutagenesis and expression of plasmid borne BLM in a human cell 
line. 
1.2. Determine the levels of sister chromatid exchange in the presence of BLM 
variants in a human cell line. 
1.3. Determine the presence and frequency of chromosomal gaps, breaks, and 
formation of quadriradial structures in BLM variants in a human cell line. 
Aim 2: Perform biochemical analysis of the BLM variants  
2.1. Construct a eukaryotic expression vector for purification of BLM variants.  
2.2. Perform site-directed mutagenesis and protein purification of BLM variants. 
2.3. Assess ATP hydrolysis activity of BLM variants. 
2.4. Assess the DNA binding of BLM variants 
2.5. Assess the helicase activity of BLM variants 
 
In Chapter 6 we sought to identify other regions of importance for BLM function. We 
described a BLM random mutagenesis screen that led to the discovery of a BLM48-15 
allele. We further suggested that identification of this allele demonstrates that the BLM 
HRDC domain has an important role in its function. As explained in Chapter 6, only 58 
out of the 100 candidates have been analyzed, thus the remaining 42 candidates should 
be sequenced. If sequencing analysis indicates a novel mutation affecting a region of 
BLM other than the helicase core, those alleles should be evaluated in a human system 
as outlined in Aims above. 
Novel protein-protein interaction for RecQL1 and RecQL4 
In this dissertation we described multiple yeast 2-hybrid screens in search for a 
novel protein-protein interaction for RecQL1 and RecQL4 (Chapter 4). From these 
screens, we have identified C10ORF137 and TRAF3IP1 to putatively interact with 
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RecQL1 and DNAJC7, MNAT1, and GLUL1 to putatively interact with RecQL4. The 
following aims outline the future directions of this project: 
Aim 1: Evaluation of legitimacy of these interaction in a human cell culture. 
1.1. Co-immunoprecipitation of endogenous proteins  
1.2. Determine the interaction domain on each protein by strategic placement of stop 
codons using site-directed mutagenesis and evaluation in a yeast system 
In the event that Aim 1.1 is not possible the following alternatives will be preformed 
1.3. Co-immunoprecipitation of tagged protein 
1.4. Determine the protein-protein interactions by Mass spectrometry 
Mass spectrometry will also allow for identification of the interacting region of 
each protein. However, it is limited to the availability of a database. 
Aim 2: Determine the role of RecQL1 and RecQL4 in the pathway associated with the 
identified interacting partner.  
Assuming all identified putative interacting partners are true interactors for RecQL1 and 
RecQL4, this aim will provide five independent projects in which each candidate is 
characterized to elucidate the role of the RecQ-homolog in the corresponding pathway. 
Genetic interaction between BLM and RECQL4, RECQL5, or both 
In Chapter 5, functional characterization of RecQL1, BLM, RecQL4, and RecQL5 
in yeast suggested genetic interaction between BLM and RecQL4 and RecQL5 in diploid 
cells. Recently it has been shown that BLM and RecQL4 physically interact and that 
RecQL4 stimulates the helicase activity of BLM (Singh, Popuri et al. 2012). However, a 
comparable interaction has not been identified between RecQL5 and BLM. The following 
experiments will elucidate possible interactions between BLM and RecQL5. 
First, Co-immunoprecipitation of endogenous proteins from human cell line will 
confirm physical interaction between the two helicases.  Second, if physical interaction is 
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not present, genetic interaction can be extrapolated by a co-localization assay of tagged 
BLM and RecQL5 in a human cell line. Last, In the event of discovery of a physical 
interaction between BLM and RecQL5 the interaction domains can be mapped in a yeast 
system using truncation studies. 
  







MATERIAL AND METHODS 
 
Yeast strains 
All haploid strains used in this study are derived from KHSY802 (MATa, ura3-52, 
trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3), or 
KHSY2583 (MATα, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3) background. Similarly all diploid strains in this study are derived 
from KHSY2599 (ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, 
his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, 
ade8/ade8, YEL069C::URA3/YEL069C::URA3) background. 
Media 
Media used in this study includes: YPD (yeast extract10g/L, peptone 20g/L, and 2% 
glucose), YPD-G418 (YPD with 200 mg/L of active G418), SD-LEU, SD-HIS or SD-TRP 
(appropriate synthetic dropout mix 2 g/L, yeast nitrogenous base without amino acid 
7.6 g/L, and peptone 20 g/L), and LB (yeast extract 5g/L,  Trypton 10g/L, and NaCl 
5 g/L). For all experiments involving galactose inducible GAL1 promoter, 2% glucose in 
media is substituted with 2%galactose or 1% sucrose and 1% galactose. 
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Colony PCR 
Colony PCR is performed to expedite the process of screening a large number of E.coli 
transformants for those that contain plasmids with the insert of interest. Transformants 
are streaked on fresh LB agar plates, supplemented with the antibiotic selecting for the 
presence of the plasmid, and incubated over night at 37°C. After incubation a small 
scoop from each isolate is inoculated in 100µl of dH2O and boiled at 100°C for 10 
minutes. Next samples are centrifuged for 2 min at 14000 rpm and 2µl from the cleared 
supernatant is used as template for a standard PCR reaction instead of purified DNA.  
Homologous-recombination-mediated yeast transformation 
(LiAc method)  
In all yeast transformations desired gene insertions or deletions are introduced in the 
parental strain employing homology-mediated integration of PCR products by the LiAc 
method as previously described by Gietz (Gietz and Woods 2006). Briefly, the insert of 
interest is amplified by PCR with 70-nucleotide primers that provide 20 nucleotides of 
homology to the template and 50 nucleotides homology to the chromosomal locus of 
insertion or plasmid locus of interest in the case of gap repair mediated transformation. 
In preparation for transformation, the yeast strain of choice is streaked out from the 
yeast strain collection on a fresh YPD agar plate and incubated at 30°C for 48 hours. 
Next, a 2-ml liquid YPD culture from a single colony of the parental strain is prepared. 
After incubation at 30°C with vigorous shaking overnight, the culture is diluted to an 
OD600=0.2 in desired amount of fresh YPD (or appropriate selective media incase of 
strains harboring plasmid) and incubated in an orbital shaker at 30°C until 
OD600=0.8 ± 0.04 is reached. Next, the cells are collected by centrifugation at 2000 rpm 
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and washed first with dH2O and then with 100mM LiAc and aliquoted into 1.5 ml tubes. 
Next 50% PEG, 1M LiAc and DNA/dH2O mixture are added to each aliquot and boiled 
salmon sperm DNA (10 mg/ml) is added as carrier DNA to each sample. Samples are 
incubated at 30°C for 30 minutes, heat shocked at 42°C for 15 minutes, and plated on 
media selecting for the presence of the insert followed by two hours of incubation at 
30°C.  
Recombination mediated plasmid cloning in yeast 
The gene or cDNA of interest is amplified from genomic DNA by PCR using primers that 
contained 20 nucleotides homologous to the template and a tail of 50 nucleotides 
homologous to the plasmid. Plasmid of interest is linearized using two restriction 
enzymes to avoid relegation. To increase efficiency a blunt end cutter is combined with a 
3’ or 5’ overhang cutter. Furthermore a NHEJ-deficient strain is utilized for recombination 
cloning to eliminate the possibility of the plasmid re-circularizing via the NHEJ pathway. 
Recombinant cloning is carried out using 100 ng of linearized plasmid and 50 µl of PCR 
product. Standard LiAc-mediated transformation (Schiestl and Gietz 1989) is used and 
transformants are selected for on appropriate selective media, thus allowing selection for 
yeast cells containing circularized plasmids repaired by HR containing the PCR insert.  
Determination of the mating type of haploid yeast cells 
To determine mating type of haploid strain or to identify diploid strains, mating type 
tester strains are used. These strains have the following genotype: KHSY1345 (MATa, 
∆thr4) and 1346 (MATα, ∆thr4). To conduct this test, a single colony from each of the 
tester strains are inoculated in a 50µl of dH2O and plated on separate YPD plates 
pre-warmed at 30°C. Next, the strain of interest is spotted on each of the plates to allow 
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mating and incubated overnight at 30°C. Following incubation the YPD plates are replica 
plated on synthetic minimal media and incubated overnight at 30°C. Since the tester 
strains are deficient in th4 they can’t grow on minimal plates. Similarly since all strains 
derived from KHSY802 or KHSY2583 are deficient in lys2Bgl, hom3-10, ade2∆1, and 
ade8, they can’t grow on minimal plates either. Consequently, by analyzing the minimal 
plates we can conclude that the strain of interest is mating type MATα if it grew on plates 
containing KHSY1345 while it is mating type MATa if it grew on plates containing 
KHSY1346. Additionally if the strain of interest is a diploid it won’t be able to mate with 
either of the mating type tester strains and consequently cannot grow on either minimal 
plates. 
Construction of diploid yeast strain 
To construct a diploid strain, two desired haploid strains with opposite mating types are 
selected, and a single colony (or small scoop of cells) from each strain are mixed in 50 µl 
of dH2O and 10 µl of the cell mixture is then spotted on fresh YPD plate followed by 
overnight incubation at 30°C. The spot is then streaked out for single colonies on a fresh 
YPD plate and incubated for two days at 30°C. Single colonies are genotyped by 
spotting on selective media and their diploidy is verified by their inability to mate with the 
tester yeast strains KHSY1345 and KHSY1346 (Appendix A).  
Sporulation of heterozygous diploids  
Diploid yeast strains heterozygous for the desired mutant (or human cDNA alleles) 
grown overnight at 30°C in YPD medium are washed and transferred to 0.1% KAc and 
incubated for five days at 30°C in an orbital shaker. To harvest spores, asci are 
incubated in the presence of zymolase (500 µg/ml in 1M sorbitol) for 20 minutes at 30°C 
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and enriched for haploid spores as previously described by Rockmill (Rockmill, Lambie 
et al. 1991). Next spores are plated on YPD agar plates followed by incubation at 30°C 
for two days and genotyped by spotting on selective media and their diploidy is verified 
by their inability to mate with the tester yeast strains KHSY1345 and KHSY1346. 
Determination of the doubling time of yeast strains 
For this assay, Overnight cultures of three independent isolates for each construct are 
diluted in 5 ml of YPD to an optical density of OD600= 0.2. Next, OD600 is measured for 
each culture in 60-min or 120-min intervals for 6 to 8 hours. Subsequently average 
doubling times of two or three independent strains for each genotype are compared in 
minutes. 
FACS analysis 
For FACS analysis, cells are grown overnight at 30°C in liquid YPD medium. Cultures 
will then be diluted in YPD to an OD600 of 0.2, and incubation is continued until cultures 
reach an OD600 of 0.6 to 0.8. Cells are then fixed in 70% ethanol for 1 hour at room 
temperature and are sonicated in 50 mM sodium citrate (pH 7). The cells are 
subsequently washed once in 50mM sodium citrate (pH 7), and RNase A is added to a 
final concentration of 250 µg/ml. After overnight incubation at 37°C, the cells are washed 
twice in 50mM sodium citrate. To stain the DNA, Sytox green (Molecular Probes) is 
added to a final concentration of 1 µM and the cells are incubated in the dark at room 
temperature for 1 hour immediately prior to fluorescence-activated cell sorting (FACS) 
on a BD LSR II analyzer. The distribution of cells throughout the cell cycle phases is 
quantified with the FlowJo v8.3.3 software program. The mean is obtained from 
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measurements of at least three cultures and standard deviations are recorded for every 
strain. 
Protein extraction by the trichloroacetic (TCA) method and 
detection by Western blot analysis 
Cells are grown to OD600=0.5 in YPD or for galactose-inducible protein expression in YP 
supplemented with 1% galactose and 1% sucrose. Whole cell extract is prepared from 
5 ml of culture by standard trichloroacetic (TCA) extraction as previously described 
(Foiani 1999).  
Protein detection by Western blot analysis 
To detect protein expression, TCA extracted protein samples are separated on a 10% 
polyacrylamide gel at 120 V for 90 minutes in 1x running buffer (250 mM Tris, 1.92M 
glycine, 1% SDS). The samples are then transferred to a PVDF (Methanol activated) 
membrane at 4oC in 1x transfer buffer (250 mM Tris, 1.92 M glycine, 20% Methanol). 
After Transfer the membrane is blocked with 4% Difco skim milk (Becton, Dickinson and 
Company) for minimum of 3hrs. Next membrane is incubated with the primary antibody 
in 4% skim milk (Or BSA in the case of anti-AD monoclonal antibody, Santa Cruz) for an 
1.5 hrs at room temperature on a shaker followed by three washes at 15 min intervals 
with 1x wash buffer (1.5M NaCl, 100mM Tris, pH7.6) at room temperature. 
Subsequently, membrane is incubated with the secondary antibody (1:5000 ECL 
anti-mouse IgG, horseradish peroxidase linked whole antibody (from sheep), GE 
Healthcare) in 4% skim milk for 1 hour at 4oC followed by three washes at 15 min 
intervals with 1x wash buffer at 4oC. For visualization membrane is incubated with 
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Amersham ECL Plus (or prime) Western Blotting Detection Reagent (GE Healthcare) for 
2 minutes and developed using Kodak film.  
Determination of sensitivity of yeast cells to DNA damaging 
agents  
For this assay an overnight culture of the desired strain is diluted in YPD to OD600 = 0.2 
and grown at 30°C to OD600 = 0.6. Next a series of 10-fold dilutions is prepared from the 
liquid yeast culture, and 2 µl are spotted on YPD and on YPD containing different 
concentrations of DNA damaging agent. Colony growth is documented after two days, 
two days of incubation at 30°C using the Gel-Doc system (UVP). For all experiments 
appropriate wild-type and mutant yeast strains are included as controls. 
 Determination of the rate of accumulating gross chromosomal 
rearrangements (GCR)  
The laboratory of Dr. Richard Kolodner (UCSD) has developed an assay for the 
detection of a broad spectrum of gross chromosomal rearrangements (GCRs) (Schmidt, 
Pennaneach et al. 2006). This assay measures the rate of accumulating 5-fluoroorotic 
acid resistant (5-FOAr), canavanine resistant (Canr) yeast colonies due to 
rearrangements within a nonessential region of chromosome 5. This region contains the 
CAN1 and URA3 genes (Figure 7.1). Cells in which both CAN1 and URA3 have been 
inactivated can be selected on media containing canavanine and 5-FOA. The rate of 
accumulating 5-FOAr Canr cells is determined by fluctuation analysis and the mutation 
rate is calculated by the method of the median (Lea and Coulson 1949). After growing 
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cultures for 2-3 day’s cells are plated on agar plates25 containing 5- FOA (1g/L) and 
canavanine (60mg/L) to select for GCRs and on YPD to determine the viable cell count. 
 
 
Figure 7.1 Chromosome V modifications for the GCR assay.  
The nonessential HXT13 gene on the left arm of chromosome V is replaced with the 
URA3 cassette, resulting in a chromosome V with two counter selectable markers, 
CAN1 and URA3. The location of the first essential gene, PCM1, is indicated by a black 
box (Schmidt, Pennaneach et al. 2006) 
 
Plasmid rescue and sequencing 
To rescue plasmid DNA from yeast strains, genomic DNA is isolated from the 
desired strain harboring plasmid. Next the plasmid containing genomic DNA is 
transformed in to electrocompetent E.coli using a Bio LabTM MicroPulser. E.coli cells 
containing plasmid DNA are selected for on LB agar plates supplemented with 
appropriate antibiotic. An over night culture of cells containing plasmid is then used for 
plasmid DNA isolation and subsequently sequenced. All sequencing services were 
outsourced and completed by MWG Operan. 
                                                
25 Here on referred to a GCR media 
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Preparation of electrocompetent E.coli cells 
This protocol is adapted from Dower 1998, (Dower, Miller et al. 1988). Briefly, to 
prepare cells for electrocompetency , an overnight culture of E.coli strain DH5α is 
incubated in 100ml of LB media till mid-exponential growth phase is reached 
(OD600 = 0.6), and cold-shock on wet ice for 30-min. Next, cells are pelleted at 4°C and 
washed three times with ice-cold %10 sterile glycerol. Afterwards, washed cells are 
re-suspended in 400µl of ice-cold GYT buffer (Tung and Chow 1995) (10% Glycerol, 
0.125% Yeast Extract, and 0.125% Trypton) and aliquot into 10 tubes of 40ul each. Last, 
20µl of %40 sterile glycerol is added to each aliquot and stored at -80°C for future use. 
Site-directed mutagenesis 
Site-directed mutagenesis of plasmid DNA was carried out as recommended by 
the QuikChange kit  (Stratagene). Briefly, a pair of 31-nucleotide long primers is 
designed with the desired nucleotide change in the middle of the primer sequence. Next, 
a 50 µl PCR reaction if prepared with the following reagents and program:  
Reagents 
5 µl of 10× reaction buffer 
X µl (5–50 ng) of template 
plasmid 
X µl (125 ng) of forward primer  
X µl (125 ng) of reverse primer  
1 µl of dNTP mix (2 mM) 
1 µl of Pfu Ultra DNA 
polymerase (2.5 U/µl) 
ddH2O to a final volume of 50 µl 
Program  
1 cycle at 95°C for 2 min 
30 cycles of 
 95°C for 30 sec 
Primer TM-5°C for 30 sec 
72°C for t min (t = (length 
of the plasmid/1000) + 1) 
One final cycle of 72°C for 
10 min 
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Appendix A: Strain Table 
Strain 
Named Genotype 
KHSY802 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY1346 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, mec3::G418 
KHSY1435 thr4- 
KHSY1436 thr4- 
KHSY2009 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::RECQL1.HIS3 
KHSY2043 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3, 
SGS1/sgs1::RECQL1.HIS3, MEC3/mec3::G418 
KHSY2044 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3, 
SGS1/sgs1::RECQL1.HIS3, MEC3/mec3::G418 
KHSY2045 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3, 
SGS1/sgs1::RECQL1.HIS3, MEC3/mec3::G418 
KHSY2046 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3 
KHSY2047 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3 
KHSY2048 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3 
KHSY2049 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3 
KHSY2050 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3, mec3::G418 
KHSY2051 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3, mec3::G418 
KHSY2052 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3, mec3::G418 
KHSY2053 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.HIS3, mec3::G418 
KHSY2177 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::RECQL4.HIS3 
KHSY2178 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3, 
SGS1/sgs1::RECQL4.HIS3, MEC3/mec3::G418 
KHSY2179 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3, 
SGS1/sgs1::RECQL4.HIS3, MEC3/mec3::G418 
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KHSY2180 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3, 
SGS1/sgs1::RECQL4.HIS3, MEC3/mec3::G418 
KHSY2331 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, lig4::loxP-G418-loxP 
KHSY2583 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY2584 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY2590 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
SGS1/sgs1::loxP-kanMX6 
KHSY2591 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
SGS1/sgs1::loxP-kanMX6 
KHSY2592 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
SGS1/sgs1::loxP-kanMX6 
KHSY2596 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1::RECQL1.HIS3 
KHSY2597 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1::RECQL1.HIS3 
KHSY2598 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1::RECQL1.HIS3 
KHSY2599 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3 
KHSY2600 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3 
KHSY2601 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3 
KHSY2602 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, sgs1::loxP-kanMX6/sgs1::loxP-kanMX6 
KHSY2603 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, sgs1::loxP-kanMX6/sgs1::loxP-kanMX6 
KHSY2604 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, sgs1::loxP-kanMX6/sgs1::loxP-kanMX6 
KHSY2620 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6 
KHSY2621 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6 
KHSY2622 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6 
KHSY2636 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
SGS1/sgs1::RECQL4.HIS3 
KHSY2637 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
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KHSY2638 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
SGS1/sgs1::RECQL4.HIS3 
KHSY2639 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6 
KHSY2640 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6 
KHSY2641 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6 
KHSY2642 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::RECQL1.HIS3/sgs1::RECQL1.HIS3 
KHSY2643 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::RECQL1.HIS3/sgs1::RECQL1.HIS3 
KHSY2644 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::RECQL1.HIS3/sgs1::RECQL1.HIS3 
KHSY2645 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::RECQL4.HIS3 
KHSY2646 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::RECQL4.HIS3 
KHSY2647 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::RECQL1.HIS3/sgs1::RECQL4.HIS3 
KHSY2674  
KHSY2675 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, Δsgs1::RECQL4.HIS3 
KHSY2676 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, sgs1::RECQL4.HIS3 
KHSY2677 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, sgs1::RECQL4.HIS3 
KHSY2678 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, sgs1::RECQL4.HIS3 
KHSY2679 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, sgs1::RECQL4.HIS3 
KHSY2723 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/SGS1.myc.HIS3 
KHSY2724 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/SGS1.myc.HIS3 
KHSY2725 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/SGS1.myc.HIS3 
KHSY2726 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C200.myc.HIS3 
KHSY2727 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C200.myc.HIS3 
KHSY2728 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C200.myc.HIS3 
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KHSY2732 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::sgs1-hd.myc.HIS3/SGS1 
KHSY2733 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::sgs1-hd.myc.HIS3/SGS1 
KHSY2734 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::sgs1-hd.TRP1/SGS1 
KHSY2735 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::sgs1-hd.TRP1/SGS1 
KHSY2736 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::sgs1-hd.TRP1/SGS1 
KHSY2791 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
KHSY2792 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
KHSY2793 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
KHSY2794 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
KHSY2795 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.TRP1 
KHSY2796 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.TRP1 
KHSY2797 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.TRP1 
KHSY2798 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::sgs1-hd.TRP1 
KHSY2799 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C200.myc.HIS3 
KHSY2826 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C200.myc.HIS3 
KHSY2827 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C200.myc.HIS3 
KHSY2828 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1C200.myc.HIS3 
KHSY2829 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1C200.myc.HIS3 
KHSY2830 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1C200.myc.HIS3 
KHSY2831 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1::sgs1-hd.TRP1 
KHSY2832 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1::sgs1-hd.TRP1 
KHSY2833 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1::sgs1-hd.TRP1 
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KHSY2837 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1C300.myc.HIS3 
KHSY2838 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1C300.myc.HIS3 
KHSY2860 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.myc.TRP 
KHSY2861 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL1.myc.TRP1 
KHSY2867 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL4.myc.TRP1 
KHSY2868 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL4.myc.TRP1 
KHSY2869 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL4.myc.TRP1 
KHSY2880 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC300 
KHSY2881 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC300 
KHSY2882 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC300 
KHSY2883 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC400 
KHSY2884 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC400 
KHSY2885 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC400 
KHSY2886 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC500 
KHSY2887 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC500 
KHSY2888 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC500 
KHSY2889 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC600 
KHSY2890 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC600 
KHSY2891 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC600 
KHSY2892 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC700 
KHSY2893 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC700 
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KHSY2894 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC700 
KHSY2895 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800 
KHSY2896 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800 
KHSY2897 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800 
KHSY2898 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1C1428.myc.His3 
KHSY2899 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC1428 
KHSY2928 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC400 
KHSY2929 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC400 
KHSY2930 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC400 
KHSY2931 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC500 
KHSY2932 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC500 
KHSY2933 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC500 
KHSY2934 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC600 
KHSY2935 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC600 
KHSY2936 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC600 
KHSY2937 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC700 
KHSY2938 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC700 
KHSY2939 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC700 
KHSY2940 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC800 
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KHSY2941 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC800 
KHSY2942 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC800 
KHSY2943 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1428 
KHSY2944 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1428 
KHSY2945 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1428 
KHSY3130 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ 
KHSY3131 MATα, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ 
KHSY3181 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC1100 
KHSY3182 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC1100 
KHSY3183 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC1100 
KHSY3184 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN100 
KHSY3185 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN100 
KHSY3186 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN100 
KHSY3187 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN100 
KHSY3188 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN100 
KHSY3189 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN100 
KHSY3190 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/N647-SGS1-C-BLM  
KHSY3191 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/N647-SGS1-C-BLM  
KHSY3192 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/N647-SGS1-C-BLM  
KHSY3203 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3204 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
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KHSY3205 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3206 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3207 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3208 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3209 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3210 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3211 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::PGAL1.TRP.blm-K695R.HIS3 
KHSY3212 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::PGAL1.TRP.blm-K695R.HIS3 
KHSY3213 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::PGAL1.TRP.blm-K695R.HIS3 
KHSY3214 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3::TRP1/YEL069C::URA3, 
SGS1/sgs1::blm.K695R.HIS3 
KHSY3215 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3::TRP1/YEL069C::URA3, 
SGS1/sgs1::blm.K695R.HIS3 
KHSY3216 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3::TRP1/YEL069C::URA3, 
SGS1/sgs1::blm.K695R.HIS3 
KHSY3217 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3 
KHSY3218 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.TRP1.SGS1 
KHSY3219 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.TRP1.SGS1 
KHSY3220 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.TRP1.SGS1 
KHSY3221 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN700 
KHSY3222 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔN700 
KHSY3329 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Δsgs1::BLM.HIS3 
KHSY3330 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::BLM.HIS3 
KHSY3331 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::BLM.HIS3 
KHSY3332 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::BLM.HIS3 
KHSY3333 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::BLM.HIS3 
KHSY3334 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::BLM.HIS3 
KHSY3335 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3336 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3337 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3338 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3339 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
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KHSY3340 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3341 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3342 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3 
KHSY3355 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY3356 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3357 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3358 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3359 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY3360 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY3361 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY3362 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY3363 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418 
KHSY3364 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418 
KHSY3365 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418 
KHSY3366 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418 
KHSY3367 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::ura3::TRP1, BLM.myc.G418.HIS3 
KHSY3368 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::ura3::TRP1, BLM.myc.G418.HIS3 
KHSY3369 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::ura3::TRP1, BLM.myc.G418.HIS3 
KHSY3370 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::ura3::TRP1, BLM.myc.G418.HIS3 
KHSY3374 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.G418.BLM.HIS3 
KHSY3375 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.G418.BLM.HIS3 
KHSY3376 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.G418.BLM.HIS3 
KHSY3377 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Pgal.G418.BLM.HIS3 
KHSY3429 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1100 
KHSY3430 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1100 
KHSY3431 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1100 
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KHSY3432 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::BLM.HIS3/sgs1::BLM.HIS3 
KHSY3433 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::BLM.HIS3/sgs1::BLM.HIS3 
KHSY3434 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::BLM.HIS3/sgs1::BLM.HIS3 
KHSY3435 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::BLM.HIS3/sgs1::BLM.HIS3 
KHSY3436 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1428.myc.HIS3 
KHSY3437 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1428.myc.HIS3 
KHSY3438 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1428.myc.HIS3 
KHSY3439 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1100.myc.HIS3 
KHSY3440 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1100.myc.HIS3 
KHSY3441 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1000.myc.HIS3 
KHSY3442 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1000.myc.HIS3 
KHSY3443 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC1000.myc.HIS3 
KHSY3444 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC900.myc.HIS3 
KHSY3445 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC900.myc.HIS3 
KHSY3446 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC900.myc.HIS3 
KHSY3447 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC800.myc.HIS3 
KHSY3448 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC800.myc.HIS3 
KHSY3449 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC700.myc.HIS3 
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KHSY3450 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC700.myc.HIS3 
KHSY3451 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC700.myc.HIS3 
KHSY3452 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC600.myc.HIS3 
KHSY3453 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC600.myc.HIS3 
KHSY3454 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC500.myc.HIS3 
KHSY3455 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC500.myc.HIS3 
KHSY3456 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC500.myc.HIS3 
KHSY3457 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC400.myc.HIS3 
KHSY3458 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC400.myc.HIS3 
KHSY3459 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC300.myc.HIS3 
KHSY3460 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/sgs1ΔC300.myc.HIS3 
KHSY3461 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/SGS1.myc.HIS3 
KHSY3462 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
PGAL.G418.BLM.HIS3/SGS1.myc.HIS3 
KHSY3525 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800.myc.HIS3, MEC3/mec3::G418 
KHSY3526 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800.myc.HIS3, MEC3/mec3::G418 
KHSY3527 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800.myc.HIS3, MEC3/mec3::G418 
KHSY3528 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
KHSY3529 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
KHSY3530 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
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KHSY3531 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
KHSY3532 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3533 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3534 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3535 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3536 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
KHSY3537 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
KHSY3538 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC1000 
KHSY3539 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3540 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3541 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3542 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1::loxP-kanMX6/sgs1ΔC900 
KHSY3548 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C800.myc.His3, mec3::G418 
KHSY3549 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C800.myc.His3, mec3::G418 
KHSY3550 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C800.myc.His3, mec3::G418 
KHSY3551 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C800.myc.His3, mec3::G418 
KHSY3552 
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, 
lig4::loxP-G418-loxP 
pBDC-RECQL4 
KHSY3553 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, yKu70::HIS3 pYES3-BLM 
KHSY3554 
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, 
lig4::loxP-G418-loxP 
pBDC-RECQL1 
KHSY3566 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::blm.HD.HIS3 
KHSY3604 
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KHSY3605 
















trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
pBDC.RECQL4 
KHSY3610 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3 
KHSY3611 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3 
KHSY3686 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL1.HIS3 
KHSY3687 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3 
KHSY3688 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3 
KHSY3689 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3 
KHSY3690 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL1.HIS3, MEC3/Δmec3::G418 
KHSY3691 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL1.HIS3, MEC3/Δmec3::G418 
KHSY3692 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL1.HIS3, MEC3/Δmec3::G418 
KHSY3693 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418 
KHSY3694 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418 
KHSY3695 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418 
KHSY3696 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418 
KHSY3697 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418 
KHSY3698 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418 
KHSY3699 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::G418.PGAL.blm.HD.HIS3 
KHSY3700 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::G418.PGAL.blm.HD.HIS3 
KHSY3701 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::G418.PGAL.blm.HD.HIS3 
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KHSY3702 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::G418.PGAL.blm.HD.HIS3 
KHSY3703 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL1.HIS3, Δmec3::G418 
KHSY3704 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL1.HIS3, Δmec3::G418 
KHSY3705 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL1.HIS3, Δmec3::G418 
KHSY3706 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL1.HIS3, Δmec3::G418 
KHSY3707 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3708 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3709 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3710 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3711 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3712 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3713 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3714 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-RECQL4.HIS3, Δmec3::G418 
KHSY3715 
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,  
pYES3-BLM 
KHSY3723 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418 
KHSY3724 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418 
KHSY3725 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl, 
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418 
KHSY3726 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3727 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3728 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3729 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3730 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL1.myc.G418.HIS3 
KHSY3731 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3732 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3733 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
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KHSY3734 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3735 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3736 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3737 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL1.HIS3 
KHSY3738 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL1.HIS3 
KHSY3739 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL1.HIS3 
KHSY3740 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3741 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3742 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3743 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3744 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3745 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3746 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3747 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3748 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3749 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3750 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3751 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3752 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL5.HIS3 
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KHSY3753 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3754 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::BLM.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3755 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3756 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3757 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3758 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3759 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL5.HIS3 
KHSY3760 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::RECQL5.HIS3 
KHSY3761 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::RECQL5.HIS3 
KHSY3762 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/Δsgs1::RECQL5.HIS3 
KHSY3763 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418 
KHSY3764 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418 
KHSY3765 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418 
KHSY3766 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418 
KHSY3767 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3768 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3769 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3770 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3771 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3772 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3773 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3774 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3775 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL4.myc.G418.HIS3 
KHSY3776 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::G418.PGAL1.RECQL4.myc.TRP1 
KHSY3777 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL5.HIS 
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KHSY3778 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL5.HIS 
KHSY3779 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL5.HIS 
KHSY3780 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL5.HIS 
KHSY3781 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::RECQL5.HIS 
KHSY3788 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3789 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3790 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL4.HIS3 
KHSY3808 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3809 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3810 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3811 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3812 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3813 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3814 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3815 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3816 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C1428.myc.His3 
KHSY3817 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C1428.myc.His3 
KHSY3818 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1C1428.myc.His3 
KHSY3819 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY3820 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3 
KHSY3821 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(D1064V)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3822 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(D1064V)ΔN647.HIS3, MEC3/Δmec3::G418 
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KHSY3823 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(D1064V)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3824 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(C1055S)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3825 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(C1055S)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3826 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(C1055S)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3827 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3 
KHSY3828 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3 
KHSY3829 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3 
KHSY3888 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1C1428.myc.His3/sgs1C1428.myc.His3 
KHSY3889 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1C1428.myc.His3/sgs1C1428.myc.His3 
KHSY3890 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1C1428.myc.His3/sgs1C1428.myc.His3 
KHSY3891 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL5.HIS3 
KHSY3892 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL5.HIS3 
KHSY3893 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3894 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3895 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3896 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3897 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3898 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3 
KHSY3899 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418 
KHSY3900 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418 
KHSY3901 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418 
KHSY3902 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418 
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KHSY3903 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418 
KHSY3904 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418 
KHSY3905 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418 
KHSY3906 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418 
KHSY3907 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3908 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3909 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3910 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3 
KHSY3911 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3 
KHSY3912 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3913 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3 
KHSY3914 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3 
KHSY3915 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3 
KHSY3916 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3 
KHSY3953 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3 
KHSY3954 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(C1036F)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3955 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(C1036F)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3956 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(C1036F)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3957 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3958 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3959 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3960 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3961 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
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KHSY3962 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3963 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3964 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418 
KHSY3965 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(R717T)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3966 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(Q752H)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3967 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(P868L)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3968 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(P868L)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3969 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3970 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3971 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418 
KHSY3972 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418 
KHSY3973 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418 
KHSY3974 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418 
KHSY3975 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418 
KHSY3976 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418 
KHSY3977 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418 
KHSY3978 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418 
KHSY3979 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418 
KHSY3980 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418 
KHSY3981 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418 
KHSY3982 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418 
KHSY3989 
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KHSY3991 








ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3994 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY3995 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418 
KHSY4063 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418 
KHSY4064 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418 
KHSY4065 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418 
KHSY4066 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418 
KHSY4067 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418 
KHSY4068 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418 
KHSY4069 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418 
KHSY4070 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418 
KHSY4071 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418 
KHSY4072 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1014R)ΔN647.HIS3 
KHSY4073 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(A1043D)ΔN647.HIS3 
KHSY4074 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(E1143K)ΔN647.HIS3 
KHSY4075 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4076 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4077 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(E1213K)ΔN647.HIS3 
KHSY4078 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(E1213K)ΔN647.HIS3 
KHSY4079 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3 
KHSY4080 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3 
KHSY4081 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3 
KHSY4082 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(XL-47-3)ΔN647.HIS3 
KHSY4083 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(XL-47-3)ΔN647.HIS3 
KHSY4084 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(XL-48-15)ΔN647.HIS3 
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KHSY4085 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(I658T)ΔN647.HIS3 
KHSY4086 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(I658T)ΔN647.HIS3 
KHSY4087 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3 
KHSY4088 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3 
KHSY4089 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3 
KHSY4090 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3 
KHSY4091 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3 
KHSY4092 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R791C)ΔN647.HIS3 
KHSY4093 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R791C)ΔN647.HIS3 
KHSY4094 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R791C)ΔN647.HIS3 
KHSY4095 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4096 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4097 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3 
KHSY4098 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3 
KHSY4099 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(F857L)ΔN647.HIS3 
KHSY4100 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K755E)ΔN647.HIS3 
KHSY4101 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3 
KHSY4102 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3 
KHSY4103 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(S778C)ΔN647.HIS3 
KHSY4104 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(S778C)ΔN647.HIS3 
KHSY4105 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y995H)ΔN647.HIS3 
KHSY4106 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y995H)ΔN647.HIS3 
KHSY4127 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4128 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4129 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4130 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4131 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
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KHSY4132 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4133 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(P690L)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4134 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(P690L)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4135 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4136 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP 
KHSY4137 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/mec3::G418 
KHSY4138 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/mec3::G418 
KHSY4139 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418 
KHSY4140 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418 
KHSY4141 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, MEC3/mec3::G418 
KHSY4142 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, MEC3/mec3::G418 
KHSY4143 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, MEC3/mec3::G418 
KHSY4144 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, MEC3/mec3::G418 
KHSY4147 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K1133E)ΔN647.HIS3 
KHSY4148 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4149 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4150 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418 
KHSY4151 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418 
KHSY4152 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418 
KHSY4153 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418 
KHSY4154 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418 
KHSY4155 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418 
KHSY4233 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(H660Y)ΔN647.HIS3 
KHSY4234 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P707S)ΔN647.HIS3 
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KHSY4235 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P707S)ΔN647.HIS3 
KHSY4236 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Q752H)ΔN647.HIS3 
KHSY4237 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Q752H)ΔN647.HIS3 
KHSY4238 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Q752H)ΔN647.HIS3 
KHSY4239 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(T843I)ΔN647.HIS3 
KHSY4240 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(T843I)ΔN647.HIS3 
KHSY4241 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K873N)ΔN647.HIS3 
KHSY4242 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K873N)ΔN647.HIS3 
KHSY4243 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K873N)ΔN647.HIS3 
KHSY4244 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K873N)ΔN647.HIS3 
KHSY4245 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120E)ΔN647.HIS3 
KHSY4246 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120E)ΔN647.HIS3 
KHSY4247 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R1331G)ΔN647.HIS3 
KHSY4248 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R1331G)ΔN647.HIS3 
KHSY4249 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Q1387K)ΔN647.HIS3 
KHSY4250 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(A1043D)ΔN647.HIS3 
KHSY4251 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(A1043D)ΔN647.HIS3 
KHSY4252 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K1133E)ΔN647.HIS3 
KHSY4253 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(E1143K)ΔN647.HIS3 
KHSY4254 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(K755E)ΔN647.HIS3 
KHSY4255 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(F857L)ΔN647.HIS3 
KHSY4256 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G972V)ΔN647.HIS3.MYC.TRP1 
KHSY4257 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(W803R)ΔN647.HIS3.MYC.TRP1 
KHSY4258 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3.MYC.TRP1 
KHSY4259 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R791C)ΔN647.HIS3.MYC.TRP1 
KHSY4260 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1 
KHSY4261 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1 
KHSY4262 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1 
KHSY4263 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1 
KHSY4264 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1 
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KHSY4265 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1 
KHSY4266 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1 
KHSY4267 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1 
KHSY4268 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1 
KHSY4269 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(F857L)ΔN647.HIS3.MYC.TRP1 
KHSY4270 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(F857L)ΔN647.HIS3.MYC.TRP1 
KHSY4271 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(F857L)ΔN647.HIS3.MYC.TRP1 
KHSY4272 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3.MYC.TRP1 
KHSY4273 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3.MYC.TRP1 
KHSY4274 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3.MYC.TRP1 
KHSY4275 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1 
KHSY4276 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1 
KHSY4277 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1 
KHSY4278 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1 
KHSY4290 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3 
KHSY4291 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R717T)ΔN647.HIS3 
KHSY4292 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4293 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Q752H)ΔN647.HIS3 
KHSY4294 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(Q752H)ΔN647.HIS3 
KHSY4295 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R791C)ΔN647.HIS3 
KHSY4296 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(R791C)ΔN647.HIS3 
KHSY4297 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3 
KHSY4298 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(P690L)ΔN647.HIS3 
KHSY4299 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4300 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4301 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3 
KHSY4302 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(D1064V)ΔN647.HIS3 
KHSY4303 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3 
KHSY4304 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HD.HIS3 
KHSY4305 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
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KHSY4306 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY4307 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4308 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4309 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4311 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3 
KHSY4312 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(C1036F)ΔN647.HIS3 
KHSY4313 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3 
KHSY4314 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3 
KHSY4315 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3 
KHSY4316 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3 
KHSY4317 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4318 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4319 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4320 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4321 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4322 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4323 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4324 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4325 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3 
KHSY4326 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3 
KHSY4327 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4328 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
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KHSY4329 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4330 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4331 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4332 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4333 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4334 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4335 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4336 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4337 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4338 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4339 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4340 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4341 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4342 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4343 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4344 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4345 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4346 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4347 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4348 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
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KHSY4349 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4350 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSY4351 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4352 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4353 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1055S)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4590 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120R)ΔN647.HIS3 
KHSY4591 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120R)ΔN647.HIS3 
KHSY4592 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120R)ΔN647.HIS3 
KHSY4593 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3, sgs1ΔC800-blm(G1120R)ΔN647.HIS3 
KHSY4594 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1055S)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4595 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1055S)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3 
KHSY4596 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(C1036F)ΔN647.HIS3 
KHSY4597 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(C1036F)ΔN647.HIS3 
KHSY4598 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3 
KHSY4599 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3 
KHSY4600 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(K695R)ΔN647.HIS3 
KHSY4601 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(K695R)ΔN647.HIS3 
KHSY4602 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4603 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3 
KHSY4604 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
KHSY4605 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3 
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KHSY4606 
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, 
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, 
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3 
KHSYR1-1 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL1 
KHSYR1-2 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL1 
KHSYR1-3 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL1 
KHSYR4-1 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL4 
KHSYR4-2 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL4 
KHSYR4-3 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3, 
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL4 
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Oligo # Oligo Name Sequence 
1029 1029-TRP1-5'Chk GCCAACCAAGTATTTCGGAGTGCC 
1030 1030-TRP1-3'Chk GGCACTCCGAAATACTTGGTTGGC 
1031 1031-HIS3-5'Chk TCGAGTGCTCTATCGCTAGGGGACC 
1032 1032-HIS3-3'Chk AGTGCGTTCAAGGCTCTTGCGGTTG 
1033 1033-G418-5'Chk TAATCGCGGCCTCGAAACGTGAGTC 
1034 1034-G418-3'Chk AATAGGTTGTATTGATGTTGGACG 
1043 1043-SGS1PGAL-F CTGATCTAAAAGCTGATATACGGATCAATAGAGGGCACTTAGCAGGCTGGGAATTCGAGCTCGTTTAAAC 
1044 1044-SGS1PGAL-R TCCTTTAACCATTTGTGCTCCCATCTTAAGTTATGTGACGGCTTCGTCACCATTTTGAGATCCGGGTTTT 
1045 1045-SGS1CONFIRM GGTTGATATACCAGCCAGCA 
1066 1066-BLM-F ATGGCTGCTGTTCCTCAAAA 
1067 1067-BLM-R TTATGAGAATGCATATGAAG 
1116 1116-BLM-F ATTATTGTTGTATATATTTAAAAAATCATACACGTACACACAAGGCGGTAATGGCTGCTGTTCCTCAAAA 
1117 1117-BLM-R TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTATTTTTCTACTCTTTATGAGAATGCATATGAAG 
1118 1118-UNIV-F GAGCAGATTGTACTGAGAGTGCACC 
1119 1119-UNIV-R CTCCTTACGCATCTGTGCGGTATTTC 
1143 1143-SGS1-5'chk CTGGGTGATCATTGGTGATAC 
1144 1144-SGS1-3'chk GCACACCACAATATGTCGTG 
1187 1187-SGS1-UNIV-D TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTATTTTTCTACTCTGAGCAGATTGTACTGAGAGTGCACC 
1189 1189-BLM-confirm CAAAGTGACTTTGGGGTGGTG 
1211 1211-BLM-F-tag CACCGAAGCCTATAAATAGACCGTTTCTTAAGCCTTCATATGCATTCTCACGGATCCCCGGGTTAATTAA 
1212 1212-BLM-R-tag TAATTTCAGATGCTGACAAACAAGAAAGAGGGTCTATGTACATTGAGATTGAATTCGAGCTCGTTTAAAC 
1213 1213 BLM-tag confirm GTGCCGCTGAGGAGCTTGAC 
1224 1224-BLM-Pgal-R GAGTGACGTTCTAGTTGCTCCTGTAGATTATTTTGAGGAACAGCAGCCATCATTTTGAGATCCGGGTTTT 
1229 1229-RecQ1-seq TGCAAGTGACAAAGTCCACG 
1230 1230-RecQ4-seq AGGAGAAGTTCTCCAGCAGG 
1233 1233-SGS1-int GAACACCCACCACCATCTTG 
1236 1236-UNIV-XhoI-F CAATCTCGAGGAGCAGATTGTACTGAGAGTGCACC 
1237 1237-UNIV-XhoI-R CAATCTCGAGCTCCTTACGCATCTGTGCGGTATTTC 
1240 1240-RECQ5-INT AGTCCGTGAAGAAGGTAC 
1245 1245-RECQL1-INT-F TTGGCGATTGGTGTCGTAGTTATAAGTAACACTATTTATTTTTCTACTCTATGGCGTCCGTTTCAGCTCT 
1246 1246-RECQL1-INT-R ATTATTGTTGTATATATTTAAAAAATCATACACGTACACACAAGGCGGTAATGGGAGCAGATTGTACTGAGAGT 
1253 1253-RECQL4-KI-F TTGGCGATTGGTGTCGTAGTTATAAGTAACACTATTTATTTTTCTACTCTATGACCAGGAAGCAACGGGA 
1254 1254-RECQL4-KI-R ATTATTGTTGTATATATTTAAAAAATCATACACGTACACACAAGGCGGTAATGGGAGCAGATTGTACTGAGAGT 
1256 1256-SGS1-Seq1 ATGGTGACGAAGCCGTCACA 
1257 1257-SGS1-Seq2  GTATAGGCAAACAGCTCGAA 
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1258 1258-SGS1-Seq3 ACTGTGACCCTCCTGTAATA 
1259 1259-SGS1-Seq4 GTTCCCTCAAATGGCCAAAA 
1260 1260-SGS1-Seq5 GAGGAAGACGATTTTGATGA 
1261 1261-SGS1-Seq6 GAAGTCTTTAAACTGCCTGG 
1262 1262-SGS1-Seq7 CTGCAAGTGAACAAGTCAGA 
1263 1263-SGS1-Seq8 GCAGACAATGATCCAGAAGG 
1264 1264-SGS1-Seq9 GCTGACTGGAAAAATGGAGA 
1265 1265-SGS1-Seq10 GATCAAGCGAGGATCATGAA 
1266 1266-SGS1-Seq11 CCGAGGTCACTACAGAGGAA 
1267 1267-SGS1-Seq12R TAACCATTTGTGCTCCCTTC 
1268 1268-SGS1-Seq13R CTTGAAGGCGGATCACCTCT 
1269 1269-RECQL4-F1 ATGACCAGGAAGCAACGGGA 
1270 1270-RECQL4-F2 CCTGCACGCAGCCTGGGTCC 
1271 1271-RECQL4-F3 CCCCAGGACCCAGAAGGGTC 
1272 1272-RECQL4-F4 GGCCGTGTGCAGGCCCGGGA 
1273 1273-RECQL4-R1 GTGCGGCGTGTGGCTGTGGC 
1274 1274-RECQL1-F1 ATGGCGTCCGTTTCAGCTCT 
1275 1275-RECQL1-F2 GGAGCATGTTAAATGGGTTC 
1276 1276-RECQL1-F3 TGCAGAATCTGGGAATTCAT 
1277 1277-RECQL1-F4 GCAGGCAGAGGAACTGAATG 
1278 1278-RECQL1-R1 CCAGTTTAAAGACATTTTGC 
1279 1279-RECQL1-Pgal-R AGCTCACTGGTTATAGAATCCAGTTCCTCAGTTAGAGCTGAAACGGACGCCATTTTGAGATCCGGGTTTT 
1280 1280-RECQL4-Pgal-R ACCTGGGCTGCCCGAATCTTCTGCAGGACAGATTCCCGTTGCTTCCTGGTCATTTTGAGATCCGGGTTTT 
1281 1281-RECQL1-tag-F CTGGTTCTAAGAATACAGGAGCTAAGAAAAGAAAAATCGATGATGCCCGGATCCCCGGGTTAATTAA 
1282 1282-RECQL4-tag-F ATGCCCTGGTGGGCCTGGCCACGGAAGAGCTCCTGCAGGTGGCCCGCCGGATCCCCGGGTTAATTAA 
1283 1283-RECQL1/4-tag-R ACTGAAGACTGCGGGATTGCTCTCGGTCAAGCTTTTAAAGAGGCCCTACTGAATTCGAGCTCGTTTAAAC 
1300 1300-RECQL1-F5 CTACAGGAGGTGGAAAGAGC 
1301 1301-RECQL1-F6 CTGCTGTAGTCAGTGGGGAC 
1302 1302-RECQL4-F5 TCAAGAGGCTGAGCAGCTTA 
1357 1357-RECQL4+1051 AAAGCCTGTACGGTAAGCTG 
1367 1367-BS-Q673R-F GCATAATTTTAGAACTAATCGGCTAGAGGCGATCAATGCTGC 
1368 1368-BS-Q673R-R GCAGCATTGATCGCCTCTAGCCGATTAGTTCTAAAATTATGC 
1369 1369-BS-C878R-F GCCTAAAAAGGTGGCATTTGATCGCCTAGAATGGATCAGAAAGC 
1370 1370-BS-C878R-R GCTTTCTGATCCATTCTAGGCGATCAAATGCCACCTTTTTAGGC 
1371 1371-BS-H963Y-F CGGACGTGCGATTTGTGATTTATGCATCTCTCCCTAAATCTGTGG 
1372 1372-BS-H963Y-R CCACAGATTTAGGGAGAGATGCATAAATCACAAATCGCACGTCCG 
1373 1373-BS-C1036F-F CTGTGAAAATATAACAGAATTCAGGAGAATACAGCTTTTGGCC 
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1374 1374-BS-C1036F-R GGCCAAAAGCTGTATTCTCCTGAATTCTGTTATATTTTCACAG 
1375 1375-BS-C1055S-F AATGGATTTAATCCTGATTTTTCTAAGAAACACCCAGATGTTTC 
1376 1376-BS-C1055S-R GAAACATCTGGGTGTTTCTTAGAAAAATCAGGATTAAATCCATT 
1377 1377-BS-C1055G-F AATGGATTTAATCCTGATTTTGGTAAGAAACACCCAGATGTTTC 
1378 1378-BS-C1055G-R GAAACATCTGGGTGTTTCTTACCAAAATCAGGATTAAATCCATT 
1379 1379-BS-C1055R-F AATGGATTTAATCCTGATTTTCGTAAGAAACACCCAGATGTTTC 
1380 1380-BS-C1055R-R GAAACATCTGGGTGTTTCTTACGAAAATCAGGATTAAATCCATT 
1381 1381-BS-C1066Y-F CAGATGTTTCTTGTGATAATTACTGTAAAACAAAGGATTATAAA 
1382 1382-BS-C1066Y-R TTTATAATCCTTTGTTTTACAGTAATTATCACAAGAAACATCTG 
1383 1383-BS-D1063V-F CACCCAGATGTTTCTTGTGTTAATTGCTGTAAAACAAAGGATTA 
1384 1384-BS-D1063V-R TAATCCTTTGTTTTACAGCAATTAACACAAGAAACATCTGGGTG 
1415 1415-RECQL4+1092 GGTAGCACAGCAAAGTCTCG 
1416 1416-RECQL4+1153 ACGGCAATGGGTATAGGT 
1417 1417-BLM-seq-F1 CAAGACAGACTGTCTTCCAG 
1418 1418-BLM-seq-F2 CACGTTTTGTTATTGATGAA 
1419 1419-BLM-seq-R3 GTGTCGTGAATAAGCAGATC 
1420 1420-BLM-seq-F4 TCAAAAGATCTTTTGTCAAA 
1421 1421-BLM-seq-R5 CTGACACATTAGTTACAGAT 
1422 1422-BLM-seq-F6 CTGGGCTGAAACACCAAGAC 
1423 1423-BLM-seq-F7 CTGTCCAGCAGCAGAGGCCC 
1436 1436-BS-K695T-F TGATGCCGACTGGAGGTGGTACGAGTTTGTGTTACCAGCTCCC 
1437 1437-BS-K695T-R   GGGAGCTGGTAACACAAACTCGTACCACCTCCAGTCGGCATCA 
1438 1438-BS-K695A-F TGATGCCGACTGGAGGTGGTAGGAGTTTGTGTTACCAGCTCCC 
1439 1439-BS-K695A-R   GGGAGCTGGTAACACAAACTCCTACCACCTCCAGTCGGCATCA 
1445 1445-BLM-seq-F9 CTGCTTTTCTATACCTATCA 
1533 1533 - SGS1 PGAL R  TCCTTTAACCATTTGTGCTCCCTTCTTAAGTTATGTGACGGCTTCGTCACCATTTTGAGATCCGGGTTTT 
1534 1534 - SGS1 5’ Chk for PGAL  GCAATGCACATATAACAAGA 
1559 1559-BLM SEQ REV GCTGTAAACTTATCTGTCTA 
1562 1562-pOBD2-RECQL1 F AAGATACCCCACCAAACCCAAAAAAAGAGATCGAATTCCAGCTGACCACCATGGCGTCCGTTTCAGCTCT 
1563 1563-pOBD2-RECQL1 R CTACGATTCATAGATCTCTGCAGGTCGACGGATCCCCGGGAATTGCCATGTCAGGCATCATCGATTTTTC 
1564 1564-pOBD2-RECQL4 F AAGATACCCCACCAAACCCAAAAAAAGAGATCGAATTCCAGCTGACCACCATGACCAGGAAGCAACGGGA 
1565 1565-pOBD2-RECQL4 R  CTACGATTCATAGATCTCTGCAGGTCGACGGATCCCCGGGAATTGCCATGTCAGCGGGCCACCTGCAGGA 
1568 1568-BLM YES3-R no-stop TAAGGCGGCCGCTTTGAGAATGCATATGAAGGCT 
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1569 1569-BLM YES3-R TAAGGCGGCCGCTTTTATGAGAATGCATATGAAG 
1570 1570-BLM YES3-F CTTAGAGCTCATGGCTGCTGTTCCTCAAAA 
1586 1586-SGS1-BLM-647F ATGAGGAAGACGATTTTGATGACGATTTTTCATTAAGTGATATAGTGAGTAGTTTTCCTCATACAAAGGA 




1688 1688-SGS1n647-Recql4 ATGAGGAAGACGATTTTGATGACGATTTTTCATTAAGTGATATAGTGAGTATGACCAGGAAGCAACGGGA 
1690 1690_SGS1n647-recql1 ATGAGGAAGACGATTTTGATGACGATTTTTCATTAAGTGATATAGTGAGTATGGCGTCCGTTTCAGCTCT 
1758 1758-pOAD-spec-F AATACCACTACAATGGATGATG 
1759 1759-pOAD-spec-R TGCACGATGCACAGTTGAAG 
1797 1797-pACT2AD-F AATACCACTACAATGGATGA 
1798 1798-pACT2-R TGAAAAACCCCGCAAGTTCA 
1941 1941-blmR717T-F GTCATTTCTCCCTTGACATCACTTATCGTAGATC 
1942 1942-blmR717T-R GATCTACGATAAGTGATGTCAAGGGAGAAATGAC 
1943 1943-blmQ752H-F CAAATATTTACCTCCACTTATCAAAAAAAGACC 
1944 1944-blmQ752H-R GGTCTTTTTTTGATAAGTGGAGGTAAATATTTG 
1945 1945-blmR791C-F GAGGAAGCTCTTGGCATGTTTTGTTATTGATG 
1946 1946-blmR791C-R CATCAATAACAAAACATGCCAAGAGCTTCCTC 
1947 1947-blmA1043D-F GAATACAGCTTTTGGACTACTTTGGTGAAAATG 
1948 1948-blmA1043D-R CATTTTCACCAAAGTAGTCCAAAAGCTGTATTC 
1949 1949-blmE1213K-F GTGTCTCAGAGGGAAAAGATGGTTAAAAAATG 
1950 1950-blmE1213K-R CATTTTTTAACCATCTTTTCCCTCTGAGACAC 
1951 1951-blmP690L-F GTTTTATCCTGATGCTGACTGGAGGTGGTAA 
1952 1952-blmP960L-R TTACCACCTCCAGTCAGCATCAGGATAAAAC 
1953 1953-blmV1198M-F CAGAAAATTCCAGCAGTATGAAAAAACAAAAAGC 
1954 1954-blmV1198M-R GCTTTTTGTTTTTTCATACTGCTGGAATTTTCTG 
1955 1955-blmH1324Y-F GAAATACCCGTATCTTCCTACTACTTTGCAAGTAAAAC 
1956 1956-blmH1324Y-R GTTTTACTTGCAAAGTAGTAGGAAGATACGGGTATTTC 
1957 1957-blmX47-3F GACTTATAATGATGGAAAAAAGATGGAAACCATCATACAAG 
1958 1958-blmX47-3R CTTGTATGATGGTTTCCATCTTTTTTCCATCATTATAAGTC 
1959 1959-blmX48-15F GTCCAGCAGCAGAGGCCCGGAAGAAGTGCCGCTGAGG 
1960 1960-blmX48-15R CCTCAGCGGCACTTCTTCCGGGCCTCTGCTGCTGGAC 
1961 1961-blmP868L-F GAAATACTATGTATTACTGAAAAAGCCTAAAAAG 
1962 1962-blmP868L-R CTTTTTAGGCTTTTTCAGTAATACATAGTATTTC 
1975 1975-pact2ADF ACCACTACAATGGATGATGT 
2012 2012-AIMP2-5'CHK GGTTTGCGTTGATCACGATG 
2013 2013-AIMP2-3'CHK AACCTTCTCAAGTGCTTTGG 
2043 2043-BLM-658F CAAAGGAAATGATGAAGACTTTTCATAAAAAATTTGG 
2044 2044-BLM-843F GTACAGAAGGACATCCTGATTCAGCTGAAGATTCTCAG 
2045 2045-BLM-1331F CTTTGCAAGTAAAACCGGAAATGAAAGGAAGAGG 
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2046 2046-BLM-778F GCAAGTAACAGACTCATTTGTACTCTGGAGAATCTC 
2047 2047-BLM-995F CCTGCTTTTCTATACCCATCATGATGTGACCAGAC 
2048 2048-BLM-873F ACCGAAAAAGCCTAAAAACGTGGCATTTGATTGCC 
2049 2049-BLM-1387F GCCTCACATACTTCTAAAGCGACATCAGGAGCC 
2050 2050-BLM-1133F GTCAGGTATATTTGGAGAAGGATCTGCTTATTCAC 
2051 2051-BLM-1143F TTCACGACACAATGCCAAAAGACTTTTTAAAAAGC 
2052 2052-BLM-658R CCAAATTTTTTATGAAAAGTCTTCATCATTTCCTTTG 
2053 2053-BLM-843R CTGAGAATCTTCAGCTGAATCAGGATGTCCTTCTGTAC 
2054 2054-BLM-1331R CCTCTTCCTTTCATTTCCGGTTTTACTTGCAAAG 
2055 2055-BLM-778R GAGATTCTCCAGAGTACAAATGAGTCTGTTACTTGC 
2056 2056-BLM-995R GTCTGGTCACATCATGATGGGTATAGAAAAGCAGG 
2057 2057-BLM-873R GGCAATCAAATGCCACGTTTTTAGGCTTTTTCGGT 
2058 2058-BLM-1387R GGCTCCTGATGTCGCTTTAGAAGTATGTGAGGC 
2059 2059-BLM-1133R GTGAATAAGCAGATCCTTCTCCAAATATACCTGAC 
2060 2060-BLM-1143R GCTTTTTAAAAAGTCTTTTGGCATTGTGTCGTGAA 
2073 2073-BLM-803F CACATTGTGTCAGTCAGCGGGGACATGATTTTCGTC 
2074 2074-BLM-811F GATTTTCGTCAAGATTGCAAAAGAATGAATATGC 
2075 2075-BLM-972F CCCTAAATCTGTGGAGGTTTACTACCAAGAATCTG 
2076 2076-BLM-1014F GAAAAAGATGGAAACCATCGTACAAGAGAAACTCACTTC 
2077 2077-BLM-660F GAAATGATGAAGACTTTTTATAAAAAATTTGGCCTG 
2078 2078-BLM-1120F GGTCGACATTTTCTTGGAGAGTAAGAGTGCAAAAATC 
2079 2079-BLM-857F GTGTTTAGCATGAGCTTGAACAGACATAATCTGAAATAC 
2080 2080-BLM-707F CCCTGCCTGTGTTTCTCTTGGGGTCACTGTTGTCATTTC 
2081 2081-BLM-755F CAAATATTTACCTCCAGTTATCAGAAAAAGACCCAATCATAAAAC 
2082 2082-BLM-803R GACGAAAATCATGTCCCCGCTGACTGACACAATGTG 
2083 2083-BLM-811R GCATATTCATTCTTTTGCAATCTTGACGAAAATC 
2084 2084-BLM-972R CAGATTCTTGGTAGTAAACCTCCACAGATTTAGGG 
2085 2085-BLM-1014R GAAGTGAGTTTCTCTTGTACGATGGTTTCCATCTTTTTC 
2086 2086-BLM-660R CAGGCCAAATTTTTTATAAAAAGTCTTCATCATTTC 
2087 2087-BLM-1120R GATTTTTGCACTCTTACTCTCCAAGAAAATGTCGACC 
2088 2088-BLM-857R GTATTTCAGATTATGTCTGTTCAAGCTCATGCTAAACAC 
2089 2089-BLM-707R GAAATGACAACAGTGACCCCAAGAGAAACACAGGCAGGG 
2090 2090-BLM-755R GTTTTATGATTGGGTCTTTTTCTGATAACTGGAGGTAAATATTTG 
2110 2110-BLM-707-F2 CTGCCTGTGTTTCTCTTGGGGTCACTGTTGTCATTTC 
2111 2111-BLM-707-R2 GAAATGACAACAGTGACCCCAAGAGAAACACAGGCAG 
2112 2112-BLM-873-F2 CCGAAAAAGCCTAAAAACGTGGCATTTGATTGCCTAG 
2113 2113-BLM-873-R2 CTAGGCAATCAAATGCCACGTTTTTAGGCTTTTTCGG 
2114 2114-BLM-843-F2 CAGAAGGACATCCTGATTCAGCTGAAGATTCTCAGACC 
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2115 2115-BLM-843-R2 GGTCTGAGAATCTTCAGCTGAATCAGGATGTCCTTCTG 
2116 2116-BLM-660-F2 GAAATGATGAAGATTTTTTATAAAAAATTTGGCCTGC 
2117 2117-BLM-660-R2 GCAGGCCAAATTTTTTATAAAAAATCTTCATCATTTC 
2118 2118-traf3ip1 3'chk TTACAATGTTATTATCCAGC 
2119 2119-traf3ip1 5'chk ACGTGCGGAGCTTCTCTATC 
2120 2120-c10 137 3'chk GTACCTCGGTATTAACAGAC 
2121 2121-c10 137 5'chk GCAGGTGGACGATAACGTTG 
2140 2140-BLM-660F3 CATACAAAGGAAATGATGAAGATTTTTTATAAAAAATTTGGCC 
2141 2141-BLM-660R3 GGCCAAATTTTTTATAAAAAATCTTCATCATTTCCTTTGTATG 
2147 2147 - Sgs1Seq11F  ACCACTACAATGGATGATGT 
2148 2148 - Sgs1Seq12F  TCTGCCCAGCCCCTTGGAAT 
2149 2149 - Sgs1Seq13F  TGCCCATTCCAGCTACATGA 
2150 2150 - Sgs1Seq14F  CTCAGAACAATGCAAGAGAG 
2151 2151 - Sgs1Seq15F  ATAGAATGGTTCCTCCAGTT 
2152 2152 - Sgs1Seq3R  AGGCCTGAAATCGTGGCCCC 
2153 2153 - Sgs1Seq4R  AGTACTTTGGGCAATCCCAT 
2209 2209-blmG1120R-F GTCGACATTTTCTTGAGGAGTAAGAGTGCAA 
2210 2210-blmG1120R-R TTGCACTCTTACTCCTCAAGAAAATGTCGAC 
2287 2287-DNAJC7 CTGCATGGACCGTGCCCTAG 
2288 2288-RORC CTGACAGAGATAGAGCACCT 
2289 2289-CLU CCAGCATCATAGACGAGCTC 
2290 2290-MNAT1 ACAATGTGGATTTGGACAAC 
2291 2291-NISCH GTGCTCATGGGCTACCAGAC 
2292 2292-ACTL7B GTGTGGCGGCTGCACTATGC 
2293 2293-MRPL38 TCCACGGTGCCACCTTTGTG 
2294 2294-PSMB9 GGTATATGGAACCCTGGGAG 
2321 2321-Sgs1-P701L-F GTTTTTGTTCTTATGCTAACAGGGGGTGGTAAATCTC 
2322 2322-sgs1-P701L-R GAGATTTACCACCCCCTGTTAGCATAAGAACAAAAAC 
2323 2323-sgs1-I732T-F GTCATCTCTCCGCTAACTTCCCTGATGCAAGATCAAG 
2324 2324-sgs1-I732T-R CTTGATCTTGCATCAGGGAAGTTAGCGGAGAGATGAC 
2325 2325-sgs1-R804C-F CAGACGGTAAGTTGGCTTGTATTGTTGTAGATGAAG 
2326 2326-sgs1-R804C-R CTTCATCTACAACAATACAAGCCAACTTACCGTCTG 
2327 2327-sgs1-W816R-F CACATTGTGTTTCTAACCGGGGCCACGATTTCAGGC 
2328 2328-sgs1-W816R-R GCCTGAAATCGTGGCCCCGGTTAGAAACACAATGTG 
2329 2329-sgs1-Y824C-F GGGGCCACGATTTCAGGCCTGATTGTAAAGAATTAAAATTTTTC 
2330 2330-sgs1-Y824C-R GAAAAATTTTAATTCTTTACAATCAGGCCTGAAATCGTGGCCCC 
2331 2331-sgs1-F870L-F GTTTTCCTAAAACAAAGTCTTAATAGAACAAATTTG 
2332 2332-sgs1-F870L-R CAAATTTGTTCTATTAAGACTTTGTTTTAGGAAAAC 
2333 2333-sgs1-K881L-F CAAATTTGTATTACGAAGTAAACCTGAAGACCAAAAATACC 
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2334 2334-sgs1-K881L-R GGTATTTTTGGTCTTCAGGTTTACTTCGTAATACAAATTTG 
2335 2335-sgs1-G983V-F GTTCCCCGAACATTAGAAGTCTATTATCAAGAAACCGGCCG 
2336 2336-sgs1-G983V-R CGGCCGGTTTCTTGATAATAGACTTCTAATGTTCGGGGAAC 
2337 2337-sgs1-G1115R-F GCCAAGATGTCTTTAAACGTTCGAGAAGCTCC 
2338 2338-sgs1-G1115R-R GGAGCTTCTCGAACGTTTAAAGACATCTTGGC 
2341 2341-sgs1.P701L-F GTTTTTGTTCTTATGCTAACAGGGGGTGGTAAA 
2342 2342-sgs1.P701L-R TTTACCACCCCCTGTTAGCATAAGAACAAAAAC 
2343 2343-sgs1.I732T-F GTCATCTCTCCGCTAACTTCCCTGATGCAAGATC 
2344 2344-sgs1.I732T-R GATCTTGCATCAGGGAAGTTAGCGGAGAGATGAC 
2345 2345-sgs1.R804C-F GACGGTAAGTTGGCTTGTATTGTTGTAGATG 
2346 2346-sgs1.R804C-R CATCTACAACAATACAAGCCAACTTACCGTC 
2347 2347-sgs1.W816R-F CATTGTGTTTCTAACCGGGGCCACGATTTCAG 
2348 2348-sgs1.W816R-R CTGAAATCGTGGCCCCGGTTAGAAACACAATG 
2349 2349-sgs1.Y824C-F GATTTCAGGCCTGATTGTAAAGAATTAAAAT 
2350 2350-sgs1.Y824C-R ATTTTAATTCTTTACAATCAGGCCTGAAATC 
2351 2351-sgs1.F870L-F CCTAAAACAAAGTTTGAATAGAACAAATTTGTA 
2352 2352-sgs1.F870L-R TACAAATTTGTTCTATTCAAACTTTGTTTTAGG 
2353 2353-sgs1.K881L-F GTATTACGAAGTAAACCTGAAGACCAAAAATACC 
2354 2354-sgs1.K881L-R GGTATTTTTGGTCTTCAGGTTTACTTCGTAATAC 
2355 2355-sgs1.G983V-F CCCCGAACATTAGAAGTCTATTATCAAGAAAC 
2356 2356-sgs1.G983V-R GTTTCTTGATAATAGACTTCTAATGTTCGGGG 
2357 2357-sgs1.G1115R-F CAAGATGTCTTTAAACGTTCGAGAAGCTCCA 
2358 2358-sgs1.G1115R-R TGGAGCTTCTCGAACGTTTAAAGACATCTTG 
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Appendix C: Plasmid Table 
Plasmid ID Description Source 
pRS415 CEN/ARS, LEU2 (Sikorski and Hieter 1989) 
p2823112 pOBT7-RECQL1 Open Biosystems 
p3634266 pOBT7-RECQL4 Open Biosystems 
pKHS229 pFA6a-13Myc-kanMX6 (Longtine, McKenzie et al. 1998) 
pKHS230 pFA6a-13Myc-TRP1 (Longtine, McKenzie et al. 1998) 
pKHS235 pFA6a-kanMX6-PGAL1 (Longtine, McKenzie et al. 1998) 
pKHS236 pFA6a-TRP1-PGAL1 (Longtine, McKenzie et al. 1998) 
pKHS257 pFA-kanMX (Goldstein and McCusker 1999) 
pKHS337 pCR2.1-HIS3MX6  this study 
pKHS338 pOBT7-RECQL1.HIS3 this study 
pKHS339 pOBT7-RECQL1.HIS3 this study 
pKHS340 pOBT7-RECQL1.HIS3 this study 
pKHS344 pOBT7-RECQL4.HIS3 this study 
pKHS345 pOBT7-RECQL4.HIS3 this study 
pKHS346 pOBT7-RECQL4.HIS3 this study 
pKHS392 pBDC (Uetz, Giot et al. 2000) 
pKHS401 pBDC-RECQL1 this study 
pKHS402 pBDC-RECQL1 this study 
pKHS403 pBDC-RECQL4 this study 
pKHS404 pYES3/CT-BLM this study 
pKHS408 pBDC-BLM this study 
pKHS481 pRS415-SGS1  (Mullen, Kaliraman et al. 2000) 
pKHS487 pOAD (Uetz, Giot et al. 2000) 
pKHS560 pRS415-sgs1-P701L  this study 
pKHS562 pRS415-sgs1-I732T this study 
pKHS564 pRS415-sgs1-R804C this study 
pKHS566 pRS415-sgs1-W816R this study 
pKHS567 pRS415-sgs1-Y824R this study 
pKHS569 pRS415-sgs1-F870L  this study 
pKHS572 pRS415-sgs1-K881L  this study 
pKHS574 pRS415-sgs1-G983V  this study 
pKHS577 pRS415-sgs1-G1115R  this study 
pRS303 HIS3 (Sikorski and Hieter 1989) 
pRS304 TRP1 (Sikorski and Hieter 1989) 
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Appendix E: Chapter 4.2 supplementary figures 
 
Figure E.1 Re-evaluation of candidates 1 through 384 obtained from the initial 
screen for RecQL4 interacting proteins  
To reduce the number of false positives the initial 1200 candidates were re-evaluated on 
(from left to right) SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar 
plates. The SC-LEU-TRP agar plates controlled for the presence of both bait and prey 
plasmids, the SC-LEU-TRP-HIS agar plates provided low stringency selection for 
protein-protein interactions, and the SC-LEU-TRP-HIS+3AT agar plates provides a more 
stringent selection for protein-protein interactions. Colonies that appeared on 
SC-LEU-TRP-HIS+3AT agar plates were selected for Western blot analysis to confirm 
expression of the cDNA insert. 
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Figure E.2 Re-evaluation of candidates 385 through 768 obtained from the initial 
screen for RecQL4 interacting proteins  
To reduce the number of false positives the initial 1200 candidates were re-evaluated on 
(from left to right) SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar 
plates. The SC-LEU-TRP agar plates controlled for the presence of both bait and prey 
plasmids, the SC-LEU-TRP-HIS agar plates provided low stringency selection for 
protein-protein interactions, and the SC-LEU-TRP-HIS+3AT agar plates provides a more 
stringent selection for protein-protein interactions. Colonies that appeared on 
SC-LEU-TRP-HIS+3AT agar plates were selected for Western blot analysis to confirm 
expression of the cDNA insert. 
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Figure E.3 Re-evaluation of candidates 769 through 1200 obtained from the initial 
screen for RecQL4 interacting proteins  
To reduce the number of false positives the initial 1200 candidates were re-evaluated on 
(from left to right) SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar 
plates. The SC-LEU-TRP agar plates controlled for the presence of both bait and prey 
plasmids, the SC-LEU-TRP-HIS agar plates provided low stringency selection for 
protein-protein interactions, and the SC-LEU-TRP-HIS+3AT agar plates provides a more 
stringent selection for protein-protein interactions. Colonies that appeared on 
SC-LEU-TRP-HIS+3AT agar plates were selected for Western blot analysis to confirm 







SC-LEU-TRP SC-LEU-TRP-HIS SC-LEU-TRP-HIS+3AT 
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Figure E.3 Western blot analysis of the 166 candidates identified in the screen of 
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Cells were grown to an OD600 = 0.5 in SC-LEU-TRP, and whole- cell extracts were 
prepared from 5 ml of culture (3.5 × 107 cells) by standard TCA extraction to confirm 
expression of DNA activation domain and the testis cDNA library (Foiani, Liberi et al. 
1999). 10 µμl of TCA extract was separated on 10% SDS-PAGE, transferred to a PVDF 
membrane (Bio-Rad), probed with anti-AD monoclonal antibody (Santa Cruz), and 
visualized by chemiluminescence (ECL Plus, GE Healthcare). Molecular weight marker 
(Broad Range) was obtained from Bio-Rad. The table to the right of each blot provides 
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Appendix F: Chapter 6 supplementary figures  
Figures F Patch assay for the analysis of gross-chromosomal rearrangements 
(GCR) 
Panels 1 through 11 show the 1000 independent transformation analyzed by the patch 
assay. The previously described GCR assay (Schmidt, Pennaneach et al. 2006) was 
modified for the purposes of this screen. Yeast transformants harboring mutagenized 
pKHS404 plasmids were positively selected for by plating on SC-TRP agar plates. To 
induce BLM expression from the GAL1 promoter, colonies were picked at random from 
the transformation plate and streaked (1 cm long) on an SC/Gal-TRP plate followed by 
four days of incubation at 30˚C. Each streak was then patched as a 1” by 1” square on a 
fresh SC/Gal-TRP agar plate and incubated for four days. This plate is referred to as the 
master plate and is used to recover the mutated plasmid of interest. The patched plates 
are then replica-plated onto a GCR/Gal agar plate to screen for loss of accumulation of 
GCRs. In this media, dextrose was substituted with galactose.  
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